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Effective early stage drug toxicity testing is imperative to minimize failures in the 
late clinical stages of the drug development process. Two-dimensional (2D) cell cultures 
have been dominantly used in the preclinical phase drug screening; however, it is 
becoming apparent that they cannot adequately estimate actual toxic effects of drug 
molecules due to the limited capability in restoring original cellular behaviors in three-
dimensional (3D) tissues. As a potential solution to improve the predictive power of in 
vitro screening procedures, this dissertation explored a new opportunity of in vitro tissue 
engineering as a part of the drug development process. 
Besides the biological significance in functional tissue formation, here scaffolds 
should be transparent and support standardized tissue growth. Inverted colloidal crystal 
(ICC) hydrogel scaffolds having standardized 3D structure and materials as well as 
retaining a high analytical capability were developed for this purpose. Uniform size 
spherical pore arrays prepared with cell repulsive polyacrylamide promoted homogenous 
HepG2 liver tissue spheroid formation, while the transparent hydrogel matrix allowed 
convenient characterization of cellular processes. The standardized spheroid culture 
model was successfully applied to the in vitro toxicity testing of CdTe and Au 
nanoparticles. Significantly reduced toxic effects were observed compared to the 
conventional 2D culture attributed by tissue-like morphology and cell phenotypic change 
in the spheroid culture.  
xiii 
 
In addition, ICC scaffolds combined with a layer-by-layer (LBL) surface 
modification technique served as a platform for engineering primary lymphoid tissue, i.e. 
bone marrow and thymus. Under dynamic culture condition, floating hematopoietic stem 
cells (HSCs) could travel deep into the scaffold via interconnecting channels, while they 
were temporarily entrapped due to limited channel size and number. As a result, HSCs 
extensively interacted with stromal cells growing along the LBL coated pore surface. 
Such intimate cell-cell and cell-matrix interaction is the key process in HSCs survival and 
differentiation that was substantiated by ex vivo expansion and B-/T-cell differentiation 
of HSCs.  
Overall this thesis introduces a promising application of in vitro tissue 
engineering as a practical and valuable early stage toxicity testing tool. ICC scaffolds 
exhibited unique advantage in preparation of spheroid culture model and lymphoid tissue 
engineering. Standardized in vitro tissue models established in ICC scaffolds substantiate 







1.1. Engineered tissue based in vitro drug testing 
The drug development is a prolonged, expensive and complicate process that 
involves multiple-stage screening: (i) Identification and isolation of promising target 
compounds, (ii) Preclinical stage toxicity and efficacy testing of drug candidate 
molecules based on in vitro cellular assays and animal models, (iii) Clinical trials in 
human subjects, (iv) FDA approval and marketing. Average time and cost for launching a 
single drug is usually 10-12 years and $800 million, respectively.[1] (Figure 1.1A)  
To improve such a long and expensive development process, the pharmaceutical 
industry has prodigiously invested in the development of novel technologies such as high 
throughput-screening (HTS)[2], high content analysis (HCA)[3], systems biology[4] etc. 
However, the low productivity issue remains same. For instance, the pharma industry 
heavily invested in HTS technology which is expected to bring 20-fold improvements in 
throughput, but it has yielded few products[5]. Figure 1.1B also shows that over the last 
several years global R&D expenditure increased almost 4 times, but total number of 
Investigational New Drug (IND) application and their acceptance ratio did not change.[6] 
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Vice versa R&D productivity has actually decreased which in turn sharply 
increases the average costs for a new drug development[7].  
 
Figure 1.1 Current drug development process and low productivity issue. (A)  Typical drug 
development process (B) Increased gap between R&D expenditure and IND application over the 
last few years[6].   
 
One obvious reason of the low efficiency is the lack of effective early stage drug 
testing tools that are indicative of drug’s interactions in a human body. Currently 
pharmaceutical industry exclusively relies on in vitro cell-based assays and animal 
studies in the preclinical stage drug testing. However, they are far limited to predict a 
drug’s behavior and toxicity in the body. For example, although animal models have 
made a significant contribution to drug-target validation, essentially they are different 
species from human. Therefore, they often have markedly different pharmacokinetics. 
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The result of this is that time and money are invested in many potential drugs that 
eventually fail late in the testing process. In fact it is quite common that drug candidates 
can fail as late as clinical trials, after spending huge amount of time and money.[8]  
In addition, in vitro cell-based assays have been performed mostly on 2D culture 
substrates such as micro-well plates, tissue culture flasks, and Petri dishes because of the 
convenience, and high cell viability of 2D culture. These conventional 2D cell culture 
systems notably improved the understanding of basic cell biology, but disadvantages lie 
in the using a 2D substrate. In the body, nearly all tissue cells reside in an extracellular 
matrix (ECM) consisting of a complex 3D fibrous meshwork with a wide distribution of 
fibers and gaps that provide complex biochemical and biophysical signals.[9] 
Additionally, each type of cells is embedded in a considerably different 3D 
microenvironment. For example, osteoblasts are located on the surface of bone in a sheet-
like arrangement of cuboidal cells, hepatocytes are closely packed together in the liver in 
hexagonal shaped lobules, and lymphocytes are individually suspended in circulating 
blood or lymphatic vessels.[10] (Figure 1.3A, D & G) The differential niches of stem 
cells are inherently 3D, and their biochemistry and topology strongly affect the 
differentiation process.[11] Two-dimensional substrates are considerably limited in 
emulating those complex 3D microenvironments due to not only the lack of structural 
architecture but also finite material selections. Furthermore, the adaptation of cells to a 
2D rigid substrate requires a dramatic adjustment by the surviving cells because of the 
lack of the unique ECM environment of each cell type. These drawbacks can alter cell 
metabolism and reduce functionality.[12-14] For that reason, 2D culture substrates not 
only fall short of reproducing the complex and dynamic environments of the body, but 
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also are likely to misrepresent findings by forcing cells to adjust to an artificial flat and 
rigid surface.  
The ideal preclinical drug testing tool would be a 3D human cellular assay that 
allow the drug to be tested on human cells organized in a tissue where cells can interact 
as they would in the body. Recent advances in tissue engineering and stem cell research 
suggest potential to realize this idea. Although conventional tissue engineering aims to 
create functional human tissues for the clinical implantation, faithfully prepared human 
tissues also can be directly used for in vitro drug testing. Small pieces of engineered 
human tissues having intermediate stage physiological or pathphysiological complexity 
can significantly improve the predictive power of preclinical stage drug screening as 
bridging in vitro 2D cell culture and in vivo 3D human tissue. (Figure 1.2) Accompanied 
with significant progress in ex vivo manipulation of human stem cells, e.g. expansion and 
directed differentiation, this approach is becoming more feasible.[15, 16] 
 
 
Figure 1.2 Engineered 3D human tissue based drug testing can fill the gap between in vitro 





1.2. Three-dimensional cell culture matrices 
3D cell culture matrices have been introduced to overcome 2D culture limitations. 
Basically they are porous substrates supporting cell growth, organization, and 
differentiation on or within their structure. There is much more architectural and material 
diversity among 3D matrices than among 2D substrates. In part, such a variety of 
biomatrices is due to the large range of tissues and the need to produce cellular supports 
with different physical appearance, porosity, permeability, mechanical characteristics, 
and nano-scale surface morphology. (Figure 1.3)  A variety of fabrication processes and 
biomaterials have been developed or adapted to meet this array of properties. The chosen 
fabrication process specifically affects the resulting matrix architecture. For example, 
electro-spinning[17] and particulate-leaching[18] methods create fibrous-mesh and 
sponge like structures, respectively. Solid free-form (SFF) fabrication techniques[19] can 
manufacture matrices with specific architectures and properties. In addition to fabrication 
processes, biomaterials have expanded the diversity of 3D cell culture matrices.[20, 21] 
The selection of biomaterial is determined by the selected fabrication technique and by 
the particular application of the 3D matrix. For instance, only a few biodegradable 
polymers are available for the purpose of making implantable 3D matrices.[22] In 
addition, engineering materials and fabrication processes can endow 3D cell culture 
matrices with complex functionalities, such as releasing growth factors that induce 
cellular differentiation.[23-25] New material-processing technologies are being 






Figure 1.3 Comparison of natural cell/tissue morphology cultured on 2D and 3D substrates. 
Natural tissues and cells have distinct 3D organized morphological features; histological images 
of (A) bone and (B) liver[10], and (C) SEM image of thymus[26]. When tissue cells are cultured 
on 2D substrate, they show a similar morphological pattern i.e. stretched; optical microscope 
images of (D) osteoblasts, (E) hepatocytes, and (F) co-culture of lymphocyte-stromal cells[26]. 
Cell morphologies are closer to natural tissue when cultured on 3D matrices; different appearance 
of (G) osteoblasts[27], (H) hepatocytes[28], and (I) mononuclear cells in growing 3D formation.  
 
The eventual goal of artificial 3D cell culture matrix design is to mimic natural 
ECM features sufficiently enough that cells function in the simulated environment as they 
would in vivo. Natural ECM is an intricate interwoven fiber meshwork of collagen and 
elastic fibers, embedded in a highly hydrated gel-like material of glycosaminoglycans, 
proteoglycans, and glycoproteins.[9] The unique compositional and structural 
combination provides appropriate biophysical and biochemical functions, such as 
facilitating the transport of soluble signaling molecules, nutrients, and metabolic wastes, 





3D Matrix Biology 
Natural  
A 
C. Thymus (Immune cells)B. Liver A. Bone 
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stresses.[10] The interaction between cells and ECM is dynamic. For example, ECM 
structure can guide morphological changes and cellular organization[29], and specific 
signaling molecules on ECM can direct cell differentiation into a particular lineage.[30] 
Cells also can respond to their local environment, remodeling local ECM by degrading 
and/or synthesizing new ECM elements.[31] As every tissue has a unique ECM 
environment, 3D cell culture matrix design should imitate certain features of ECM 
specific to each application. Nevertheless, there are also common characteristics to be 
considered, such as high porosity and biocompatibility.[32] In the following section, 
these common features in structural and material aspects will be reviewed focusing on 
structural properties that need to be considered at multiple length scale and essential 
material properties and some functional modification strategies.   
 
1.2.1. Structures 
A multi-scale approach to 3D matrix structure is especially important in 
mimicking living systems, as nature often derives properties from multi-scale or 
hierarchical structures that previously have been difficult to mimic. For example, bone 
has multiple organizational scales that yield superior mechanical properties, from 
interacting nano-scale collagen and hydroxyapatite crystals to micro-scale lamella and 
osteons.[10]  With a growing variety of techniques to manipulate natural and synthetic 
materials, matrix design has become increasingly precise from the macro- to nano-scale. 
Multiple levels of structural control allow for the engineering of unique properties 
including matrix size and shape, pore size and geometry, porosity, pore interconnectivity, 
and surface topology. Here, the multiple scales accessible to 3D matrix design are 
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defined in three categories: macro-scale (10-1 ~ 10-3 m), micro-scale (10-3 ~ 10-6 m) and 
nano-scale (10-6 ~ 10-9 m).   
Macro-scale design 
The macro-scale structure (10-1 ~ 10-3 m) determines such properties of a 3D 
matrix as size and shape. (Figure 1.4A-B)  For in-vitro 3D cell culture applications, the 
size and shape of a matrix can be controlled for convenience and functionality, i.e. fitting 
to a well-plate or bioreactor. In tissue engineering, it is important to match matrix size 
and shape to the anatomical defect. For example, a scaffold for bone tissue engineering 
should have a properly designed macro-scale structure to allow for integration with 
proper adjacent tissues, as well as for generation of properly sized tissue.[33]  
Appropriate design of anatomic shape also is important for cosmetic purposes. A major 
challenge of macro-scale control over implantable scaffolds is that the relevant properties 
(i.e. defect site size and shape) vary from patient-to-patient. One approach to achieve this 
level of design control is to utilize computer-based medical imaging tools such as 
computed tomography (CT), magnetic resonance imaging (MRI) and design strategies 
such as computer-aided design (CAD), become useful in customizing a 3D architecture to 
match a wound site.[19]  This design can be manufactured utilizing SFF fabrication. The 
importance of macroscopic structural design of 3D matrices, along with their fast and 
individualized production, will become more important with increase the potential 







Controllability on the micro-scale (10-3 ~ 10-6 m) is valuable to mimic 
microscopic tissue structure, such as the multi-cellular spatial organization within ECM 
proteins. Tissue architecture and function are closely interrelated. For example, blood 
vessels consist of the three distinct layers of endothelium, smooth muscle, and connective 
tissue. A circularly oriented smooth muscle layer surrounded by longitudinally oriented 
inner endothelium and outer connective tissue layers regulates blood flow.[10]  Although 
micro-scale 3D matrix design should be specific for each application, there are also 
general but essential design parameters such as porosity, pore interconnectivity, pore 
geometry, pore size distribution, and some surface topography.  
In addition to the diffusion of nutrients, metabolic wastes, and soluble molecules, 
one of the critical issues in microscale design is the facilitation of mass transport within 
3D matrices to control the efficiency of cell seeding.[32]  The inclusion of sufficiently 
sized open pores and a well-interconnected geometry improves diffusion throughout the 
scaffold interior. Pore geometry and pore size distribution are other critical factors. 
Three-dimensional matrices with similar porosity but dramatically different pore 
geometry, such as fibrous versus spherical pores, can yield different mass transport 
profiles. (Figure 1.4C-D)  A large pore size distribution can lead to areas with poorer 
accessibility, potentially limiting cell seeding and migration efficiency. 
Individual cells recognize structures which have comparable dimension to cellular 
size (10~100 mm).[37]  Therefore, micro-scale surface morphological texture needs to be 
considered among design criteria. Micro-scale surface features can activate certain genes 
and modulate cellular behavior in differentiation or proliferation. For example, 
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microscopic surface patterns and grooves on 2D surfaces guide neuronal cell 
polarization[38] and myoblast alignment.[39]  Beyond that, there is a poor understanding 
of how the topology of 3D scaffolds affects cell development. For instance, it is difficult 
to answer how the change of fibrous substrate to a support with leached pore morphology 
affects the differentiation of stem cells.  
Micro-scale structural design also affects the mechanical properties of the bulk 
scaffold. Sufficient mechanical properties are important in tissue engineering, in which 
the scaffold may be required to withstand forces generated by the body, and in 3D cell 
culture, in which the matrix must withstand cell attachment forces, handling by scientists, 
and media convection in bioreactors. Oftentimes, a stochastic micro-structural 
architecture, such as those resulting from particulate leaching fabrication techniques, 
requires high porosity to ensure complete interconnectivity. The high porosity sacrifices 
mechanical properties by reducing the amount of material present in the matrix. Precise 
design of matrices, where architecture is optimized to provide complete interconnectivity 
at higher porosities, can improve mechanical strength while preserving effective diffusion.  
Overall, some of the most fundamental matrix design criteria require control on 
the micro-scale. With improving technologies, it is becoming increasingly obvious that 
precise micro-scale design is necessary to maximize these microscale properties. 
Although there are numerous fabrication methods to make 3D matrices with micro-scale 
resolution, only few techniques, such as SFF fabrication[40] provide precise 






Cells interact with ECM via nanoscale proteins, responding to their environment 
by modulating various cellular activities. Therefore, specific attention to matrix design on 
the nano-scale (10-6 ~ 10-9 m) is logical, because most individual ECM components are in 
nano-meter scale. For example, collagen fibrils have a diameter range of 50 to 200 nm, 
and fibronectin are 60 to 70 nm long and 2 to 3 nm thick.[9] 
Aside from the inhibition of nutrient supply by microscale geometry, nano-scale 
structural features provide the most significant influence on cell functions as a part of 
surface topography. This is not surprising because many cell-signaling mechanisms 
involve nano-scale molecules. Nano-scale surface topography has been demonstrated to 
regulate cell adhesion, organization, morphology, and differentiation.[41]  Still, 
compared with surface chemistry, limited 3D nano-scale fabrication techniques leave the 
effects of surface topology insufficiently investigated. Currently, nano-sized 3D surface 
structural features can be achieved in four ways. The first method involves using nano-
materials such as 3D peptide hydrogels directly, entrapping cells in a 3D nano-scale 
fibrous structure.[42, 43] (Figure 1.4E)  The second method incorporates nano-sized 
materials into bulk materials before matrix manufacture.[44] (Figure 1.4F)  A great deal 
of research in bone tissue engineering has focused on integrating nano-sized features into 
scaffolds to improve osteoblasts adhesion, proliferation, and calcium deposition. For 
example, hydroxyapatite nano-particles incorporated into the matrix of poly-L-lactic acid 
(PLLA) scaffolds yielded nano-scale topology that significantly increased protein 
adsorption.[45]  The third method controls processing conditions during fabrication. 
(Figure 1.4G) A nano-scale fibrous structure can be produced on the surface of a 3D 
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matrix through thermally induced phase separation of PLLA solution in organic solvent, 
followed by a crystallization process during freeze drying. Electrospinning techniques 
can also reduce fiber diameter to the nano-scale.[46]  The last approach is post 
fabrication surface treatment or surface coating. (Figure 1.4H)  For example, brief 
exposure of 3D polyester scaffolds to sodium hydroxide created nano-scale surface 
roughness, which improved the adhesion of osteoblasts and chondrocytes.[47]  Although 
the above techniques are successful at generating nano-scale surface structures, feature 
controllability on 3D structures presents a major challenge. 
Proper design of 3D cell culture matrix structure on multiple scales can provide 
distinct features to the matrix, such as macro-scale shape, micro-scale internal 
architecture, and nano-scale surface topology. Therefore, 3D biomatrix design should 
incorporate all scales to mimic the hierarchical structure of natural tissue that is 
correlated with cellular organization and functionality. However, controllability is highly 
dependent on material properties and selected fabrication processing, as will be discussed 
in later sections. Development of processing approaches that will allow freedom in 
choice of macro-, micro-, and nano-scale is one of the most difficult challenges in 3D 






Figure 1.4 Overview of multi-scale 3D cell culture matrix structure design criteria (A[19]. 















As researchers are diverging from traditional 2D glass and tissue culture 
polystyrene, cellular responses to the materials are becoming increasingly apparent. 
Many new biomaterials have been developed to mimic the unique characteristics of 
natural ECM. In general, these biomaterials can be divided into four groups: metals, 
ceramics, polymers, and composites.[52]  Among them, polymeric materials receive 
substantial attention because of the great flexibility in designing the composition and 
structure for specific needs. Polymeric materials can be divided into natural and synthetic 
polymers. (Table 1.1)  Innate properties of these natural and synthetic polymers have 
been reviewed extensively elsewhere [22, 52-54], whereas commonly required features to 
design 3D matrices have not been comprehensively examined before. Beyond the 
increased controllability in chemical and physical properties of those synthetic polymers, 
the development of various materials engineering and hybridization techniques emulates 
ECM functions in an artificial environment. Here the key parameters are addressed in 
selecting and engineering polymeric 3D matrix materials from the viewpoint of bulk and 
surface properties. (Figure 1.5) 
Table 1.1 Materials for 3D matrix building 
Synthetic polymers Natural polymers 
Poly (glycolic acid) (PGA), Poly (lactic acid) (PLA) 
Poly (ε-carpolactone) (PCL), Poly (ethylene glycol) (PEG), 
Poly (vinylalchol) (PVA), Poly (propylene fumarate) (PPF), 
Poly(acrylic acid) (PAA), and various copolymers  
e.g. Poly (lactic-co-glycolic acid) (PLGA) 
*Peptide, DNA 
 
Collagen, Gelatin, Hyaluronate 
Glycosaminoglycan, Chitosan 






Bulk material selection is the first consideration of 3D matrix design because it 
dictates various fundamental properties of the matrix from biological effects to 
processability. Here, several key parameters of bulk materials for matrix design are 
discussed including biocompatibility, wettability, transparency, biodegradability, and 
mechanical properties, as well as examples of bulk material modifications that are used to 
emulate natural ECM.  
Biocompatibility of the bulk material is a critical parameter, because it determines 
the ability of materials to perform their desired functions with appropriate cellular or host 
responses. Biocompatibility can be understood as a graded characteristic, for which the 
requirements change depending on the specific application. The degree of 
biocompatibility can vary from the lack of toxicity with respect to transformed cell 
cultures to the lack of long-term immunological systemic response of the human body. 
The strictest requirements are applied to implantable scaffolds to avoid undesired 
responses, such as a strong immune reaction or fibrous encapsulation. Ideally, the body 
should be able to metabolize degraded substances. Natural materials tend to show better 
biocompatibility than synthetic materials, but their animal sources raise concerns about 
disease transfection. The more relaxed definition of biocompatibility is applied to 3D 
scaffolds to be used ex vivo, but the more complex the cellular system is, the more 
stringent the compatibility requirements are. Fabrication processes that use harsh 
chemicals decrease biocompatibility and sometimes cause matrix toxicity even if the bulk 
materials are biocompatible. 
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Because natural ECM is a fully hydrated gel, wettability is a key 
consideration.[55]  Bulk materials with more hydrophilic chemistry are better at 
mimicking the aqueous in vivo environment. For this reason, hydrogels, networks of 
hydrophilic polymer chains, have been used extensively as 3D matrix materials.[53, 56]  
The hydrogel structure also creates a gradient of soluble signaling molecules within a 3D 
matrix and absorbs mechanical tensions. Nevertheless, poor cell adhesion due to the 
hydrophilicity of hydrogels and the lack of cell binding motifs is a common 
drawback.[53]  These limitations can be overcome by conjugating cell-binding motifs 
such as arginine-glycine-aspartate (RGD) on polymer chains[23] or by coating surfaces 
with bioactive materials post-fabrication.[57]  
Transparency of bulk materials is an important parameter for 3D in vitro 
modeling applications in which cellular behaviors within the 3D matrix require 
microscopic detection. Many sensing and quantification techniques, such as 
immunostaining and enzyme-linked immunosorbent assay, also use optical-based 
instrumentation, including confocal microscopes and micro-plate readers. Thus, 
transparent materials are advantageous to collect optical signals passing through the bulk 
structure without dissipating light beam. One may also consider a broader definition of 
transparency beyond the traditional ultraviolet-visible spectroscopy ultraviolet-visible 
spectroscopy (UV-vis) range of electromagnetic waves between 300 and 800 nm. 
Transparency in the X-ray region is reasonably high for most materials, which will be 
important to use for analysis of cell behavior in 3D scaffolds. X-rays can penetrate to 
depths that are not possible for confocal microscopy images even in the most transparent 
media. However, X-ray contrast of live cells in most 3D matrices is poor. The 
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development of appropriate contrast agents for cells for 3D X-ray tomography using 
nano-particles is a burgeoning research area with much promise.[58-61]  Much 
contribution can be made in this field by further improving image contrast and resolution 
particle delivery to the cells and introducing X-ray ‘‘color’’ with different nano-particles, 
which will greatly improve the research process in 3D scaffolds. 
Controlled biodegradability is an essential requirement for implantable 3D 
scaffolds, because these scaffolds are generally designed to degrade at the rate that in-
growing tissue replaces them. Generally, synthetic materials degrade hydrolytically[62] 
and natural materials undergo an enzymatic degradation process.[63]  Hydrolytic 
degradation is more predictable and adjustable than enzymatic degradation. For example, 
the degradation profile of poly(lactic-co-glycolic acid) (PLGA) scaffolds can be 
manipulated by adjusting the composition and molecular weight of poly(lactic acid) 
(PLA) and poly(glycolic acid) (PGA) polymers.[64]  On the other hand, enzymatic 
degradation of natural materials is more dependent on local enzyme concentration 
secreted from cells.[65]  Thus, the degradation profile and mechanism under 
physiological conditions for scaffold materials, as well as the implantation site and 
desired scaffold function, need to be carefully considered when designing an implantable 
scaffold. 
Mechanical properties of bulk materials represent an important set of 
characteristics to consider in 3D matrix design. First, bulk materials are fundamental 
contributors to the mechanical integrity of 3D matrix structure. This is especially so in 
tissue engineering for structural tissues. For instance, bone regeneration scaffolds may 
endure substantial mechanical stresses immediately after implantation.[66]  If the 
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scaffold cannot bear sufficient loads, it might fracture before the bone healing process is 
complete; however, excessively strong mechanical properties can damage adjacent bone 
or retard new bone regeneration via stress shielding. This becomes even more 
complicated when bulk materials start to degrade, because the mechanical properties of 
the scaffold should retain integrity and gradually transfer loads to ingrowing bone. 
Therefore, the scaffolds should have mechanical properties resembling those of healthy 
tissue over the period of tissue regeneration. 
Second, the bulk mechanical properties directly shape surface mechanical 
properties, such as surface stiffness or elasticity, which elicit clear cellular responses. For 
example, cells on 2D cultures initially recognize adhesive proteins on the substrate 
through transmembrane integrin receptors receiving mechanical signals, which activate 
actin-filament polymerization and promote focal adhesion formation. Later, cells apply 
traction forces to pull the ligands from a substrate and sense the surface stiffness.[67]  
Recently, a modified fluorescence resonance energy transfer technique was used to 
measure cell tracking forces quantitatively on 2D substrates with different degrees of 
stiffness. It demonstrated that stiffer substrates support preosteoblast proliferation and 
that softer substrates promote differentiation.[68]  In another seminal work, the response 
of human mesenchymal stem cells (hMSCs) on a 2D hydrogel matrix with different 
grades of elasticity was studied. hMSCs displayed a phenotype of neurogenic lineage on 
the softest substrates, a myogenic phenotype on moderately stiff matrices, and an 
osteogenic phenotype on the stiffest substrates.[16]  Even though these results were 
derived from a 2D model system, they provide valuable information for 3D matrix design. 
For example, the timing of different functions of the scaffolds, such as early proliferation 
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and late differentiation, can be developed as a strategy for many tissue regeneration 
applications. A gradual switch from cell proliferation to cell differentiation can be 
obtained by progressive softening of the scaffolds during the biodegradation process. 
Bulk properties are frequently modified to replicate the multi-functional tasks of 
natural ECM on an artificial 3D matrix. There are numerous materials engineering and 
hybridization techniques, but here three distinct strategies are discussed. The first 
approach involves hybridizing natural and synthetic materials to improve the biological 
and physical properties of a 3D matrix. For example, limited bioactivity of synthetic 
materials can be improved by covalently incorporating multifunctional ligands from 
natural materials (e.g., fibronectin, vitronectin, and laminin) onto synthetic polymers. 
[69-71]  Depending on the application the ligand type and concentration can be adjusted. 
Weak mechanical properties of natural materials can be improved by incorporating 
synthetic polymers. Photopolymerizable hyaluronan and collagen conjugated with 
synthetic cross-linkers can be copolymerized with synthetic polymers.[72, 73]  This 
significantly enhances the physical stability of the 3D structure in a controlled manner 
while preserving the inherent biological properties of natural materials. Currently, critical 
concerns are control over the spatial distribution of ligands and their configuration 
change after immobilization in a 3D matrix. 
The second approach is the incorporation of soluble signaling molecules within a 
3D matrix. In nature, the temporal release of soluble signaling molecules from ECM in a 
spatial gradient significantly influences various cellular behaviors. In 2D culture, the 
delivery of soluble signaling molecules is rapid and uniform but lacks a spatial gradient. 
It can be advantageous to create gradient signaling profiles in 3D culture, although 
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diffusion may be considerably impeded. For this purpose, soluble bioactive molecules, 
such as growth factors and deoxyribonucleic acid (DNA) encoded for the desired protein 
synthesis, are mixed in 3D matrix materials.[25, 74]  Often these molecules are pre-
encapsulated within biodegradable polymeric carriers, such as PLGA, for longer periods 
of release with a controlled profile. Encapsulation can also minimize the deformation of 
the 3D configuration of protein during the fabrication process. Moreover, multiple 
components can be secreted at different time points by taking advantage of different 
release kinetics. For example, Richardson et al. developed a dual growth factor–delivery 
system with different release kinetics in PLGA scaffolds: rapid release of vascular 
endothelial growth factor (VEGF) without a carrier and slow release of pre-encapsulated 
platelet-derived growth factor (PDGF).[75]  VEGF first stimulated endothelial cell 
proliferation and channel formation, and PDGF recruited smooth muscle cells around the 
channels, which remodeled and matured the nascent vascular networks. As a result, the 
diameter and density of vessels were significantly greater than those of vessels in single 
growth factor releasing and blank scaffolds. 
The delivery of DNA is also beneficial in maintaining physical integrity and 
enhancing effectiveness, because DNA is merely a 1D linear base sequence; preservation 
of configuration is not as much of a concern. Like proteins, DNA delivery is normally 
combined with viral vectors such as retroviruses and adenoviruses, but non-viral vectors, 
such as cationic polymers and lipid complexes, are also used to deliver the DNA 
sequence to cell nuclei.[76] Current challenges include the improvement of 




The third method that can be used to make an analogous ECM is to hybridize 
biomaterials with various functional nano-materials. For example, bone tissue ECM is 
composed of organic collagen and inorganic hydroxyapatite.[10]  Polymeric materials 
only represent the organic element of bone tissue ECM; therefore, hydroxyapatite nano-
particles are often incorporated, demonstrating greater osteoblastic differentiation than 
polymeric materials alone.[45]  Recently, carbon nanotubes (CNTs) have been used as a 
hybridization material for 3D matrices because of their unique physical and chemical 
properties and flexibility of surface functionalization. The excellent mechanical strength 
of CNTs lends them to be incorporated into scaffolding materials for structural 
reinforcement.[77]  Additionally, the metallic properties of CNTs allow them to be used 
as a contrast enhancement reagent for non-optical-based imaging tools.[78] Electrically 
conductive CNT composite films have also been applied for stimulation of neuron cells 
by electrical pulses.[79, 80]  Moreover, CNTs support neuronal cell outgrowth and 
differentiation because their fibrous or tubular structure is similar to those of neural 
processes with comparable dimensions.[81]  Although great potential exists for using 
nano-materials, several problems should be clarified, such as dispersion in nano-
composite solutions, effective functionalization, biocompatibility, and potential systemic 









Surface properties are crucial in controlling interactions between cells and a 
substrate. Although surface properties are often derived from the bulk properties of 
materials, the bulk materials do not entirely define them, because 3D matrices are coated 
with proteins almost immediately after implantation in the body or immersion in culture 
media.[82]  Surface chemistry and topography determine the identity, quantity, and 
conformational change of these adsorbed proteins. 
Surface properties include stiffness, charge, polarity, and chemistry, among a 
multitude of others. For example, the surface charge density determines the amount of 
protein adsorption and resultant cell adhesion.[83]  Greater surface charge brings a 
greater density of protein coating, leading to better cell adhesion.[84]  Positively charged 
surfaces support better osteoblast adhesion than do negatively charged surfaces with 
similar charge density. It is believed that different protein species adhere to the scaffold 
depending on surface charge polarity, causing this distinction.[85]  Surface chemistry 
also modulates the bioactivity of coated proteins by causing different configurations of 
adsorbed proteins. For instance, an equal amount of fibronectin pre-coated on 4 different 
substrate having OH, NH2, COOH, and CH3 functional groups resulted in adherence of 
different configurations of fibronectin and led to a specific class of integrin activation on 
osteoblasts. As a result, OH and NH2 terminated surfaces supported better osteoblastic 
differentiation, alkaline phosphatase activity, and matrix mineralization than COOH and 
CH3 groups.[86]  
Surface properties can be modulated through the attachment of specific functional 
groups or proteins with necessary biological functions to regulate cellular behavior. 
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Fewer techniques are applicable to 3D substrates than to 2D biological surface 
modification methods because of limited diffusivity within the porous internal structures. 
Layer-by-layer (LBL) surface coating is a promising technique to modify 3D matrix 
surface properties with various materials.[87]  LBL is described as the sequential dipping 
of a substrate into baths of oppositely charged solutions alternating with rinses in water, 
yielding monolayer control over the surface properties of the substrate.[88]  Complex 3D 
porous structures can be coated using the LBL technique as long as there is no serious 
mass transport limitation. Various biomolecules can be incorporated in LBL films with 
minimal loss of bioactivity and can be delivered to cells in a sustained manner by using 
hydrolytically degradable polyelectrolytes.[89]  For example, LBL films containing bone 
morphological protein-2 (BMP-2) and transforming growth factor-b1 (TGF-b1) mediated 
the bone tissue formation of embryonic stem cells.[90] 
Vapor phase deposition is another technique to modify 3D substrates. Because 
this surface-coating process operates in the vapor phase, 3D matrices should be dried 
before processing. In a low-pressure chamber, monomeric compounds diffuse easily into 
the internal area of a 3D matrix, aided by air flow to reinforce diffusivity.[91]  Plasma 
processing has been applied to coat 3D porous PLA scaffolds with amine groups to 
improve embryo 3T3 fibroblast adhesion. Amino groups grafted to the surface promoted 
adsorption of adhesive proteins, approximately doubling the number of cells initially 
adhering to the scaffold.[48] 
Another interesting approach is coating 3D matrix surfaces with natural ECM by 
culturing stromal cells and removing them from the matrix. Because the natural ECM 
consists of a complicated mixture of organic and inorganic components originally 
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produced from cells, scaffolds coated with bone-like ECM secreted by osteoblasts 
significantly enhanced differentiation of rat mesenchymal stem cells (MSCs) into 
osteoblasts.[92] 
There are a large number of criteria for the design of 3D cell culture matrices. On 
a structural level, there are multiple scales of features that influence the matrix function 
on cells, as well as the function of cells residing within the matrix. From a biomaterials 
point of view, bulk and surface properties have to be considered. Although they are not 
mutually exclusive, structural and biomaterial features can be chosen and manipulated 
depending on the desired application of the matrix. As discussed in the next section, 3D 
matrix design becomes increasingly complex depending on the chosen matrix fabrication 




Figure 1.5 Summary of biomaterial considerations 
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1.3. Current fabrication techniques 
Parallel to the development of advanced materials and process engineering, 3D 
matrix formation and fabrication techniques have evolved considerably to manufacture 
more elaborate 3D structures with a broad range of biomaterials. The earliest is the 
encapsulation of cells within a hydrogel matrix. In this culture format, a hydrated nano-
scale fibrous structure similar to natural ECM surrounds cells are completely. Typical 
cellular behaviors, unrecognized on conventional 2D culture, became reproducible in this 
3D culture environment.[93]  Under the tissue-engineering theme, various micro-scale 
3D porous matrix fabrication procedures were introduced. Many types of scaffolds are 
under investigation to construct pilot model tissues for bone[94], cartilage[95], skin[96], 
liver[97], blood vessel[98], and muscle[99].  Computer-assisted fabrication systems 
emerged with the greater necessity for complex and customized 3D matrix structure 
design and manufacture. Currently, the SFF technique, also called rapid prototyping, is 
the most broadly used of computer-assisted methods. SFF ultimately allows for control 
over macroscopic properties, such as scaffold shape, as well as microscopic internal 
architecture.[19]  Conventional microfabrication technologies, such as soft lithography 
and photo lithography, have excellent control over micro-scale structure.[100, 101]  
Nevertheless, these manufacturing processes are limited to constructing freestanding 3D 
matrices. These structures are defined as 2.5D and excluded them from the scope of this 
review, except for a newly emerging multiphoton absorption polymerization (MAP) that 
can create an intricate 3D structure with a high aspect ratio.[102]  
Although all of the fabrication methods have unique advantages, there is no one 
standard or superior fabrication process, and new methods are being researched. In this 
26 
 
section, current 3D matrix fabrication techniques are reviewed from the viewpoint of 
structural and materials design criteria and introduce some valuable modifications. 
Selected examples in each 3D matrix are also discussed in terms of in vitro models and 
tissue-engineering applications 
 
1.3.1. 3D Cell entrapment  
Technique 
The process of 3D cell entrapment is conceptually simple. A hydrogel precursor 
solution is mixed with a cell suspension and then quickly gelled using random or self-
assembling polymerization via changes of physical or chemical conditions.[103]  The 
unique advantage of this technique is that cell culture is performed within a 3D 
environment that completely surrounds cells, enabling the delivery of intense signals to 
cells from all directions. 
Structure 
It is difficult to control the 3D matrix structure because of the rapid cell 
entrapment and gelling process. Normally, the mold in which they are formed defines 
macroscale structures. In the case that cell-entrapping precursor solution is dropped into 
an initiator solution, the structure takes on a spherical shape.[104]  There is no distinct 
microporous structure; thus, mass transport mainly depends on slow diffusion through 
submicron-size pores. Still, the high water content (95.0–99.5%) enables sufficient 
exchange of essential biomolecules and metabolic end products to maintain cell viability 
in a limited thickness.[105] On the nanoscale, the interwoven mesh structure is beneficial 
27 
 
for emulating an in vivo physical environment. For example, fiber diameters of 10 to 150 
nm are in a range similar to the size of ECM fibers, providing a similar atmosphere for 
cell growth Pore sizes of 5 to 400 nm are comparable to those of natural ECM, 
reproducing the slow diffusion of soluble molecules to create a gradient signaling profile 
within the 3D matrix.[105] Although the ECM-like environment is an ideal condition for 
cell culture, weak mechanical properties are a major limitation of the exceptionally 
hydrophilic nature of the matrix.  
Biomaterials 
Three-dimensional cell entrapping materials are natural or synthetic hydrogels 
that can undergo fast yet gentle polymerization around cells. The monomeric components 
must be nontoxic and biocompatible, because cells are mixed with the precursor solution 
before gelling. The polymers can be hydrolytically or enzymatically degradable. In 
addition, 3D hydrogel matrices show excellent wettability, and many demonstrate 
superior transparency in the UV-vis range. Surface properties of entrapping hydrogel are 
derived from bulk properties because 3D matrix completely surrounds cells. Stiffness and 
topography of the matrix can be manipulated by adjusting the concentration of monomer 
and cross-linker.  
Natural hydrogels, like Matrigel, fibrin gel, and alginate gel, are commonly 
applied as cell-entrapping materials because of their outstanding biocompatibility and 
mild gelling conditions. However, some of the major drawbacks include poor control of 
gelation kinetics, uncontrolled material composition, and lack of mechanical integrity. 
Matrigel is composed of solubilized basement membrane proteins extracted from a rat 
chondrosarcoma. These soluble proteins undergo self-assembled polymerization when 
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incubated at 37°C, forming a 3D gel.[106] Although Matrigel is an excellent biomaterial 
because of its abundance of natural biological molecules, its heterogeneous and 
unidentified molecular components reduce a degree of experimental control. Additionally, 
the animal-derived source of the material may be contaminated with viruses, potentially 
affecting experimental results. For example, mouse-derived Matrigel is sometimes 
contaminated with a lactate dehydrogenase-elevating virus. Fibrin gel is made by mixing 
two blood coagulation components: fibrinogen and thrombin. Polymerization initiates 
when fibrinogen is converted to fibrin upon addition of thrombin. As fibrin polymerizes, 
interactions between polymers cause gelling into a 3-dimensionally organized clot, 
commonly seen in classic wound healing.[107] Alginate, a family of linear copolymers 
composed of 2 monomers (a-Lguluronic acid and b-D-mannuronic acid), is extracted 
from seaweed. The gelation of alginate occurs by adding ionic cross-linkers or divalent 
cations such as Ca2+, Ba2+, and Sr2+. The quantity and binding affinity of ionic cross-
linkers determine gel properties.[108] (Figure 1.6A-B) 
Synthetic hydrogels have been introduced for greater control over physical and 
chemical properties of 3D culture environments. The homogeneous nature of synthetic 
hydrogels provides much better matrix uniformity and simpler biochemical assays than 
natural hydrogels. Additionally, it significantly promotes reproducibility of experimental 
results. For example, a 3D matrix constructed of simple peptide-based building blocks 
provides a blank background, minimizing noise in biochemical analysis. Thus, an assay 
determining the accumulation of cartilage ECM macromolecules (e.g., proteoglycans and 
glycosaminoglycans) synthesized from differentiated chondrocytes can be performed 
without concern about initial contamination of those molecules in the matrix.[109] 
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Synthetic hydrogels normally are not explicitly bioactive, and harsh polymerization 
conditions (i.e., free radical initiation and limited biocompatibility of monomeric 
components) frequently prevent the use of synthetic hydrogels as cell-entrapping 
materials. 
Currently, three types of synthetic gels are used: poly(ethylene glycol) (PEG), 
peptide, and DNA gels. PEG hydrogel has been used because of its high biocompatibility 
and precise control of reaction kinetics during rapid photopolymerization, providing a 
spatially well-controlled 3D gel for cell entrapment.[110] (Figure 1.6C-D) Peptide gels 
are composed of macroscopically self-assembled synthetic peptides. Small quantities of 
elemental peptides (0.1 ~ 5.0 %) dispersed in water are mixed with a cell suspension, 
which then undergoes a self-assembling process under the right ionic conditions. Self-
assembled peptides generate a stable nano-fibrous structure, entrapping cells. Two types 
of synthetic peptides currently used in this fashion are amyloid-like fibrils[111] and 
peptide amphiphiles.[112] (Figure 1.6E-F) Recently, DNA has been used as a building 
block to construct hydrogels with the invention of an oligonucleotide synthesizer to 
design a specific sequence of DNA and polymerase chain reaction to amplify the DNA. 
Elaborately designed DNA molecules, which have a branched structure with a 
complementary sticky end, can be hybridized to each other via DNA ligase, self-
assembling into a 3D DNA hydrogel.[113, 114]  (Figure 1.6G-H) 
Natural and synthetic polymers are frequently hybridized to compensate for the 
shortcomings each may possess alone. For example, copolymerization of PEG and PEG 
conjugated with natural polymers such as hyaluronan[73], collagen[72], and biological 
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ligands[115] enables better control over the physical and biochemical properties of 
natural and synthetic cell entrapping materials, respectively. 
Modifications 
From a structural manufacturing standpoint, the cell-entrapping technique is based 
on the self-assembly of materials around cells, rather than the shaping of a bulk material 
to a specific architecture. Therefore, modification techniques are focused more on 
engineering unit biomolecules for directed assembly or to induce certain functionality 
than on manufacturing processes. The first example is advanced hybridization of natural 
and synthetic materials to create a cell-responsive 3D culture environment. Here, PEG 
macromers are covalently conjugated with cell adhesive and proteolytic cleavage ligands 
such as matrix metalloproteinase (MMP) degradation sites. [116] Cells cultured within 
this modified PEG-based hydrogel can grow and migrate deep into the matrix, creating 
spaces after local matrix degradation using cell-secreted MMPs. Hybridization also 
allows for a mild polymerization process separate from photopolymerization without 
generating free radicals, called a Michael-type addition reaction. In this process, gelation 
initiates after 2 building groups, end- functionalized macromers and bi-functionalized 
peptides, are mixed as cross-linkers.[117] (Figure 1.6I)  
Another method of materials engineering involves the molecular design of unit 
peptides to have specific functionalities. Versatile alteration of amino acid sequences in 
the hydrophilic peptide head groups provides specific cell-binding or cell-signaling 
environments for the systematic investigation of cell differentiation.[118] (Figure 1.6J) 
The last example is a modification of the cell entrapping process involving a patterned 
multi-cellular organization instead of a random distribution of cells within 3D PEG 
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hydrogel. Positive dielectrophoretic forces generated along a micro-patterned dielectric 
mask direct the 3D spatial organization of cells suspended in a PEG precursor solution 
because of the negative net charge of the cell membrane. After PEG photopolymerization 




Figure 1.6 Overview of 3D cell entrapment techniques. (A) Fibroblast cells encapsulating 
alginate micro-spheres[104]. (B) Ionically cross-linked alginate hydrogels with defined 
macroscopic shape transferred from a mold[120]. (C) Photo-polymerized PEG hydrogel.[121] 
(D) Safranin-O stained cartilage cells entrapped in PEG hydrogel.[122] (E) SEM image of a 
peptide amphiphile nanofiber network.[123] (F) Illustration of self-assembled peptide 
amphiphiles forming cylindrical nanotubes.[123] (G) Schematic of DNA hydrogel structure.[124] 
(H) DNA hydrogel made in a cylindrical mold.[114] (I) Scheme for the preparation of MMPs 
sensitive PEG hydrogel.[125] (J) Examples of variation of self-assembling peptide amphiphile 










Natural hydrogels PEG Peptide DNA
Defined by a mold 
No distinct structure 

















1.3.2. Polymer processing to obtain porous 3D matrices 
Techniques 
Numerous polymer-processing techniques have been developed to fabricate 3D 
porous matrices with particular applications in tissue engineering. Specific details of each 
method are described extensively elsewhere.[54, 126] Here, representative polymer 
processing techniques that yield 3D matrices with a stochastic architecture are discussed, 
the structures of which are divide into fibrous and sponge-like. The internal structures of 
the 3D matrices discussed here are highly dependent on the chosen fabrication process. 
Matrices with a fibrous structure are typically fabricated using an electro-spinning 
process that can continuously generate micro- or nano-scale diameters of fibers with 
simple set-up, inexpensive handling costs, and versatile material selection. The benefits 
of a 3D fibrous matrix include a high surface-to-volume ratio and a structure similar to 
the 3D fiber network of collagen and elastin in natural ECM. A major hindrance to cell 
culture is that small pores among fibers considerably hamper cell migration. 
All other types of matrices displaying stochastic architecture can be described as 
having a sponge-like structure. Sponge-like 3D substrates have a porosity and surface-to-
volume ratio that is similar to or lower than those of fibrous matrices but larger pores that 
can significantly improve cell seeding and migration. Sponge-like fabrication techniques 
can be divided into 2 groups based on whether a porogen is employed. Freeze-drying and 
gas foaming are widely accepted methods that do not use a porogen. The freeze-drying 
process includes blending a solvent–polymer mixture and an appropriate volume of water 
to form an emulsion. The emulsion is quickly frozen in liquid nitrogen and freeze-dried, 
leaving behind a porous structure where water has been evaporated.[127] The use of 
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organic solvents to dissolve polymer has been recognized as a major hindrance that can 
be avoided with gas foaming. The gas-foaming process involves high-temperature 
compression molding of the polymer to form a solid disk-like structure. The structure is 
then exposed to a high pressure CO2 chamber for several days, during which the gas 
infiltrates the polymer. As the pressure is decreased, the gas escapes the polymer, leaving 
a porous, sponge-like structure.[128] The gas-foaming process is favorable for 
incorporating biological molecules because no organic solvent is used.[75] 
Solvent casting and particulate leaching are representative methods of achieving a 
sponge-like porous matrix with a porogen. The concept behind particulate leaching is to 
mix polymer and solvent with particulates that can be dissolved with a separate solvent. 
Generally, synthetic polymers are dissolved in an organic solvent and mixed with 
porogen particles. Typical porogens include salt or sugar particles, because they are 
insoluble in organic solvents and can be removed by exposure to liquid water. The 
polymer–solvent–particulate mixture is then cast into a mold, and the solvent is 
evaporated, leaving a solid polymer–particulate construct. After exposing the construct to 
the particulate solvent, the remaining polymer will have a porous structure with empty 
cavities where the crystals resided.[18] Again, using an organic solvent is a major 
disadvantage. An important consideration of sponge-like structures is pore 
interconnectivity. In porogen-based techniques, particles in a porogen are frequently 
fused together, by exposure to greater humidity for salt particles or by heat treatment of 
paraffin spheres, to improve pore interconnectivity.[129, 130] Gas-foaming and freeze-
drying processes can incorporate salts or sugar porogens in polymer solution to enhance 




The shape and size of the mold in which it is created or cutting or punching out a 
structure from a larger matrix piece normally determines the macro-scale structure of 3D 
matrices. (Figure 1.7A-B) Scaffolds often have a simple cylindrical or rectangular shape. 
In clinical applications, a patient-specific macro-scale scaffold structure is typically 
achieved by using 3D molds fabricated using computer-assisted fabrication methods; 
more detail will be discussed in the next section.  
Characteristics of the micro-scale structure of fibrous 3D matrices include fiber 
diameter, fiber alignment, and pore size among fibers. (Figure 1.7C-E) Fiber diameter is 
sensitively affected by physical and electrical properties of polymer solution such as 
viscosity and conductivity.[17] Fiber alignment can be achieved by modifying the design 
of the collector (i.e., a high-speed rotating frame)[133] or by using 2 conductive 
electrodes separated by an insulating gap.[134] Pore size can be controlled by co-
spinning of polymer solutions with different degradation kinetics, such as 
polycaprolactone (PCL) and gelatin[135], or by using multi-layer spinning to create 3D 
matrices having micro-fiber (~5-mmdiameter) and nano-fiber (~600-nm diameter) 
layers.[136] Here, by reducing fiber diameter to the nano- scale, nano-scale structural 
features can be achieved. (Figure 1.7I)  
The micro-scale structural characteristics of sponge-like 3D matrices include 
porosity, pore interconnectivity, pore size and geometry, and pore-size distribution. 
(Figure 1.7F–H) The internal architecture of 3D sponge-like matrices manufactured 
without a porogen is entirely dependent on the fabrication process. Although relatively 
thick matrices are achievable, these matrices frequently have uncontrolled architectures 
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and isolated pores that limit cell–cell interactions and full tissue infiltration. A porogen-
based technique can yield a more controllable and interconnected 3D microstructure, but 
the thickness is limited to less than 2 mm.[137] A moderate level of nano-scale structure 
can be controlled using post-fabrication surface treatments.[51] (Figure 1.7J) 
The overall stochastic structure of this type of scaffold contributes to the 
simplicity of its preparation but may not be beneficial in terms of its mechanical and 
mass transport properties. Difficulties also exist with in silico modeling of biological 
processes in it and computer-assisted analysis of the 3D images. 
Biomaterials 
The electrospinning process employs a diverse set of synthetic polymers. 
Combinations of synthetic and natural materials (e.g., collagen, alginate, chitin, and silk) 
and functional nano-materials (e.g., CNTs, DNA, hydroxyapatites, and proteins) are also 
used as jetting materials. Concurrent spinning of different materials on the same collector 
can create scaffolds of multiple materials.[49, 135] Because of the absence of organic 
solvent, many biologically active molecules (e.g., growth factors[75] and DNA[138]) can 
be incorporated into PLGA-based bulk materials for scaffolds fabricated using gas 
foaming. In the solvent casting particulate leaching technique, salt crystals, sugar spheres, 
and paraffin spheres are commonly used as porogen particles. Virtually any material that 
undergoes liquid to solid transition can be used as a bulk material, but synthetic polymers, 
particularly PLA, PGA, and their copolymers, are commonly used. Many functional 
nano-materials and biological molecules can be incorporated with bulk materials and 
combined with carrier systems to protect biological molecules from organic solvents. 
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Still, considering these methods of scaffold preparation, there is an important 
problem that needs to be solved in the preparation of similar matrices with a high content 
of biodegradable inorganic material such as hydroxyapatite. This is important for bone 
implants and manufacturing materials with the stiffness necessary for bone engineering. 
Hybrid organic–inorganic materials with a high content of inorganic material in the 
composite similar to that observed in bone are difficult to make starting from polymer 
solutions. 
Modification 
The flexibility of polymer processing techniques enables the construction of 3D 
structures for specific applications. Teng et al. developed a PLGA-based 3D matrix with 
2 distinct structures to treat spinal cord injuries.[139] The inner and outer regions of the 
3D matrix were fabricated separately and then combined. The inner region, fabricated 
using a salt-leaching process (250- to 500 mm diameter) and consisting of larger pores, 
was seeded with neural stem cells (NSCs). The outer region, with smaller (<50 mm 
diameter) and axially oriented pores, was prepared using a solid–liquid phase-separation 
technique. Axially oriented smaller pores were designed to guide axonal extension and to 
allow proper fluid transport while inhibiting ingrowth of scar tissue. The NSC-seeded 
multi-component scaffolds were implanted into a rat for one year. Rats implanted with 
the scaffolds with NSCs showed significantly better functional recovery than lesion and 
cell-only control groups.[139] (Figure 1.7K) 
Combining polymer processing techniques makes it possible to build 3D matrices 
with multi-scale structural properties. Ma et al. created nano-fibrous scaffolds with 
nanoscale (50–500 nm) fibrous surface textures on a micro-scale pore surface by 
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combining the particulate leaching technique and the phase-separation process.[140] A 
homogeneous mixture of PLLA and an organic solvent infiltrated into paraffin- or sugar-
based porogen undergoes a polymer-rich and polymer-lean phase separation process 
below a critical temperature (-70°C). When freeze-dried, the polymer-lean phase ends, 
and the polymer-rich phase undergoes a crystallization process, generating a randomly 
organized nano-scale fibrous structure. The nano-scale fibrous surface morphology was 
an analogue of type I collagen fibrils on natural ECM, and the micro-scale open porous 
structure overcame the cell-seeding and cell-migration limitation of the electrospun 
matrix.[141] Combined with a modified SFF process, which will be discussed in the next 
section, the final scaffolds could have controlled macro- and micro-scale 3D structures, 

















Figure 1.7 Overview of polymer processing techniques for obtaining porous structures. 
Macro-scale structure of (A) electrospun fibrous mesh sheet and (B) PLGA scaffolds.[142] 
Micro-scale fibrous structures (C[143], D[144], E[136]) and micro-scale sponge-like structure 
(F-G[145], H[131]). Nano-scale (I) alginate based nanofibers[146] and (J) nano-scale topology 
after surface treatment[147]. Modification of polymer processing techniques: (K) compartmented 
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1.3.3. Computer assisted fabrication  
Technique 
Computer-assisted fabrication has several advantages over non-computer-assisted 
fabrication techniques. Primarily, scaffolds can be manufactured as customized multi-
scale 3D structures, which are essential for clinical applicability. Additionally, 
manufacturing is time effective and economical. Efficient manufacture is essential in 
clinical applications, in which the window for implantation is often critical. Currently, 
SFF fabrication is the most popular and powerful technique to construct 3D matrices with 
this level of design and efficiency.[148] The overall procedure of SFF fabrication 
consists of up to 3 steps: acquiring 2D image slices of a target specimen from CT, MRI, 
quantitative ultrasound, or other nondestructive imaging methods; designing micro-scale 
internal architecture and reconstructing the macro-scale 3D matrix shape using CAD or 
other software; and fabrication of the 3D matrix using automated layer-by-layer 
construction with SFF processes.[19] (Figure 1.8A–C) The 3 main types of SFF 
processing techniques are laser-based, nozzle-based, and printer-based systems. (Figure 
1.8D) Laser-based techniques include photopolymerization and selective laser sintering 
(SLS).  photopolymerization requires the exposure of liquid monomer solution to a UV 
beam, which polymerizes the exposed layer. The specimen, which is sitting on an 
elevator, is then lowered into a vat of monomer to coat the polymerized layer; this new 
monomer layer is then exposed to the UV laser to build the next layer.[149] SLS uses a 
laser beam to scan a powder bed, raising the temperature of the exposed area and 
sintering the powder into a fused solid.[150] Fused deposition modeling (FDM), a 
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nozzle-based technique, extrudes molten scaffold material through a nozzle as it moves in 
the x-y plane, directly building a layer of the scaffold with each sweep across its cross-
section.[151] Another emerging extrusion technique is robocasting, which deposits a 
slurry of ceramic powder, a volatile solvent, and chemical modifiers through a 
syringe.[152] After a layer is deposited, it solidifies as the solvent evaporates, allowing 
for deposition of the next layer. After all layers are deposited, the structure is sintered. 
Three-dimensional printing is a process that deposits a liquid binder solution onto a 
powder bed using an ink jet printer. The binder solution causes powder particles to join 
and harden, forming the 3D matrix in layers.[153] 
Recently, MAP, an advanced form of micro-fabrication technique, has been used 
in 3D matrix fabrication because of its significantly enhanced structural resolution and 
flexibility of architecture design. Here, an ultra-fast multiphoton generating laser beam is 
focused on a microscope objective. It creates local excitation within the focal volume of 
the beam, providing precise polymerization in the confined space.[102] By scanning the 
focal point in a pre-designed pattern, a complex 3D matrix can be constructed. [154-156] 
Structure 
3D matrix structural design for computer-assisted fabrication can be based on 
homogenization theory or CAD to design unit cells with various materials, porosities, and 
internal architectures. These unit cells are then combined for a desired overall 
architecture. This determined architecture is then used as instructions for the 3D printing 
of a matrix. These methods are discussed further below in the context of using SFF 
matrices as modeling tools. 
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An important potential for computer-assisted manufacturing that sets it apart from 
other manufacturing techniques is the ability to construct matrices with specific macro-
scale architecture (shaped for a wound site). Still, the ability to build a matrix layer by 
layer in any 3D configuration is limited in many manufacturing techniques. For example, 
photopolymerization does not use a support material, which limits the possible shapes in 
which the matrices can be constructed.[148] FDM uses a support material, which allows 
for building in any direction and fabricating almost any shape matrix. For many materials, 
control over macroscale structures is limited.  
Micro-scale features can be moderately controlled in that many geometries can be 
constructed, allowing for the design of numerous internal architectures. (Figure 1.8E-G) 
Still, the lack of support material also hinders the fabrication of certain cavity shapes, 
such as spherical or other rounded surfaces. Additionally, control of internal structure on 
the scale of a few hundred microns and smaller is limited because of inherent constraints 
of manufacturing parts (e.g., laser spot size, nozzle diameter, degree of position controller 
handing), as well as material constraints (e.g., particle size of powders). Currently, the 
minimum feature size is restricted to approximately 100 to 500 mm, depending on the 
fabrication process selected.[148, 157]  
Matrices manufactured using SFF do not possess distinct nano-scale features, 
because the minimum resolution of most fabrication techniques is larger than 100 
µm.[19] Most methods of introducing nano-scale features to SFF matrices are post-
fabrication processes. Limited nano-porosity can be introduced into hydroxyapatite 
scaffolds by varying the sintering temperature. Russias et al. demonstrated the 
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precipitation of hydroxyapatite nanoparticles onto the surface of robocast printed 
PLLA/bioglass scaffolds.[158] 
MAP provides an excellent alternative to overcome the limitations of the 
aforementioned methods of computer-assisted fabrication. 3D structures constructed 
using MAP provide excellent control over micro- and nanoscale, although the 3D matrix 
is dependent on a 2D mold.[154] With current techniques, the minimum resolution of one 
volume element exposed using multi-photon absorption (i.e. a voxel) is 100 nm.[102] 
Although MAP has been less investigated than SFF as a 3D cell culture substrate, its 
excellent controllability of structure holds great potential, particularly for the application 
of in vitro 3D model tissue construction. (Figure 1.8H) 
Biomaterials 
Customized hard tissue engineering has traditionally been the most promising 
application of SFF 3D matrices; therefore, the mechanical properties and biodegradability 
of bulk materials are stressed in these scaffold designs. Functional materials, such as 
calcium phosphate particles[159] and hydroxyapatite[160], are often mixed with basic 
bulk materials to mimic bone ECM composition. These composite materials often 
improve the mechanical properties of bulk material.[159] Surface properties have been 
emphasized to a lesser degree because of limited material selection and feature size 
control. Typically, the selected fabrication process determines the choice of applicable 
materials. For example, nozzle-based techniques are limited to synthetic polymers 
because the material is melted before extrusion. Here, PCL is extensively used in a FDM 
system because of its low glass-transition temperature and high decomposition 
temperature.[161] Printing-based processes, such as 3D printing, use mainly PLA, PGA, 
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and PLGA as basic building materials and chloroform as a binding solution.[153] The use 
of organic solvents is a problem with this method. For photopolymerization, the selection 
of precursor solution is limited to materials that can undergo UV polymerization (e.g. 
hydrogels and PPF-based polymeric materials).[162] SLS employs powdered materials 
such as ultra-high-molecular-weight polyethylene[163] and PCL[40]. MAP uses acrylate 
polymers that can undergo radical polymerization, such as PEG-diacrylate, and other 
materials including siloxanes, epoxy resins, and organic–inorganic hybrids.[102] 
Modifications 
Limited material selection and lack of submicron-scale structural resolution are 
the major shortcomings of SFF techniques. Indirect SFF was developed to alleviate these 
restrictions.[164] The original SFF matrix is used as a negative mold to construct a 3D 
structure with a broader range of materials. Wax is commonly used as a molding material 
because 2 types of wax, one for support and one for the mold, can be directly printed and 
easily removed after casting the desired matrix material. Various polymeric materials 
(e.g., PPF, PLA, and PLGA) and their composites with ceramics have been used as 
casting materials. Additional processing of secondary materials, such as phase separation 
of PLLA, can generate sub-micron-level structure.[165] (Figure 1.8I) A negative wax 
mold was fabricated using 3D printing, and PLLA was cast into the mold before phase 
separation at 20°C and dissolving the wax mold. This resulted in a nano-fibrous structure 
on the walls of the matrix that increased proliferation and mineralization of 
preosteoblastic cells.[165] 
Three-dimensional cell printing is an interesting derivation of the SFF process 
used to construct a 3D cell–matrix hybrid structure. With most scaffolds, the method of 
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seeding cells onto scaffolds after fabrication can lead to limited 3D cell distribution and 
depth. A regular ink-jet printer or a SFF robotic platform is remodeled for use in 3D cell 
printing. A cell suspension is mixed into in situ cross-linkable hydrogels (e.g., gelatin, 
agarose, alginate gel) in a cartridge and then printed following a programmed 3D pattern. 
As a result, a 3D cell–matrix hybrid structure is constructed.[166] Cell viability as high as 
90% indicates the ink-jet process conditions are not harsh enough to cause severe 
cytotoxicity.[167, 168]  This 3D cell matrix with a spatially well-organized structure can 
potentially accelerate the organization of cells into a functional tissue. (Figure 1.8J) 
Another way to build a 3D cell–matrix hybrid structure is 3D cell patterning. 
Instead of a typical SFF process, a modified photolithographic technique is used to build 
a patterned 3D cell–matrix construct. A mixture of cells and PEG–hydrogel precursor 
solution is deposited on a 2D surface, and a mask is placed on top so that only the 
unmasked area polymerizes under UV light. Multiple layers of a 3D hydrogel matrix can 
be layered atop previous layers. This method also significantly improves the homogeneity 
of cell distribution within a 3D matrix. Tsang et al. demonstrated a 3D hepatic tissue 
model constructed using this additive photo patterning technique, controlling the matrix 
architecture and optimizing hydrogel chemistry to attain high cell viability and liver-
specific functions.[169] Currently localized cell seeding and spatially organized co-





Figure 1.8 Overview of computer assisted 3D matrix fabrication techniques. (A) 2D scanning 
with µ-CT or MRI, image from (http://www.custard.org/~andrew/visualization/introduction/) (B) 
3D image reconstruction and 3D matrix design with CAD software. (C) 3D matrix fabrication by 
SFF equipment. (D) Representative SFF fabrication processes, image from The Worldwide Guide 
to Rapid Prototyping (http://hime.att.net/~castleisland/) (E) Macro-scale scaffold design and 
manufactured by selective laser sintering method.[150] Micro-scale structures fabricated by SFF 
process: (F) selective laser sintering,[40] (G) 3D printing.[151] (H) Nano-scale structure 
prepared using MAP.[154] (I) Indirect fabrication using negative molding: wax mold (left) and 
cast ceramic mold (right).[164] (J) 3D cell printing of hepatocytes with gelatin.[167] (K) 3D cell 
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1.4. Dissertation framework 
This dissertation explores a new opportunity of in vitro tissue engineering as a 
part of the drug development process. Specifically it aims to create standardized human 
liver and primary lymphoid tissue models for the development of tissue based toxicity 
assays. Multiple studies have indicated that 3D scaffold structure and materials actively 
regulate the growth and differentiation of cells. Various recent efforts have successfully 
demonstrated in vitro tissue models that can recapitulate to some extent tissue level 
physiological behaviors. Nevertheless, practical applications of these models have been 
limited mostly due to batch-to-batch variation of experimental outcomes. One of obvious 
reasons is poorly controlled structure and materials of 3D scaffolds which in turn 
generate heterogeneous culture environment. Under this motivation, my key hypothesis is 
that standardized 3D scaffolds in their structure and materials can significantly improve 
the standardization of engineered tissue model. 
The first part of dissertation is engineering 3D scaffolds that have highly 
regulated 3D structure and material, as well as can mimic both the 3D organization and 
the differentiated function of tissues in the body. In addition, 3D matrix accessibility 
through optical or other imaging tools and processability to precisely control matrix 
properties are other important consideration. Here, the inverted colloidal crystal (ICC) 
geometry and transparent synthetic hydrogel are the selection of the 3D structure and 
material.  
The second part consists of engineering of in vitro 3D tissue models based on ICC 
hydrogel scaffolds. The specific goal is to replicate human primary lymphoid tissues, i.e. 
bone marrow and thymus, and liver tissue spheroids. Besides the functional tissue 
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development, standardization of tissues is equally important for running massively 
reproducible assays. ICC scaffolds promote homogenous and size controlled liver tissue 
spheroid formation.   
The last part is the development of a tissue based in vitro toxicity screening 
platform. Ideally, the assay platform would be formatted to utilize already present 
laboratory equipment and assay reagents for easy acceptance from the pharmaceutical 
industry. In this line, liver tissue spheroid culture model was prepared in a standard 96/48 
micro-well plate, the most commonly utilized in vitro cell based assay format. For this 
part, nanoparticle (NP) toxicity testing based on the standardized liver tissue spheroid 
culture model was demonstrated. (Figure 1.9) 
 
 




INVERTED COLLOIDAL CRYSTAL HYDROGEL SCAFFOLDS 
 
2.1. Introduction  
Scaffolds for in vitro drug development application should have three distinct 
properties: (i) biological significance in creating functional in vitro tissue models; (ii) 
standardized 3D structure and materials for the reproducible and homogenous tissue 
formation; (iii) easy handling and compatibility with existing hardware. Different from 
2D culture substrates providing identical environment to universal cell types, each 
scaffold design should be optimized for the target tissue development. Simultaneously, 
engineered tissues must have a similar level of biological performance in order to 
generate reproducible assay outcomes. Consistent regulation of structural design and 
material properties of scaffolds should be preceded. Indeed standardization of assays is 
essential to realize the practical application of in vitro tissue engineering to the drug 
development process. Lastly engineered tissues need to be integrated into the current 
drug evaluation protocols for easy acceptance in the pharmaceutical industry. For this 
purpose, scaffolds should be transparent and compatible with micro-well plates.   
Traditional scaffolds do not meet these requirements because they are primarily 
designed for clinical implantation. For example, the scaffold geometry fabricated by 
49 
particulate leaching, gas foaming, freeze-drying, and electro-spinning methods highly 
depends on the process which generates poorly ordered or chaotic structure. Recently, 
rapid prototyping, 3D deposition techniques[19] and multi-photon fabrication[102] were 
developed to construct more controlled 3D architecture assisted by computer-aided 
design and complex robotic equipment. Although these techniques allow researchers to 
design 3D scaffolds with desired properties including porosity, interconnectivity and pore 
size, they are heavily equipment-dependent and suffer from limited material section or 
inadequate resolution. 
Colloidal crystals (CC) are hexagonally packed lattices of uniform spherical 
particles. Inverted colloidal crystal (ICC) is similarly organized structures where the 
spheres are replaced with cavities, while the interstitial spaces are filled. (Figure 2.1A) 
ICC represents an exceptionally dynamic area of research capitalizing on the unique 
spatial organization and diffraction characteristics of sub-micron scale lattices.[170-173] 
Although these structures are primarily designed for applications in optics[174], 
sensors[175] and catalysis[176], when the ICC pores exceed the single cell diameters (D 
> 10~20µm) the same structure can be used as a 3D cell scaffold.  
Highly regulated ICC geometry becomes an exceptionally attractive 3D cell 
culture substrate for in vitro tissue engineering. Such unique ICC structure also can be 
easily and reproducibly prepared without the need for complex computer design 
programs and facilities, by taking advantage of utilizing CCs as a template. In addition, it 
enables to control multi-scale structure design. For example, microscale pore and 
interconnecting channel diameters can be readily regulated by changing bead size and 
annealing condition, respectively. Macroscopic shape and dimension can be tailored via a 
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mold design. In terms of biomaterials, any precursor solution capable of undergoing a 
liquid-to-solid transition while does not dissolve a CC mold can be used. In this thesis, 
polyacrylamide hydrogel is mainly used for scaffolding material because of its 
biocompatibility, transparency and good mechanical stability. (Figure 2.1B) 
Besides the standardized structure and materials, ICC hydrogels open an 
interesting opportunity for a rather unexpected, but tremendously important area of 
science related to cell communication. In particular, the ICC scaffold modulates two 
distinct types of cellular interactions. First, the ICC geometry prepared with cell repulsive 
hydrogel matrix provides an ideal micro-environment for intense cell-cell contacts in 
static culture conditions which in turn promotes multicellular aggregation formation, so 
called spheroid. The spheroid formation restores original tissue-like morphology and 
functions corresponding to the increased cellular interactions that basically depend on the 
size of spheroids.[177]  
Second, under dynamic culture conditions, surface modified ICC scaffolds induce 
intensive cellular interactions between floating and adherent cells. For example, floating 
cells can travel deep into the scaffold while temporarily entrapped in an ICC chamber due 
to the restricted channel size and dimension. As a result, they intimately communicate 
with the adherent cells growing on the surface modified ICC pore surface. Such cellular 
interaction is particularly important for the creation of hematopoietic stem cell (HSC) 
niches in the bone marrow and thymus where they undergo self-renewal and 
differentiation processes[178].  
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This chapter will focus on the fabrication of ICC hydrogel scaffold and the 
characterizations of their structural and physical properties. Specific applications will be 
discussed in following chapters. 
 
 
Figure 2.1 Schematic of ICC scaffold design and engineering parameters. (A) CC (top) and 
ICC (bottom) in photonic crystal research[179]. When the pore size exceeds a single cell 
dimension, the same structure can be used as a tissue engineering scaffold. (B) Schematic of ICC 
scaffold and engineering parameters.  
 
 
2.2. Materials and Methods 
2.2.1. Colloidal crystal construction 
Utilizing uniform size of polystyrene microspheres (D=50-160 µm) 
Polystyrene (PS) spheres with a diameter of 50, 100, 120 and 160µm (Duke 
Scientific, 3x104 particles per milliliter and 1.4~4.8% size distribution) were dispersed in 
isopropanol solution before use. A 0.5ml plastic centrifugation tube was glued on a 
plastic dish and the top of centrifuge tube was cut and connected with a long Pasteur 
glass pipette.  The complex unit was attached on the bottom of a glass beaker, and the 
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glass beaker was placed on the ultra-sonic bath (VWR).  Two drops were released 
through a long Pasteur glass pipette in 15 minute intervals (25 intervals total) under 
gentle agitation generated by the ultra-sonic bath. To reduce thermal motions of the 
spheres, the bath temperature was maintained below 20ºC. After finished dropping, 
isopropanol was evaporated for overnight at 60°C. Prepared colloidal crystals were heat-
treated at 120ºC for 4 hours, which caused partial melting of the beads’ surface. As a 
result, PS microspheres fused together and the free standing colloidal crystal was 
extracted from the mold. Typical dimensions of CCs were 6.4mm in diameter and 
0.5~1mm in thickness. 
Utilizing uniform size soda lime glass microspheres (D=50-330 µm) 
Dried 1g of soda lime glass beads with diameters of 50, 100, 140, 170, 200, 280 
and 330µm (DukeScientific, standard deviation ± 2.2~5.7µm) were dispersed in 5ml of 
ethylene glycol. A borosilicate glass shell vial (D=8mm, H=35mm) (Fisher Scientific) 
connected with a long Pasture glass pipette was used as a mold for CCs preparation. The 
complex unit was inserted in a glass tube (D=10mm, H=75mm) (Fisher Scientific) that 
was halfway immersed in an ultra-sonic water bath, and the inner space of mold was 
filled with ethylene glycol. A few drops of glass bead suspension were released to the 
mold in 20-30 min intervals until the thickness reached approximately 0.5-1mm. After 
complete evaporation of ethylene glycol at 160°C, the CCs were annealed for 4 hours at 
667-690°C depending on the size of beads. Annealed CCs were extracted from the mold.  
Utilizing less uniform size of soda lime glass beads (D=75-300 µm) 
Dried 500 g of soda lime glass beads with three different sizes (≤ 106µm, 150-
212µm and 212-300µm) were purchased from Sigma-Aldrich. Using sieves and a sieve 
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shaker (Fisher scientific) the range of glass beads size was narrowed down in three 
groups: 75-90µm, 160-180µm, and 250-280µm. There are some other sizes, but most of 
beads were in these ranges. CC preparation was the same as the uniform size glass beads.   
2.2.2. ICC hydrogel scaffold fabrication 
ICC preparation with PS CCs 
Hydrogel precursor solution composed of 30wt% acrylamid, 5wt% of N,N 
methylenebisacrylamide (NMBA) cross-linker and 0.5vt% N,N,N',N'-
tetramethylethylenediamine (TEMED) was prepared with N2 purged deionized water. 
The precursor was infiltrated into the colloidal crystal by centrifugation at 5800rpm for 
10~20 minutes. An initiator, 1wt% of potassium peroxide solution was added and 
polymerization occurred in a glass vial. After completing polymerization, the colloidal 
crystal containing the hydrogel part was cut out and scratched with a razor blade to 
remove extra hydrogel covering CCs. Then the hydrogel-CCs were soaked in 
tetrahydrofuran (THF) for 24 hours to dissolve PS beads.  Finally ICC hydrogel scaffolds 
equilibrated in deionized water.   
ICC preparation with glass CCs 
The precursor solution preparation, infiltration, polymerization and removal extra 
hydrogel steps were same as the PS beads case. After that, hydrogel-CCs were immersed 
in 5% (v/v) hydrogen fluoride (HF) solution for 24 hours to dissolve the glass beads. 
Later, ICC scaffolds were sequentially washed with pH 2~3 acid solution for 4~6 hours, 
phosphate buffered saline (PBS) solution for 1 day, and deionized water for 2 days. In 
each washing step, the solutions were changed at least 3~4 times. ICC scaffolds were 
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further freeze-dried to completely remove potentially remaining HF and kept in a dried 
state until used.  
2.2.3. Characterizations 
Confocal microscopy 
Fluorescent ICC hydrogel scaffolds were prepared by adding 0.05wt% of 
fluorescent monomer (Polyfluor 511, Polyscience Inc.) in the hydrogel precursor solution. 
Fluorescent ICC hydrogel scaffolds were transferred to a glass bottom culture dish 
(MatTeck Corporation) and imaged with confocal microscope (Leica SP2) using a 470nm 
excitation laser utilizing 10X and 20X objective lenses.  
Scanning electron microscope (SEM) 
ICC hydrogel scaffolds were fixed in 2% cacodylate-buffered glutardaldehyde for 
2 hours and then washed three times with 0.1M cacodylate buffer for 30 minutes. The 
fixed hydrogel scaffolds were dehydrated through a series of ethanol solutions 
concentrations of 50, 70, 90, 95, and 100% for 10 minutes. Dehydrated samples were 
further freeze-dried overnight and were coated with gold for 180 seconds using a sputter 
coater (Desktop 2, Denton Vacuum Inc.).  Cross-section images of the internal 
architecture were obtained after cutting the sample with a razor blade. Samples were 
observed with a Philips XL30 or FEI Nova Nanolab SEM (The University of Michigan 
Electron Microbeam Analysis Laboratory) 
Micro-computed tomography (µ-CT) 
Colloidal crystals were three-dimensionally imaged by µ-CT to visualize their 
internal packing structure and to calculate porosity. The scan was performed by MS-130 
high-resolution µ-CT scanner (GE Medical Systems) at 15m voxel resolution and 75kV.  
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Porosity calculation 
Porosity of ICC hydrogel scaffold was measured combining an effective cellular 
porosity including only pores larger than single cell size (D=5~15µm) and bulk hydrogel 
porosity. µ-CT based image analysis was applied to calculate the effective cellular 
porosity. First, three-dimensionally rendered CC images were created with MicroView 
(GE Medical Systems). Image threshold levels were automatically adjusted. Then, the 
region of interest (ROI) set to include entire CCs, and the volume fraction of CC within 
the ROI was calculated with MicroView.  
In order to calculate bulk hydrogel porosity, two assumptions were made: (i) 
specific density of water is 1g/cm3 and (ii) pore space in a bulk hydrogel is completely 
filled with water. As comparing the volume and weight of a bulk hydrogel slab in both 
fully hydrated and dehydrated states, total weight of water and hydrogel polymer were 
calculated separated. Based on these data, bulk hydrogel porosity was estimated.  
Mechanical testing 
Compressive moduli of hydrated ICC scaffolds were measured at a constant strain 








2.3. Results and Discussion 
2.3.1. Preparation of CCs with microspheres 
The diameter of the spheres commonly used as CCs is around 100-1000nm for the 
purpose of matching the optical band-gap in the visible region. Various methods such as 
electrophoretic deposition[180], solvent evaporation[181], dipping[182], agitation[183, 
184] and most recently spin coating[185] have been developed to construct the highly 
ordered CC structure. In order to utilize the unique geometry of the ICC as a scaffold, the 
sphere size has to be increased to the 10-1000µm range. However, it is difficult to obtain 
the same degree of order with micron scale beads using the methods developed for 
nanoscale spheres, mainly due to their larger volume and heavier mass. Fortunately, 
microsize beads offer two advantages over nanosize spheres. First, the agitation of beads 
by shear force works more effectively because of their larger volume.[186] Second, the 
sedimentation rate is faster due to their greater mass. However, the sedimentation rate 
was often too fast to self-assemble into a closely-packed ordered array. The opposite 
problem, viz., how to retard sedimentation rate, was solved by introducing a Pasture glass 
pipette before beads entered into the mold. The pipette extended sedimentation distance 
and worked as a thin funnel, which caused a bottleneck effect for precipitating beads. 
(Figure 2.2A)   
Once beads precipitated at the bottom of the mold, gentle agitation generated by 
an ultrasonic bath, assisted the movement of beads and positioned them at the lowest 
energy spots. This led to a highly packed and ordered array of spheres. When the bottom 
area was covered with beads, their rugged surface served as a template for the formation 
of the second layer. Since structural defects accumulated from the bottom area, 
57 
incomplete layers and less ordered arrays were usually observed on the top area. (Figure 
2.2B) 
The sedimentation rate was controlled further by adjusting the concentration of 
beads in the solution and the time interval between injections. For example, decreasing 
the amount of beads and increasing the interval period provided more time for the 
repositioning of precipitated beads. The use of isopropanol for PS beads guaranteed that 
the agitation was not too violent to destroy the whole structure, while its buoyancy made 
it easier for the PS beads to rearrange. Relatively high density of ethylene glycol 
(ρ=1.11g/cm3) (c.f. water ρ=1g/cm3 or isopropanol ρ=0.78g/cm3) was used to retard the 
precipitation speed of high density of glass beads (ρ=2.5g/cm3). 
 
 
Figure 2.2 Colloidal crystal preparation (A) Experimental set-up: A long glass pipette is 
connected to a plastic or a glass tube mold immersed in an ultrasonic water bath. (B) CC 
construction procedure and key driving force in each step.  
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After sedimentation, the solution media were evaporated. During this process, 
capillary force further improved ordered bead packing. Following evaporation, the CCs 
were heat treated which resulted in partial melting of the spheres. This step allowed the 
beads to stick together and on subsequent cooling (re-solidification), junctions were 
created between the spheres setting the structure in place. The resulting free standing CCs 
were strong enough to be easily handled and removed from the mold. These junctions 
later prevented breakage of the crystal lattice during the infiltration of precursor solution 
and ensured the connectivity between spheres and continuity of the chain of pores in the 
final scaffold. The channel diameter was determined at this stage, because the size of 
melted area depended on the annealing temperature. However, too much annealing led to 
the cracking of the CC and/or incomplete precursor solution infiltration. SEM 
investigations of free standing CCs revealed highly ordered hexagonally close-packed 
structure. (Figure 2.3) 
 
Figure 2.3 SEM images of free standing colloidal crystals. Different locations of CCs prepared 
with (A) PS beads (D=100µm) and (B) soda lime glass beads (D=160µm). Regardless of the bead 
sizes, highly ordered 3D packing structure was easily achieved. 
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2.3.2. Preparation of ICC hydrogel scaffolds 
Polyacrylamide hydrogel was selected as a scaffolding material since the hydrogel 
is a broadly used in biomedical research fields due to its biocompatibility, mechanical 
strength, transparency, non-fouling property and cost effectiveness[53, 56, 187]. In 
addition, relatively low viscosity of the precursor solution compared to other natural 
hydrogel such as alginate, fibrinogen, and peptides allows easy and completely 
infiltration into the CCs. Monomer concentration was set low enough to prevent 
incomplete infiltration due to increased viscosity, and simultaneously to prevent 
deformation of the geometry during solvent extraction. Normally PS CCs are floating 
before the precursor solution infiltration due to entrapped air but they precipitate once the 
interstitial space is filled. In case of glass CCs, infiltration of hydrogel precursor solution 
is faster owing to their heavy weight.  
After completion of radical polymerization, the transparent hydrogel including 
CCs was cut out and then CCs surface was scratched multiple times with a razor blade to 
remove excess hydrogel. In fact, the scratching step is critical to ensure open pores in the 
scaffold. PS and glass CC templates were dissolved by THF and HF solution, 
respectively. In THF solution, hydrogel-CCs shrank and turned white while in HF 
solution, hydrogel-CCs remained same. (Figure 2.4) 
 
Figure 2.4 ICC hydrogel scaffold fabrication steps 
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The CC template structure was transferred to the ICC geometry intact. The diameter of 
the beads is directly proportional to the diameter of the resulting cavities. After 
stabilization in aqueous solution, the final hydrogel pore size was moderately (~10%) 
enlarged. This allowed near perfect fitting into a single well of a standard 96 well-plate. 
(Figure 2.7C) Similarly, the size of channels connecting the cavities can be tuned by the 
bead diameter, as the degree of contact upon annealing is greater for larger beads, and 
also by annealing temperature and time. Normally the channel diameters reach around 
20-30% of pore size. (Figure 2.5)   
 
Figure 2.5 SEM images of three different sizes of CCs and ICCs (A) CCs prepared with 50, 
100 and 200µm diameters of glass beads, (B) Hydrogel ICC scaffolds prepared with the three 
different bead sizes. Note that pore sizes in ICC hydrogel scaffolds were significantly shrank after 
dehydration process.  
 
Pore and channel diameters were determined considering the single cell 
dimensions (D=5~20µm) and manufacturing superiority. For example, in our previous 
study of pore size effects, ICC scaffolds having 75 µm pore diameter favored bone 
marrow stromal cells nesting[188]. A 10µm pore diameter was too small for cell seeding, 
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whereas a 160µm pore diameter was too large for effectively cell entrapment. Also, 
O’Zinger et al. investigated osteoblast-like cell cultures on well-defined 2D cavities 
which were analogous to ICC scaffolds, and found that 100µm cavities favored osteoblast 
attachment and growth[189]. Considering these information, the smallest pore size was 
determined as 50µm because its channel size (~10µm) is comparable to a single cell 
dimension. The largest pore diameter was 330µm since the pore size larger than this can 
be manufactured utilizing other fabrication techniques[19], although producing a 
multilayer of spherical hydrogel cavities is still superior.  
Polyacrylamide hydrogel retained excellent transparency which made it easier to 
monitor cellular processes deep inside the scaffold using optical and confocal microscope. 
Normally it was possible to observe the cell growth in ICC scaffolds at a depth greater 
than 500µm under confocal microscope. Transparency of the 3D matrix also improved its 
accessibility to optical-based assays (i.e. absorbance, luminescence or fluorescence) 
which are commonly used in pharmaceutical screenings. In addition, transparency 
enables easy sterilization of the scaffolds under UV light. (Figure 2.6)  
 
Figure 2.6 Transparent and fluoresent ICC hydrogel scaffolds. (A) Optical image of 
transparent ICC scaffold (D=100µm), (B-C) Confocal images of fluoresent monomer included 
ICC hydrogel scaffolds (D=170µm): (B) 2D section and (C) 3D reconstructed image. 
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Besides the standardization, running HTS assays is equally important to obtain 
statistically meaningful data. Currently micro well-plates are the standard format for HTS 
assays in the pharmaceutical industry, biotechnology and other fields. In order to improve 
the compatibility with HTS hardware, the macroscopic dimension of ICC scaffolds was 
tailored to fit with a single well of a 96 well-plate. (Figure 2.7) 
 
Figure 2.7 Optical images of ICC scaffolds compatible with a 96 well-plate. (A) CCs prepared 
with PS beads, (B) ICC hydrogel scaffolds, (C) The scaffold placed in a single well of 96 well-
plate, and (D) Prototype of a 96 well-plate containing ICC hydrogel scaffolds.  
 
2.3.3 Characterization of ICC hydrogel scaffolds 
Porosity 
An ICC hydrogel scaffold includes two different scale of pores; macro-scale pores 
which are larger than cellular dimension (D<10µm) (i.e. effective porosity) and sub-
cellular (D<5µm) scale pores (i.e. bulk hydrogel porosity). (Figure 2.8A) The overall 
porosity of the scaffold should be estimated by combining these two porosities. An 
effective cellular porosity was measured by µ-CT image analysis that is commonly 
63 
utilized for estimating a fraction of bone in a defined volume, i.e. ROI.[190] The high 
contrast of microspheres, particularly glass beads, with background air produced clear 3D 
rendered images. In order to obtain an inverse volume fraction (i.e. the space of beads in 
the ROI), the protocol was slightly modified as subtracting the calculated percentage 
value from one. The ideal macro-scale porosity is 74%; however, the actual porosity is 
around 68% probably due to some loosely packed spots. (Figure 2.8B-C) 
 
Figure 2.8 Effective cellular porosity calculation via µ-CT image analysis. (A) Row CC 
images of X, Y and Z section. (B) 3D rendered µ-CT image. (C) Define the ROI (yellow volume) 
for porosity calculation. (CCs were prepared with glass beads, D=330µm)  
 
Bulk hydrogel porosity was calculated by measuring the water content in a 
hydrogel slab. As shown in Figure 2.9A, hydrogel matrix has a highly porous structure, 
and in aqueous solution, all these sub-cellular dimension pores are filled with water. 
Therefore, bulk hydrogel porosity can be approximated by calculating the percentage of 
water volume in a hydrogel slab as measuring the weight and volume of a fully hydrated 
and dried the bulk hydrogel slab. A volumetric fraction of water in the hydrogel slab was 
around 97%. (Figure 2.9B)  
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Figure 2.9 Bulk hydrogel porosity calculation via water saturation method (A) SEM image 
of sub-micron scale pores in a bulk hydrogel matrix. (B) Schematic of hydrogel porosity 
calculation procedure.  
 
Mechanical strength 
The compressive modulus of ICC scaffolds was 189.4 ± 5.89 KPa. (Figure 2.10) 
Compared to the mechanical strength of other porous hydrogel substrates, it showed 
stronger mechanical stability[191, 192] due to higher contents of polymer and highly 
ordered pore structure. Indeed the achieved compressive modulus was within the range of 
normal articular cartilage[193], adequate to construct artificial supports of soft tissues. 
 
 
Figure 2.10 Mechanical testing result of ICC hydrogel scaffolds 
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Biocompatibility 
Although the biocompatibility of polyacrylamide hydrogel has been extensively 
demonstrated, ICC hydrogel scaffolds can be potentially toxic since the fabrication 
process involves harsh chemicals such as THF and HF. To minimize such chemical 
induced toxic effect, the scaffolds were extensively washed with deionized-water and 
further dried to completely evaporate any chemical residue. According to our in vitro and 
in vivo experimental data in the following chapters, properly washed ICC hydrogel 
scaffolds did not induce any toxic effect, even after implanted into a mice.  
 
2.4. Summary 
The ICC hydrogel scaffold was developed in order to culture and test cells in a 
reproducible manner. The ICC matrix consists of empty spherical cavities arranged in a 
hexagonally array, providing a consistent and fully interconnected structural 3D 
microenvironment. The chosen scaffolding material provides a nontoxic, transparent and 
hydrophilic environment for cell culture. In addition, the hierarchical porosity makes 
possible efficient nutrient transport while providing a large surface area for cell adhesion. 
The scaffold can be provided as a stand-alone substrate or it can be fit into the wells of 
several sizes of well plates, which are the current standard format for HTS used in the 
pharmaceutical industry. Such unique features of ICC scaffolds would significantly 
improve standardized in vitro tissue development. As a result, it will serve as a valuable 




ENGINEERING HUMAN LIVER TISSUE SPHEROIDS 
 
3.1. Introduction 
3D spheroid culture has been used for in vitro models of various cell types 
including tumor, primary, and stem cells due to distinct advantages: (i) the extensive cell-
cell interactions analogous to the in vivo environment promote the recovery of 3D 
structure/morphology and partial function of the original tissue physiology[29, 177, 194]; 
(ii) the culture can be maintained without vascularization since the diameter permits the 
penetration of oxygen and nutrients up to 200µm inside of the spheroid[195]; (iii) the 
spherical shape is beneficial in simplifying various tissue modeling problems, such as 
diffusion studies for drugs or toxic chemical penetration.[196-198]  
Multiple techniques have been introduced to achieve spheroids. The general 
strategy is to prevent cell-substrate interactions while maximizing cell-cell interactions. 
Typical methods include the hanging drop technique[199], continuous agitation of 
suspension culture in a rotary cell culture vessel[200] or a spinner flask[201], preparation 
of cell repulsive substrates[202], and entrapment within biologically inert 3D hydrogel 
matrices[203, 204]. In these culture conditions, single cells spontaneously self-assemble 
and form a spheroid aggregate. Spheroid formation can be accelerated and controlled by 
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providing external forces (e.g. ultrasound trap[205] and micro-fluidic[206]) or confined 
geometry (e.g. micro-milling[207] and micro-molding[208]). Many of these techniques 
are fairly complex, offer little control over the spheroid diameter, and do not yield high 
numbers of the spheroids.[209, 210]  
There are multitudes of open questions in cell biology involving cellular functions 
that may depend on cluster diameter. Spheroids of small diameters may or may not 
provide proper tissue-level physiological properties due to insufficient numbers of 
interacting cells, while large spheroids can suffer from hypoxia owing to the depletion of 
oxygen at the center.[177] Characterization of these cellular processes has been strongly 
impeded by large deviations in spheroid sizes that create different intensities of cell-cell 
interactions, thereby causing variation in cellular activity levels. Understanding the 
fundamental changes in cell biology with cell cluster size is quite important for tissue 
engineering, basic organ physiology, and drug discovery.[211-213]  
This chapter introduces an ICC hydrogel scaffold-based spheroid culture system 
with conceptual advantages over other 3D matrixes stemming from the CC topology and 
materials selection of the scaffold. First, these scaffolds offer a high yield of spheroids 
with tight control over their diameters. Tight control of aggregate diameters is significant 
when considering assay development since this requires both a high degree of 
optimization and narrow experimental spread to enable discrimination of similar drugs. 
Second, the combination of hydrogel material and specific 3D ICC topology provide a 
unique hierarchical porosity of the cell growth matrix. Third, the described 3D matrixes 
are completely transparent that allow simple monitoring of cellular processes using 
traditional optical techniques while avoiding specialized experimental set-ups required 
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for some other 3D cell cultures. The dimensions of scaffolds were tailored to fit in a 
standard 96 well-plate. Human hepatocarcinoma cell line, HepG2, was selected as a 
model culture system for ICC scaffolds because of its well documented physiology, ease 
of maintenance, and practical usage for drug screening.[214, 215]  
 
3.2. Materials and Methods 
3.2.1. Pocket ICC scaffolds 
CCs were prepared with uniform size glass beads (D=50, 100, 140, 170 and 
200µm, standard deviation ± 2.2-5.7µm). Obtained free-standing CCs were transferred to 
a glass vial (D=8mm, H=5mm) and infiltrated with hydrogel precursor solution by 
centrifugation for 10 minutes at 5500rpm. Polymerization occurs after adding a radical 
initiator (1% (w/w) potassium peroxide) and accelerator (1% (v/w) TEMED). A hydrogel 
slab including CCs was taken out from the glass vial and only bottom side hydrogel was 
removed using a razor blade. The other side of hydrogel was cut out remaining only small 
amount of hydrogel (< 0.5mm). The glass beads were then dissolved with 5% HF 
solution and thoroughly washed sequentially with acid solution, PBS and deionized water. 
In this way, ICC hydrogel scaffolds have open pores only on top side while the bottom 
and edge side pores remain closed. Due to its pocket-like structure, it is named a Pocket 
ICC scaffold. 
3.2.2. Cell culture within ICC scaffolds 
Rehydrated ICC scaffolds were sterilized under UV light and then transferred into 
a 48 or 96 well-plate (Corning, NY). HepG2 human hepatocellular carcinoma cells (HB-
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8065) (ATCC, VA) were maintained with Eagle’s Minimum Essential Medium (EMEM) 
supplemented with 10% Fetal Bovine Serum (FBS) and 1% Penicillin-Streptomycin. 
Cells were cultured in T-75 culture flasks at 37°C with 5% CO2 until they reached the 
desired population. Cells were detached from the culture flask using 2.5% Trypsin-EDTA 
solution. The concentration of the collected cell suspension was adjusted to 25x106 
cells/ml and then 5x105 cells in 20 µl was dropped on top of ICC scaffolds. Cell-seeded 
ICC scaffolds were transferred to 48 and 96 well-plate and total culture volume was 
maintained at 1ml and 0.25ml, respectively. Half volume of media (0.5ml and 0.125ml) 
was changed every day. For 2D cell culture, 48 or 96 well-plates were used and 1x105 
cells were seeded and the half volume of culture media was changed daily.   
3.2.3. Characterization of spheroid formation 
Initial cell seeding profile and the diameter of mature spheroids were imaged 
using an inverted optical microscope with imaging software (QImaging). The number of 
cells initially seeded was further analyzed using ImageJ (NIH) software. 
3D characterization of cell aggregation process was characterized using confocal 
microscope. For confocal imaging, HepG2 cells were stained with 5µM of fluorescent 
chloromethyl derivatives dye (CMRA CellTracer, Invitrogen) prior to seeding or after 
forming mature spheroids. During seven days, spheroid formation process on ICC 
scaffold was imaged. In addition, cell viability was observed using a Live/Dead Viability 
Kit (Invitrogen) under the confocal microscope. 
Morphological evolution of single spheroid was characterized under SEM. Cell-
scaffold samples were collected at different culture points (Day1, Day3, Day5, and Day7) 
and fixed with 2.5% glutaraldehyde solution. Fixed samples were dehydrated through 
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immersion into a series of ethanol solutions. After gold sputter coating, these samples 
were observed under SEM (FEI Nova Nanolab). Some samples were cut into several 
pieces before the dehydration step using a vibratome or a razor blade to observe the 
inside structure of spheroids. Histological sectioning and hematoxylin and eosin (H&E) 
staining were performed by the Tissue Core of the University of Michigan 
Comprehensive Cancer Center.  
3.2.4. Liver specific functional assays 
Albumin secretion 
Albumin secretion from HepG2 spheroids with different sizes was characterized 
by a sandwich enzyme-linked immunosorbent assay (ELSIA) using a human albumin 
ELISA kit (Bethyl Laboratories, Montgomery, TX). 500µl of culture medium was 
collected every 24 hours and kept until analysis. Sample media was diluted 10 times and 
the standard curve was prepared using a reference human albumin. The assay result was 
normalized by total DNA.  
Induced Cytochrome P450 (CYP450) activity 
The spheroid culture was maintained for 5 days and the 2D culture was reached 
approximately 80% confluence before introducing an induction reagent, a 1µM of 3-
Methlycholanthrene in William E Media for 3 days. The induction media was changed 
every 24 hours. As control groups, 0.1% Dimethyl sulfoxide (DMSO) and pure William 
E medium treated samples were also prepared. CYP450 activity was measured by the 
ethoxyresorufin-O-deethlylase (EROD) assay. The induction media was changed to a 
500µl of 8µM 7-ethoxyresorufin and 40µM Dicumarol in William E Media. After 3 
hours incubation, the media and cells/spheroid-scaffolds were separately collected. The 
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cells/spheroid-scaffolds were homogenized using the same way for dsDNA assay sample 
preparation. EROD activity from both the media and cells/spheroid-scaffolds 
homogenized solution activity was measured by the microplate reader. Also the DNA 
content from the homogenized solution was quantitated and used for normalizing the 
EROD assay results. 
DNA quantification 
Total DNA content of both 2D and spheroid cultures were measured using a 
PicoGreen dsDNA assay kit (Invitrogen).  A spheroid-scaffold from 3D culture and a 
trypinzed cell suspension from 2D culture were transferred into a 1.5ml centrifuge tube, 
and 500µl of 1x cell lyses buffer (Promega) was added. The cells and scaffolds were 
destroyed under a brief (5-10 seconds) sonication. Sample solutions were centrifuged for 
5 minutes at 1,000rpm and 25µl of supernatant solution was collected for DNA 
quantification. After adding assay reagents, fluorescent intensity at 590nm by the 
excitation at 540nm was measured by a Synergy2 microplate reader (BioTek, VT).    
Statistical analysis 
Measurement of pore sizes and spheroid diameters were completed in triplicate 
with five scaffolds in each group. Comparisons between multiple groups were performed 







3.3. Results and Discussion 
3.3.1. Pocket ICC scaffold design 
Standardization of spheroid diameters and total cell numbers are critical issues in 
obtaining reproducible analytical results from the 3D spheroid culture. The biological 
activity of a spheroid is closely related to the size of its diameter.[216] For instance, 
spheroids having excessively small diameters would not have the proper tissue level of 
physiological properties and would instead remain at the cellular level due to the lack of 
cell-cell interactions. Increasingly large diameters cause cells at the center of the spheroid 
to suffer from hypoxia and inadequate nutrient transport owing to the limited diffusion of 
oxygen and nutrients.[177] As a result, a significant portion of cells ultimately undergo 
necrosis. Therefore, to achieve a homogeneous and meaningful level of biological 
properties, spheroids should have appropriate diameters with the narrowest size 
distribution possible. Also, total cell numbers need to be consistently regulated for the 
convincing quantification of intra- and extra-cellular proteins because these assay results 
are intrinsically dependent on the number of cells involved.  
The ICC topology created with a cell-repulsive hydrogel matrix exhibits excellent 
physical and chemical properties for spheroid formation with a narrow size distribution 
while also retaining a high optical analytic capability. However, open porous ICC 
scaffold design releases a significant amount of cells right after seeding from the bottom 
or edge side pores, which caused difficulty in controlling the total cell number within the 
scaffold. Moreover, the released cells grew in a 2D environment on the bottom of the 
well-plate, hindering the reproducibility of the experiment and reducing the 3D culture 
effect. (Figure 3.1A&C) To circumvent this issue, the ICC scaffold design was slightly 
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modified to have open pores only on the top side, which is used for cell seeding, while 
pores on the bottom and edge planes are enclosed by bulk hydrogel to reduce the chance 
for cell loss. (Figure 3.1B&D) Although macroscale pores are sealed, sufficient oxygen 
and nutrient exchange is still maintained in the scaffold due to the presence of submicron 
scale pores in the bulk hydrogel.  
 
 
Figure 3.1 Comparison of cell seeding effect between open and pocket ICC scaffolds. (A) 
Open ICC scaffold loses a significant number of cells right after seeding: (left) schematic and 
(right) experimental images. (B) A pocket ICC scaffold considerably reduces cell loss through its 
closed bottom and edge plane pores: (left) schematic and (right) experimental images. 
Quantitative comparison of cell loss issue between (C) open and (D) pocket ICC scaffolds. Since 
cell proliferation in ICC scaffolds is considerably retarded compared to the cells on well-plates, 
after 5 days of culture, the amount of cells growing on a well-plate became similar to the amount 





3.3.2. Liver tissue spheroid formation  
The initial cell seeding profile and the subsequent 3D cell aggregation process 
were characterized. The transparency of hydrogel matrix was beneficial to using confocal 
microscopy for this task. Homogeneous cell seeding was easily achievable with the 
inoculation of a dense cell suspension on top of slightly dehydrated scaffolds. The 
equally-sized spherical cavities promoted the distribution of consistent cell count within 
each pore. Non-fouling polyacrylamide hydrogel pores facilitate an initial cell 
aggregation followed by intensive cell-cell interactions while minimizing cell-substrate 
interaction. As a result, cells gradually self-assemble and form solid 3D spheroids over a 
period of 5 days. (Figure 3.2A)  
Morphological changes during spheroid formation in the scaffolds can be 
categorized by several phases. (Figure 3.2) In the initial phase, cell aggregates are 
generally 2D in respect to curved surfaces of the pores and individual cells are easily 
distinguishable (Day 1). Subsequently, cell sheets begin to coalesce driven by cell-cell 
interactions (Day 2-3). Afterward, cell aggregates acquire a nearly perfect spherical shape 
(Day 3-5), but individual cells remain identifiable. In the final phase, past Day 5 of 
culture, cell aggregates mature and form solid spheroids coated with an ECM protein 
layer appearing as a smooth surface; individual cells are no longer recognizable. After 




Figure 3.2 Characterization of the spheroid formation process. (A) Three dimensionally 
reconstructed confocal images of HepG2 spheroid formation in hydrogel ICC scaffolds on Day 1, 
Day 3 and Day 5 culture (Scale bar is 200µm). (B) SEM images of different stages of spheroids 
and large scale image of mature spheroids in an ICC scaffold. Individual cells aggregate and the 
surface morphology gradually changes. Once they form solid spheroids, it becomes hard to 
distinguish individual cells in the spheroid.  
 
 
Once spheroids develop, all the cells remain within the pore because the 
diameters of spheroids become larger than the channel size. (Figure. 3.3)  Such “ship-in-
a-bottle” effect is quite convenient for in situ confocal imaging of spheroid because the 
transparent matrix restricts spheroid mobility and accurately indexes their position, which 
is quite important for understanding spatio-temporal dynamic processes of intra and inter-
cellular interactions during organized spheroid formation. In addition, it can significantly 
improve the quality of 3D spheroid-based assay results by keeping the total amount of 
cells constant. At the same time, the proximity of hundreds of such spheroids to each 
other and their interconnectivity via ICC channels is a significant step toward simulation 
of actual liver tissue where functional unit of liver tissues i.e. liver lobules are connected 
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by a network of blood vessels[10]. Greater similarity of responses than those in 2D and 
some other spheroid cultures to liver tissue should be expected.  
 
 
Figure 3.3 HepG2 spheroids entrapped in ICC pores (ship-in-a-bottle effect). (A) 3D 
reconstructed confocal microscopic images of ICC scaffolds and mature spheroids entrapped in 
an ICC pore. Fluorescent monomer was used to visualize transparent hydrogel scaffold. (B) (Left) 
Geometrical model of ICC scaffold and entrapped spheroids; spheroids formed on 2nd and 3rd tiers 
of ICC scaffold can stay in the pore while having sufficient empty space for mass transport. 
(Right) 3D stacked confocal image of 250µm in depth from top and cross-section views. 
Numbers 3 and 2 represent spheroids forming in a 3rd and 2nd layer of ICC pore, respectively. 
HepG2 cells were prestained before seeding. 
 
3.3.3. Spheroid characterization 
Cell viability in the exterior and, most importantly, interior parts of mature 
spheroids were characterized by live-dead staining and observation of cell behavior. 
Fluorescence confocal microscopy revealed excellent viability of HepG2 cells within the 
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penetration depth of the stains (22.6±3.4µm); however, no fluorescent signal was 
detected in the center of spheroids for either the live or dead stains. Since effective 
diffusion coefficient of dyes in tissue is fairly low ca. 10-11 m2/s[195], there is a limited 
permeation of reagents inside the cell cluster. Indeed this phenomenon suggested a new 
challenge in 3D cultures because imaging was restricted though used scaffolding material 
was transparent. This issue can be temporarily solved by labeling cells before engineering. 
For example, when scaffolds were seeded with pre-stained cells, it was possible to obtain 
optical images in the middle of the spheroids through the ICC matrix with excellent 
homogeneity of fluorescent intensity. (Figure 3.4) Under these conditions, real-time 
visualization of spheroids at different depths and specific locations[213] would be 
possible. 
 
Figure 3.4 Comparison of confocal slicing of single spheroid between post- and pre-staining.  
(A) Cells in a spheroid were stained right before confocal imaging. The center of spheroid 
appeared as dark due to the diffusion limit of dye molecules. (B) Cells were stained before 
spheroid formation. The cells residing at the center of the spheroid can be imaged and they 




The cell viability at the center of spheroids was also directly confirmed by 
transferring individual spheroids to a 2D tissue culture plate where they disassembled and 
fully spread in a few days. (Figure 3.5) The cells residing in the inner part of spheroid are 
not only alive[217], but also retain capability to migrate and repopulate. 
 
Figure 3.5 Direct confirmation of cell viability in spheroid culture.  (A) After 7 days of 
culture, several spheroids formed on the top tier of ICC pores not completely entrapped in ICC 
pores were released out from the scaffold on purpose. (B) Released spheroids started to interact 
with the surface of a 2D tissue culture plate. (C) After 24 hours of culture, the spheroid largely 
spread and densely packed cells at the center of the spheroid appeared darker compared to the 
spread cells growing on the 2D culture substrate. (D) After 2-3 days of culture, the spheroid was 
entirely disassembled and the spreading area became larger. (Scale bar is 200µm) 
 
To obtain more detailed information about the internal structure of spheroids, the 
mature spheroids were histologically sectioned and stained by H&E.  One can see that the 
interior is fully occupied by densely packed cells and a distinct membrane of ECM 
protein surrounds the outermost region of spheroids. (Figure 3.6A) This ECM layer and 
tight cell-cell junctions slow down the diffusion of the dye/drug/nutrient molecule into 
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the spheroid, which is the obvious difference compared to 2D culture and is important for 
understanding the mechanisms drug delivery, metabolism and hypoxia.[196, 218] 
In addition, a continuous and extensive network of channels exists inside the 
spheroid. Most of these channels open to the outer fluid through pores on the surface of 
the spheroid which frequently appeared in SEM imaging. (Figure 3.6B) These conduits 
are homologous to bile canaliculi structures visualized in in vivo liver tissues. The 
diameter of the channels and openings in spheroids prepared in hydrogel ICC scaffolds 
(2-3µm) coincides very well with reported dimensions of bile canaliculi, 1-3µm 
diameter.[219] Overall, the diffusion conditions and auxiliary self-organization of cells in 
spheroids provide a more adequate description of the actual tissue than 2D cultures. 
 
Figure 3.6 Single spheroid characterizations. (A) Histologically sectioned and H&E stained 
spheroid after 7 days of culture. The surface of spheroid is covered by a thin ECM layer (Arrow 
1). There is an extensive network of channels inside spheroids. Arrow 2 indicates the opening 
pores of the channels on the surface of spheroids. (B) SEM images confirm ECM layer (left) and 
the opening of the channel (right) from mature spheroids. To characterize the ECM layer, the 
spheroid was sliced using a vibratome.    
 
3.3.4. Spheroid size control corresponding to ICC pore diameters 
Preparation of uniformly sized spheroids is critical for the consistent evaluation of 
the relationships between cell cluster diameter and biological activity. Homogeneous 
spheroid size is also important because diffusion limitations vary with spheroid 
dimensions that might or might not affect the target assays. In this respect, the 
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possibilities to control the size of spheroids in ICC scaffolds and investigate these 
relationships represent an interesting opportunity for fundamental cell biology. To 
address whether the pore sizes can control spheroid diameter with desirable precision, we 
prepared five different ICC scaffolds (D=50, 100, 140, 170 and 200µm groups), and 
seeded the same number of cells. (Figure 3.7)  
 
Figure 3.7 Different pore size of pocket ICC scaffolds and initial cell seeding profile (A) 50, 
100 and 200µm pore diameters of pocket ICC scaffolds. Arrows indicate pocket wall in each 
scaffold. (B) Initial cell seeding profile of three different pore sizes. Image analysis results 
revealed that a single cell has a diameter of 10-15µm, and approximately 8 ± 4, 37 ± 6, and 160 ± 
15 cells were seeded in each pores of ICC scaffolds having 50, 100, and 200µm pore dimensions, 
respectively. 
 
At the stage of spheroid maturity (5 days of culture), the dependence of spheroid 
diameter and their size uniformity on the ICC pore size was evaluated. We observed the 
formation of 46.5±8.1, 87.8±16.0, 120.9±14.4, 141.8±19.5, and 151.6±20.0 µm spheroids 
in scaffolds with 59.5±1.9, 108.2±3.9, 154.8±4.0, 183.5±7.2, and 218.6±6.1 µm pores, 
respectively. Indeed, a fine level of control (P<0.0005) over the diameter can be exerted. 
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Typically, the spheroid diameters reached around 77% of pore diameters or 50% of a 
pore volume. (Figure 3.8) When the ICC pore becomes too large, i.e. above 170µm, other 
mechanisms, such as nutrient delivery to the interior cells, apparently begin to play a 
greater role than space restriction and the spheroid diameter becomes less dependent on 




Figure 3.8 HepG2 Spheroid size control corresponding to pore dimensions of ICC scaffolds. 
The pore size is normally 10% larger than the bead dimension. Each group has significantly 
different pore sizes (n=50, * p<0.0005). Spheroid diameters reach approximately 78% of pore 
size except in the 200µm group (69.4%). Except in the 170µm and 200µm groups (*** p>0.01), 
each group has a significantly different sizes of spheroids. (** p<0.0005) (Five scaffolds were 
used in each group and 74-86 spheroid sizes were measured.)  
 
3.3.5. Spheroid size dependent liver specific functions 
Having the set of scaffolds with different pore diameters as a tool for systematic 
study, the dependence of albumin secretion rate and induced CYP450 activity were 
investigated from cell cluster size for three different sizes of spheroid cultures, i.e. 50, 
100 and 200µm groups, and compared the results to a typical 2D culture. As shown in 
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Figure 3.9A, the initial albumin secretion rate in all 3D groups was significantly reduced 
compared to the 2D case, but it rapidly recovered over the culture period. On the other 
hand, there was only moderate increase in 2D substrates over the cell culture period. The 
50µm group showed the fastest increment and became closer to the 2D culture level only 
after 2~3 days of culture. The albumin secretion rate in 100 and 200µm groups became 
comparable to the 2D case after one week of culture, and there was no significant 
difference between the two groups. Three points should be made from the comparison of 
albumin secretion rates in the 2D, 50, 100, and 200μm cultures: (i) Contrary to what 
might be inferred from previous studies[219, 220], all experimental groups revealed the 
general trend that at least the initial albumin secretion become initially suppressed rather 
than augmented in 3D cultures. In fact, this is not surprising because most of the cellular 
energy in Day 1-3 is probably consumed by forming multicellular spheroids and tissue 
infrastructure inside them, such as bile canaliculi. Gradual enhancement of albumin 
secretion following spheroid formation infers that cellular protein synthesis capability is 
recovered once they form stable spheroids; (ii) Smaller spheroids take less time to form, 
and hence, one can observe substantially steeper growth of albumin secretion (Day 1-3) 
in the 50µm group compared to the 100 and 200µm groups; (iii) Production of albumin 
exhibited only moderate, if any, rise in 2D culture. Fast rise and plateau after 3 days was 
observed in the 50µm group, and a continuous increase over a period of 8 days was seen 
in the 100 and 200µm groups. This suggests that phenotypic change gradually occurs in 
spheroid culture, whereas the same cellular phenotype maintains in 2D culture.[221] 
Similarity of albumin production rate after should not be used as an indication of 
phenotype identity.  
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Induced CYP450 activity was measured by an EROD assay after 5 days of culture. 
(Figure 3.9B) Since a significant amount of transformed substrate remained in 
cell/scaffold lysate solution of 3D culture, not only sample media, but also hydrogel 
matrices and spheroids were characterized. Similar to the albumin secretion results, 
EROD activity in 2D culture was higher than in all 3D cultures, and the 50µm group 
showed superior CYP450 induction to the 100 and 200µm groups. Considering the data 
on albumin secretion and mitochondrial activity in spheroids[218], the trends in EROD 
assays should be interpreted in relation to metabolic activity of cells rather than direct 
consequence of culture formats. The key parameter here should be the surface area to 
volume ratio, which increases for smaller spheroids. The percentage of cells inside the 
spheroid with a characteristically low metabolic rate increases for larger spheroid 
diameters. 
 
Figure 3.9 Testing liver tissue specific functions from HepG2 spheroid and 2D culture. (A) 
Normalized albumin secretion rate by total dsDNA content in a 24 hours period. (B) Normalized 
induced CYP450 assay result with total dsDNA content after 5 days of culture. Each bar is 
composed of EROD activity from the culture medium (yellow) and the solution of homogenized 
cells/scaffolds (green). The remaining portion of resorufin within the cells in 2D culture was 
negligible (4%), while a substantial amount of resorufin remained in the cells and the hydrogel 
matrix in 3D cultures (~30%). (* Comparison between 2D culture and all 3D cultures (P<0.005), 
** between 50µm and 200µm group (P<0.05), *** between 100µm and 200µm group (P>0.05), 
representative data from three independent experiments, N=4~8) 
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Discussing cell metabolism in spheroids, one also needs to point out that 
diffusivity of oxygen is quite high with effective diffusion coefficients of 3.4 x 10-10 
m2/s[195]. The diffusion limit of oxygen in tissues is around 150-200µm[222], so cells 
within spheroids of a diameter up to 300-400µm are not expected to suffer from hypoxia, 
while the diameters of the spheroids used here are 48-150µm. Hypoxia cannot be the 
reason for the reduction of metabolic rate. The underlying reasons behind the trend of 
reduction of cellular activity in 3D arrangements can be several: (i) Extensive cell-cell 
contacts in clusters can signal the cells to reduce metabolic rate; (ii) The diffusion of 
albumin, EROD, and other reporting molecules to and from the internal cells has a 
greater barrier than that in the 2D cell cultures; (iii) Surface cells dominating in small 
clusters and 2D cultures may be more active because they have better conditions for the 
delivery of nutrients and removal of metabolites.  
Interestingly, there is an evident contradiction between the data reported here and 
those published previously which typically show greater activity in spheroids than in 
“flat” cells[223-225]. Analysis of this discrepancy is significant in understanding cell 
biology and the proper selection of cell culture conditions for different tissue modeling 
tasks. Two potential factors are suspected. The first one is the absence of shear forces that 
have been frequently utilized in spheroid culture because the flux conditions stimulate 
cell aggregation.[206, 207, 224, 225] Presence or absence of shear force in 3D conditions 
could be the key factors determining metabolic rate of cells. Besides improving diffusion 
of oxygen and nutrients, mechanical stimulation by shear stress plays an important role in 
maintaining a proliferative state of hepatic spheroids and enhancing liver specific 
functionality. For example, Shvartsman et al. demonstrated significantly augmented 
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CYP450 activity of hepatic spheroids in perfusion culture condition.[225] Also Chang et 
al. reported that HepG2 spheroids cultured within a rotating wall vessel bioreactor 
exhibited continuous proliferation and substantially up-regulated metabolic 
activities.[224]  
In addition to shear forces, a topological factor could account for the lower 
metabolic activity since ICC matrices, unlike 2D and other 3D systems have high volume 
density of cells and interfaces. On one hand, this brings them closer to real human liver.  
On the other hand, this can induce strong contact inhibition of cells, which cause a 
substantial portion of cells to become quiescent in spheroids.[226]  Quiescent tumor 
spheroids can potentially be an excellent model for understanding tumor dormancy, as 
well as their repopulating and metastatic mechanisms.[227]  
 
3.4. Summary 
In summary, uniformly sized pores in ICC hydrogel scaffolds afford a high yield 
production of controlled size spheroids in standard 96 well-plates. Transparent hydrogel 
matrix and ship-in-bottle effect also allows for convenient monitoring of cell processes 
by traditional optical techniques. Different developmental stages of 46.5–151.6µm 
spheroids from HepG2 hepatocytes with vivid morphological similarities to liver tissue 
(bile canaliculi) were observed. A high yield of spheroids in well-interconnected pores is 
beneficial to derive tissue level biological responses without tissue vascularization. Liver 
specific function was demonstrated to be strongly dependent on the diameter of spheroid. 
 Since the aggregation of cells into clusters is a universal biological process, these 
findings and scaffolds can be applied to many other relevant cell types. Along with many 
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advantages expected of ex vivo replicas of human organs, this system also allows one to 
identify the specific challenges of 3D cell cultures and avoid fundamental experimental 
mistakes and conclusions. Most importantly the presented system will contribute to the 
development of various physiological and pathophysiological 3D tissue models which 













IN VITRO TOXICITY TESTING OF NANOPARTICLES 
 
4.1. Introduction 
In this chapter, the standardized 3D liver tissue spheroid culture model is applied 
to an in vitro toxicity testing platform. Instead of drug molecules, nanoparticles (NPs) 
were selected as testing compounds because it is getting important to access and predict 
their toxic effects in the body. Despite providing valuable information, in vitro 2D cell 
culture models do not accurately predict in vivo toxicity and other biological effects of 
NPs due to the absence of key physiological processes[212], such as transport of NPs 
through cell layers when they are brought in contact with the tissues. Also, essential 
effects of NPs and other substances are neglected with respect to cellular functions which 
are strongly dependent on 3D organization. For example, the enhanced specific protein 
secreting function of granular epithelial cells can only be observed when they form a 
three dimensionally organized acinus structure.[29] As an additional piece of evidence 
substantiating the significance of expanding cell toxicity assays from 2D to 3D cultures, 
one also must mention that it has become increasingly apparent that there is a large 
discrepancy in toxicity results depending on whether in vitro 2D cell culture or animal 
models were used.[228] For instance, recent studies on toxicity testing of quantom 
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dots[229], magnetic NPs[230], CNTs[231] and fullerenes[232] using in vitro 2D 
cell culture showed high cytotoxic effects. However, when they were tested in animal 
models, no adverse effects were observed.[233-236] (Table 4.1) 
As shown in Chapter 3, multicellular spheroid culture is expected to be the most 
effective 3D culture model. Therefore, the toxicity testing based on the spheroid culture 
would deliver more physiologically relevant toxicological information about NPs that 
might be quite different from the current cellular level cytotoxicity. Resultantly, it can 
potentially enhance the predictive power of current in vitro toxicity testing for estimating 
in vivo toxicity. 
Table4.1 Discrepancy between in vitro and in vivo NPs toxicity testing 
 Cytotoxicity  




 “Our work clearly indicated that these 
materials are toxic…”  
Nano Lett. 6, 1121 (2006)  
“No toxic side effect of SWNTs to mice 
was observed in…” 
PNAS, (2) 105, 1410 (2008)  
Fullerenes 
 “This work demonstrates both a 
strategy for enhancing the toxicity of 
fullerenes…”  
Nano Lett.  4, 1881 (2004)  
 “The results demonstrated little or no 
difference in lung toxicity effects …” 
Nano Let. 7, 2399 (2007) 
Magnetic 
NPs 
 “Exposure to increasing concentrations 
of anionic magnetic NPs results in a 
dose-dependent diminishing ability of 
PC12 cells..”  
Biomaterials, 28, 2572 (2007)  
 “…magnetic nanoparticles of 50-nm 
size did not cause apparent toxicity 
under the experimental conditions of 
this study...” 
Toxicol Sci, 89, 338 (2006)  
Quantom 
Dots 
 “…CdTe QDs induce cell death via 
mechanisms involving both Cd2+ and 
ROS …” 
 Langmuir, 4, 1974 (2007) 
“Few signs of functional toxicity or 
clinical (urinary or blood) changes were 
noted…” 
J of Nanosci. & Nanotec. 7, 497 (2007) 
 
Methods for the toxicity testing of NPs are basically the same as the techniques 
used in modern drug development; however, the toxic mechanism of NPs can be more 
diverse than that of drug compounds. NPs can be indiscriminately transported into cells 
due to their comparable dimension to biological macromolecules.[237] Fiber-shaped NPs 
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such as nanowires, nanotubes and nanofibers have a high probability for the penetration 
of cell membrane and tissue layers, as has been reported for asbestos.[238] Decomposed 
NPs generate free radical species or toxic ions which can injure plasma membrane 
functions by reducing membrane integrity or impairing ion channel transport.[239] 
Additionally, there are potentially more unrecognized harmful effects of NPs considering 
the great diversity of engineered NPs in chemical composition, size, shape, charge, 
coating, solubility, and so on.[240-242] Equally, there might be some potentially 
unrecognized beneficial effects related to the same factors. (Figure 4.1) Until now all of 
the in vitro NP toxicity testing has been performed using 2D cell cultures[243], and it will 
be very important to demonstrate a suitable 3D cell model for NPs and compare the 
results with 2D cell cultures. 
 
Figure 4.1 Various routes of nanoparticle induced toxicity 
 
The established ICC-spheroid culture system exhibits multiple advantages for NP 
toxicity testing. For instance, transparent hydrogel matrix allowed easy characterization 
of optical based assays. In addition, by utilizing standard micro well-plates, it can be 
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readily accessible to existing hardware such as a microplate reader. Consequently, the 
spheroid culture system permits the systematic and reproducible characterization of toxic 
effects of NPs on liver tissue which is one of major tissues for NP accumulation. The 
toxic effects of CdTe and Au NPs were tested using a number of different approaches, 
including morphology, membrane integrity, metabolic activity and cell death mechanism; 
and a comparison was made with conventional 2D culture-based cytotoxicity.  
 
4.2. Materials and Methods 
4.2.1. Au and CdTe nanoparticle synthesis 
Au nanoparticle synthesis 
Au NPs having two different stabilizers were synthesized following the 
previously reported method.[244] Briefly, a 20ml of aqueous solution containing 2.5x10-
4M HAuCl4 and 2.5x10-4M trisodium citrate was mixed with 0.6ml of ice-cold 0.1M 
NaBH4 solution while stirring. In a few minutes, Citrate-Au NPs were prepared with a 
diameter of 3.5±0.7 nm. A 7.5ml of aqueous solution containing 2.5x10-4M HAuCl4 and 
0.08 M cetyltrumethylammonium bromide (CTAB) was mixed with 0.05ml of 0.1M of 
ascorbic acid solution. CTAB-Au NPs with a diameter of 5.5±0.6 nm were prepared by 
adding 2.5ml of Citrate-Au solution while stirring. 
CdTe nanoparticle synthesis 
L-cysteine stabilized CdTe NPs were prepared according to the literature.[245, 
246] Briefly, 2.35mM of Cd(ClO4)2.H2O and 5.7mM of L-cysteine were dissolved in 
125ml of deionized water; the pH is rapidly adjusted to 11 using 1M NaOH and placed in 
a three-necked flask and degassed with N2.  H2Te gas is introduced to this solution by the 
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reaction of 0.46mM Al2Te3 and 20ml of 0.5M H2SO4 in a separate three-necked flask. 
The solution is nitrogen-purged for an additional 30minutes, at which time the CdTe NP 
solution is refluxed to achieve the desired NP size. The NPs were observed under atomic 
force microscopy (AFM) (Digital Instruments NanoScope III) and analyzed using 
NanoScope ® III software tools. Fluorspectroscopic measurements were performed using 
a Jobin Yvon Horiba FluoroMax-3.   
4.2.2. Spheroid culture and nanoparticle treatment 
ICC hydrogel scaffolds were prepared using glass beads (D=156.85±8.4µm). 
Dried state ICC scaffolds were rehydrated in PBS solution and then sterilized by 
immersion in 70% ethanol for 15 min under UV light. The sterilized scaffolds were 
washed with PBS three times and transferred into a non-tissue culture treated 48 well-
plate (Corning, NY). Human hepatocellular carcinoma (HepG2) spheroid arrays were 
prepared following the protocol in Chapter 3. Briefly, a 20µl of cell suspension (5x105 
cells) was dropped on top of an ICC scaffold and then 1ml of culture media was gently 
added into the well. For 2D culture, 1x105 cells were seeded in each well of a 12 well-
plate containing 1ml of culture media. A half volume of media (0.5ml) was changed daily 
both 2D and 3D cultures for 5 days.  
On Day 6 of culture, media was changed with 10µg/ml CdTe and 98.5µg/ml Au 
NP solutions in William’s E medium. A control culture was maintained with only 
William’s E medium. After 12 and 24 hours (also some interval time points) incubation, 




4.2.3. Morphological characterizations 
Optical and Confocal Microscopes 
Cell morphology was observed using an inverted microscope with 10X and 20X 
objectives (Nikon TS100) and a digital camera with imaging software. Cell viability was 
observed after staining Live/Dead dyes under confocal microscope (Leica SP2). 
Specifically, NPs exposure and control culture were incubated with 2µM calcein and 
4µM ethidium homodimer-1 for 40 minutes at 37°C. Under a laser excitation of 488nm, 
live cells were imaged as green using a 510-540 nm emission filter, and dead cells stained 
by ethidium homodimer-1 were imaged as red using a 600-630 nm emission filter. 
Scanning Electron Microscope 
A SEM was used to characterize cellular morphology. Cells in sample scaffolds 
and on 2D glass slides were fixed overnight with 2.5% glutaraldehyde solution. The 
samples were then dehydrated through a series of ethanol solution concentrations of 50, 
70, 90, 95 and 100%, and then freeze dried. After 180 sec gold sputtering, the samples 
were imaged using a FEI Nova Nanolab SEM.  
4.2.4. Toxicological assays 
LDH Assay 
 Lactate dehydrogenase leakage from dead cells was analyzed using a LDH assay 
kit (Promega, WI). Diluted supernatant of 50µL was mixed with 50µL of reagent and 
incubated for 30 minutes at room temperature. A 50µL of stop solution was then added, 
and absorbance at 490nm was measured using a microplate reader (BioTek, VT)  
MTT Assay  
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Mitochondria activity was quantified using a MTT assay kit (ATCC, VA). The 
medium was aspirated and 500µL of fresh serum-free medium was added with 50µL of 
MTT reagent. After 3 hours incubation, 500µl of detergent solution was added and 
incubated for 2 hours more. The scaffolds and cell lyses solutions were transferred into 
1.5ml centrifuge tubes. Scaffolds were completely destroyed by using forceps and further 
sonication. After centrifugation at 1,000rpm for 5 minutes, 200µl of supernatant solution 
was collected, and then the absorbance was measured at 590nm (sample) and 630nm 
(reference). The difference in activity between normal and NPs exposure cultures was 
used as a toxicity indicator. All measurements were performed in triplicate, and six 
independent experiments were carried out.  
Apoptosis Assay  
Caspase activity was measured using a Caspase 3/7 assay kit (Promega). After 
treatment of CdTe NPs, the culture media was completely removed for the LDH assay. 
The scaffolds were transferred into a 1.5ml centrifuge tube and 250µl of 1x cell lyses 
buffer solution (Promega) was added. The scaffolds were then crushed into small pieces 
with a micro centrifuge sample pestal and sonicated for 3-5 sec. In 2D cultures, 250µl of 
1x cell lyses buffer was added. Then 250µl of Caspase 3/7 assay reagent was added to 
each sample solution and incubated for 2 hours at room temperature. To maintain the 
same sample preparation conditions, the cell lysate in 2D cultures were transferred into 
1.5ml centrifuge tubes and briefly sonicated to make a homogeneous dispersion. The 
sample-containing tubes were centrifuged at 1,000rpm for 5 minutes to precipitate 
scaffolds and cell debris. A 200µl of supernatant solution was collected in a white-wall 
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luminescence plate. Luminescent intensity was measured using a microplate reader with 
10 seconds integration time.   
 
4.3. Results and Discussion 
4.3.1. Standardized hepatic spheroid culture model 
An absolute spheroid size suitable for toxicity testing and other assays has not 
been identified. Considering the previously reported data[197, 247], spheroid diameters 
were aimed to be around 100µm so as not to induce hypoxic culture conditions while 
recovering tissue level physiological properties. The spheroid diameters are dependent 
upon pore dimensions, which can be easily regulated by changing the size of the 
microspheres in the colloidal crystal template. Here glass beads with a diameter of 156 ± 
8.4µm were used for preparing colloidal crystals. Final ICC scaffolds have 174.6 ± 10µm 
diameter pores, approximately 10% larger than the template bead sizes due to swelling of 
the hydrogel matrix, and 49.6 ± 7µm diameter interconnected channels, approximately 
30% of pore diameters. (Figure 4.2) 
  
Figure 4.2 HepG2 spheroid (D~100 µm) arrays prepared in ICC hydrogel scaffolds. (A) 
SEM and (B) Confocal images 
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4.3.2. Morphological evaluation after nanoparticle exposure 
The exact mechanism of semiconductor NP (e.g., CdTe and CdSe) induced 
toxicity is unclear, however, it has been identified that the most important aspect is the 
stability of NPs both under physiological conditions, i.e. intracellular and in vivo, as well 
as during synthesis and storage since they are susceptible to photolysis and oxidation. 
Released free cadmium and reactive oxygen species impair cell function and eventually 
kill the cells.[229, 248] For example, Derfus et al. demonstrated that decreased 
photostability of CdSe NPs under exposure to ultraviolet light caused liberation of free 
Cd2+, which in turn enhanced cytotoxicity.[249] Kirchner et al. reported that the core-
shell structure of CdSe/ZnS significantly reduced the cytotoxicity of CdSe NPs by 
protecting the core from oxidation and preventing it from leaching into the surrounding 
solution.[250] The cytotoxicity of semiconductor NPs also differs depending on their 
size[233, 248] and stabilizer chemistry/surface modification.[229, 251] On the other 
hand, gold NPs have excellent stability and major factors inducing toxic effect are shape, 
size and stabilizer chemistry.[252, 253] 
In this study unmodified L-cysteine-stabilized CdTe NPs were intentionally used 
which are unstable and quite toxic in order to highlight the different cellular toxic effects 
between 2D and 3D spheroid cultures. The CdTe NPs have a photoluminescence peak of 
577nm and an average diameter of 2.9±1.0 nm. (Figure 4.3) The CdTe NP concentration 




Figure 4.3 L-cysteine stabilized CdTe NPs synthesis. (A) Emission PL spectra, peak at 577nm, 
(B) AFM image, 2.9±1.0 nm of average diameter 
 
Citrated-stabilized (D = 3.5 ± 0.7 nm) and CTAB–stabilized (D = 5.5 ± 0.6 nm) 
spherical Au NPs were also prepared. Their concentration and exposure time were 
maintained at 98.5µg/ml and 24 hours, respectively. All toxicity testing was performed 
with freshly synthesized NPs, less than a week after preparation, but increased toxic 
effect of CdTe NPs over time was observed in the 2D culture due to decomposition (Data 
not shown). In addition, to establish comparable testing conditions in both 2D and 3D 
cultures, the same culture volume (1ml) and a similar number of cells were maintained at 
the point of toxicity testing. Since the cell proliferation rate in spheroid culture is 
considerably slower than in 2D culture, five times fewer cells were seeded for 2D 
cultures (1x105 cells) than 3D cultures (5x105 cells). After 5 days of culture, the point at 
which 3D cultures form solid spheroids and NP exposure began, total cell numbers in 
both cultures were approximately equal. Additionally, toxicity assay results were 




Figure 4.4 Comparison of 2D and 3D culture of HepG2 cells after 12 hours of CdTe NP 
exposure. (A-D) Optical images of normal (A) 2D and (C) 3D spheroid cultures. After CdTe NP 
introduction, (B) 2D culture showed a dramatically different morphology, (D) while it was hard 
to distinguish any change in the 3D culture under an optical microscope. (E-H) Confocal images 
of live/dead stained normal (E) 2D and (G) 3D spheroid cultures; live cells are green and dead 
cells are red. Most cells in both cultures showed excellent viability. Again after CdTe NP 
exposure, (F) 2D culture revealed that a significant number of cells were dead. (H) Although a 
few cells located on the surface of spheroids were dead, overall the number is much smaller than 
the 2D culture. 
 
At first, the cellular morphology change was investigated because it is an obvious 
initial sign of toxic effect. In 2D cell culture, HepG2 cells normally have a flat shape after 
spreading out on a well-plate while closely attaching to each other. However, their 
morphology dramatically changed after 12 hours of CdTe exposure. A significant number 
of shrunk and rounded cells were observed with some partially detached from the well-
plate. (Figure 4.4A-B)  
In case of Au NPs, as expected, in 2D culture citrate-stabilized Au NPs did not 
induce toxic effect while CTAB-stabilized Au NPs showed high cytotoxicity. (Figure 
4.5) Interestingly toxic effects of CdTe and CTAB-stabilized Au NPs were significantly 
reduced in 3D spheroid culture. No significant morphological alteration was noticed in 
spheroid culture except only a slightly rugged spheroid surface. (Figure 4.4C-D) 
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Figure 4.5 Characterization of cellular morphology after 24 hrs Au NP exposure. (A) 
Control culture, (B) Citrate-Au and (C) CTAB-Au NPs.   
 
In order to confirm whether the reduced toxic effect is caused by the diffusion 
limit of toxic molecules within the scaffold or not, a simple diffusion test was performed 
as dropping a 500µl of rhodamin solution on top of an ICC hydrogel scaffold. The spread 
of dye molecule was characterized in real time under confocal microscope. Within 5 min 
strong fluorescent signals were detected from the entire scaffold. (Figure 4.6) This result 
supports that the diffusion of toxic molecules is not the reason of reduced toxic effects in 
the 3D spheroid culture.  
 
Figure 4.6 Real time characterization of rhodamin diffusion within ICC scaffolds 
 
To distinguish more clearly between live and dead cells, the cells were stained 
with live-dead assay dyes. In 2D culture, it was apparent that dead cells (red) morphed 
into a granular shape and fell away from the plate after losing their cell-cell and cell-
substrate interactions. (Figure 4.4E-F) Although the spheroid culture did not undergo a 
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distinct morphological change, a few dead cells were observed on the surface of 
spheroids with a rugged exterior, as discussed above. There were noticeably fewer dead 
cells in the spheroid culture than the 2D culture. (Figure 4.4G-H)   
Morphological changes were further characterized under a SEM. In normal 
conditions, individual cells are hard to distinguish in both cultures because they form 
tight cell-cell junctions covered by a pervasively developed ECM layer. After 12 hours of 
CdTe NP exposure, dying or dead cells could be distinguished as they were separating 
from a live cell colony. This phenomenon was more obvious in 2D culture. In spheroid 
culture, dead cells could be identified as protruding bulbs, but they did not separate from 
the spheroid. It seemed that cells in a spheroid were tightly packed together and formed 
intensive junctions with adjoining cells. Thus, dead cells could stay in the spheroid 
despite losing their cell-cell interactions, and the overall spherical shape could be 
maintained. (Figure 4.7)   
 To further examine the toxic effects of CdTe NPs, the exposure time was 
extended 24 hours. As expected, longer treatment caused severe damage in 2D culture. A 
significant number of cells were dead and detached from the well-plate. Even 
cytoskeletons of dead cells were readily identified. (Figure 7A-Right) Similarly, in 
spheroid culture the surface roughness increased, corresponding to an increase in dead 
cell bodies. Individual dead cells were easily recognizable but they still remained on the 
spheroid. In order to observe the inner part of the spheroids, samples fixed in 
formaldehyde were left for one week to allow partial detachment of the dead cell bodies 
from the surface of the spheroid. Characterization of the spheroids revealed that the inner 
cell mass was preserved while the outer layer of cells was severely damaged. (Figure 7B-
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Right) CTAB-Au NPs showed similar results to CdTe NPs treated culture. Again no 
significant morphological change was observed for citrate-Au NPs. 
 
Figure 4.7 SEM images of 2D (A) vs. 3D spheroid (B) cultures before and after CdTe NP 
exposure. (Left) Typical morphology after 5 days of culture. The surface is very smooth due to 
tight cell-cell junctions and a well-developed ECM layer, so that it makes hard to distinguish 
individual cells in both cultures. (Center) Representative morphology after 12 hours CdTe NP 
exposure. Dying cells gradually lose their cell junctions. Shrunken cell bodies detached from the 
cell colony were easily recognized in 2D culture, while in 3D spheroid culture, dying or dead 
cells located on the surface were partially dissociated from the spheroid and appeared as 
protruded blubs. (Right) Morphological change after 24 hours CdTe NP exposure. In 2D culture, 
most cells were dead and considerable number of cells was detached from the substrate. Although 
cells in spheroid culture were damaged, multilayered structure buffered toxic effects to inner 
cells. Intact inner cell mass were observed after partially detaching dead cell bodies on the surface 
of the spheroid by intentionally keeping the formaldehyde fixed culture for one week.  
 
Morphological study results clearly indicate that the degree of toxicity of CdTe 
and CTAB-Au NPs to the spheroid culture is substantially lower when compared to the 
2D culture. The most obvious reason for that is the diffusion of NPs into the spheroid. 
Densely-packed cells in the spheroid are covered by a well-developed layer of ECM 
common for all tissues which reduces the penetration of toxicants. Hence, the inner layer 
of cells received less damage than cells in the outer layer. Also the dead cells on the outer 
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layer of the spheroid potentially acted as a temporal protective barrier against toxic 
materials as they increased the thickness of the ECM.  
 
4.3.3. Toxicological assays 
In the next step, the toxic effects of NPs were evaluated quantitatively utilizing 
lactate dehydrogenase (LDH) and methyl tetrazolium (MTT) assays. The LDH assay 
detects the amount of LDH that leaks out from the plasma membrane of damaged cells. 
This extracellular protein assay protocol was identical in both 2D and spheroid cultures. 
The MTT assay measures the amount of enzymatically-reduced MTT in the mitochondria. 
Thus, cell lyses utilizing a detergent or lyses buffer were required. In the scaffold-based 
spheroid culture system, an additional spheroid and scaffold destruction step was needed 
to make a homogeneous cell lysate such as torn down and sonication of scaffolds. To 
keep the same assay conditions, 2D culture samples were also treated in the same manner. 
Both cultures were treated with CdTe NPs for 12 hours and gold NPs for 24 hours before 
running the assays.  
As expected from the morphological study, the toxic effects of CdTe NPs were 
significantly reduced in spheroid cultures. (Figure 4.8) Specifically, the results showed 
five times lower LDH leakage and two times more reduction of mitochondrial activity 
than in 2D cultures. The different sensitivity of the assay results was expected due to the 
nature of each assay and the different cell phenotypes. For example, the LDH assay is 
more sensitive to the number of cells at the solution interface capable of leaking their 
cytosolic contents into the media. All of the cells in 2D culture are exposed to the 
solution, while only a small portion of cells in spheroid culture make direct contact with 
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the solution interface. The remaining cells are enclosed by the outer layer of cells. For 
this reason, it caused a larger gap between two cultures. In the MTT assay, however, cells 
are dissolved before analysis and, therefore, the cell phenotype is more closely related 
than diffusivity or the number of exposed surface cells. In the case of spheroid culture, 
one can consistently see a considerably reduced proliferation rate which causes the 
accumulation of a quiescent cell phenotype, which in turn gradually reduces cell 
metabolic activity.[177] Since mitochondria produce about 90% of the adenosine 
triphosphate (ATP) required for cell survival, down-regulated mitochondrial activity in 
spheroid culture caused significantly reduced MTT activity compared to 2D culture 
despite the similar number of cells in both cultures.[218] Therefore, the MTT assay 
results after CdTe NP exposure are required to be calibrated with control samples. The 
drop in MTT activity was almost two times higher in 2D culture than 3D spheroid culture. 
(Figure 4.8B)  
 
Figure 4.8 Quantitative comparison of toxicology assays between 2D and 3D spheroid 
culture after 12 hours of CdTe NP exposure. (A) Normalized LDH assay results. LDH activity 
before treatment was similar between the two cultures. However, after CdTe exposure, LDH 
leakage in 2D culture (1047%) was almost five times higher than spheroid culture (212%). (B) 
MTT assay results. In control samples, MTT activity in the 2D culture was more than 2 times 
higher than the 3D culture due to down-regulated cellular metabolism. Upon exposure to CdTe 
NPs, the decrement of mitochondrial activity from the control group in the 2D culture (56%) was 
approximately two times higher than the spheroid culture (31%).  
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Similarly a significantly reduced toxic effect of CTAB-Au NPs was observed in 
spheroid culture. More specifically, LDH leakage and decreased mitochondrial activity 
was three times lower in spheroid culture than 2D flat culture. Citrate-Au NPs slightly 
reduced mitochondrial activity (5%), but there was no substantial change of LDH leakage 
in both types of culture. (Figure 4.9)  
 
Figure 4.9 Quantitative comparison of toxicology assays between 2D and 3D spheroid 
culture after 24 hours exposure to Au NPs having two different stabilizers. CTAB-Au NPs 
caused severe toxicity but Citrate-Au NPs induced negligible toxic effect. CTAB-Au NP toxicity 
was significantly reduced when it was tested in 3D spheroid culture. (A) Normalized LDH assay 
results demonstrate three times less LDH leakage of CTAB-Au NPs in 3D culture. (B) MTT 
assay result shows that three times less reduction of mitochondrial activity of CTAB-Au NPs in 
3D culture.  
 
 
4.3.4. Cell death mechanisms 
The MTT assay results reflect that reduced CdTe NP toxicity in spheroid culture 
is closely linked to a change of cell phenotype. With this in mind I hypothesized that 
CdTe NP-induced toxicity would cause different cell death mechanisms, i.e., dying cells 
in spheroid culture would undergo more apoptosis but less necrosis than in 2D culture. 
Necrosis is a catastrophic cell death caused by acute cellular injury, resulting in the 
release of cytosolic proteins into the intercellular space. Apoptosis is a controlled, natural 
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cell death mechanism. Compared to necrosis, the apoptotic process does not release 
intracellular constituents into the extracellular milieu but instead presents various 
signaling molecules such as caspase proteins. However, these signaling molecules are 
only temporarily presented before the cells undergo secondary necrosis, which is similar 
to necrotic cell death. Therefore, a time-dependent study is necessary to distinguish 
apoptosis from necrosis.  
In order to test our hypothesis, the intensity of apoptotic (Caspase-3/7 assay) and 
necrotic (LDH assay) processes after 1, 2, 4, 6, 8, 12 and 24 hours of CdTe NPs exposure 
were measured. (Figure 4.10) At these time points the culture medium was collected for 
the LDH assay, while the remaining cells on plates and scaffolds were further processed 
for the Caspase 3/7 assay. In both cultures the apoptosis and necrosis values had similar 
trends yet they displayed substantial differences. In 2D cultures, the LDH assay value 
gradually increased until 8 hours and then suddenly jumped, while in spheroid cultures it 
was slightly enhanced until 12 hours followed by a moderate increase between 12 and 24 
hours. Since a sudden increase of LDH leakage designates the point of prevalent necrosis 
or secondary necrosis at the end of apoptotic cell death, these data demonstrate that 
necrotic points of spheroid culture, either by necrosis or apoptosis, is much more retarded 
than 2D culture.  
The caspase assay results more clearly showed phenotypic effects. In 2D culture 
the caspase activity continuously decreased with different level of retrenchment over 
time—gradually diminishing for 2 hours before rapidly dropping. Please note that a 
relatively high concentration of unmodified CdTe NPs was intentionally used. On the 
other hand, in spheroid culture an initial jump in the caspase activity was first observed, 
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followed by a gradual decrease. I also observed inherently higher caspase activity in 2D 
cultures than spheroid cultures similar to MTT results. These data obviously indicate that 
cells in spheroid culture undergo more apoptotic processes than 2D culture due to the 
cellular phenotypic change. 
 
Figure 4.10 Kinetic studies of the cell death mechanism. Representative data of combined 
LDH and Caspase 3/7 assay results over a span of 24 hours, with measurements at 8 different 
time points. The results were normalized with dsDNA quantification data. The LDH assay, the 
absorbance value on the right Y-axis, was used as a necrosis marker. The Caspase 3/7 assay, the 
luminescence value on the left Y-axis, was used as an apoptosis indicator. (n=3 at each time point, 
total n=24 in each type of culture). 
 
 
These results are well correlated with previous animal testing results.[228, 234-
236, 254] For example, Zhang et al. reported that intravenous injection of CdTe NPs into 
rats did not cause any damage to major organs. Although locomotive activity was 
reduced shortly after dosing, it returned to normal within 24 hours. [233] In fact 
nanoscale materials undergo various physiological processes in the body, including 
circulating in the blood stream, accumulating in specific organs, cellular uptake, and 
106 
renal excretion.[78, 255-257] It seems that such diverse and complex physiological 
processes cooperatively act to mitigate the toxic effects of NPs in vivo.  
Similar to the findings, the reduced toxic effects of drug compounds in 
multicellular spheroid culture models were previously reported by other 
investigators.[258] Also there are several reports highlighting the unique opportunities of 
spheroid culture as an in vitro toxicity testing application.[211, 215, 259] Nevertheless, it 
has not been widely accepted in the actual toxicity screening field because there are still 
technical barriers preventing current spheroid culture systems from being used in 
practical and industrial applications, such as standardization, reproducibility, high yields, 
and simple manipulation for experimental intervention and assay purposes. ICC hydrogel 
scaffolds significantly improve all these issues. Highly controlled ICC structure and 
material resulted in excellent control and standardization of prepared liver tissue 
spheroids. A simple and versatile fabrication method allows the mass production of a 
diverse range of macro- and micro-scale ICC scaffolds. It can also be readily combined 
with currently utilized HTS equipment. Additionally, the transparent hydrogel matrix 
enables the deep confocal 3D imaging of spheroids that is essential for HCA.[214, 260]  
In perspective, one can also envision other advantages of spheroid culture system. 
(i) It enables long-term toxicity testing. Currently, all 2D culture-based toxicity testing is 
short term (less than a few days) due to continuous cell growth. However, longer toxicity 
testing is necessary to understand how toxic molecules affect cellular behavior not 
instantly but gradually, such as chronic exposure to toxic substances. The quiescent 
phenotype observed in spheroid culture is beneficial to treating cells for a longer period 
of time. (ii) It can be used as a model system for understanding tissue-level healing 
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processes after damage by toxic substances. As shown before, the interior spheroid was 
protected by an outer layer of cells, suggesting a capacity in spheroid culture for 
physiological repair, which is closer to real tissue biology. (iii) Applying this system to 
tumor spheroids would be a very appropriate model system for testing the effectiveness 
of newly-engineered NPs which are related to cancer treatments, such as tumor cell 
targeting and delivering therapeutics into solid tumors.  
 
4.4. Summary 
Established standardized liver tissue spheroid culture model was successfully 
applied to the in vitro toxicity testing of NPs. The results showed great differences in 
comparison with common 2D cell culture, while more correlating well with the data from 
animal tests. Two important aspects of the 3D spheroid culture exemplify the differences 
with 2D cultures and the greater resemblance to in vivo tissue-like physiological 
responses; (i) tissue like mass transport due to dense tissue-like cell clusters and ECM 
layer present and (ii) cell phenotype changes due to intensified cell-cell interactions. The 
ICC scaffold-based spheroid culture system clearly indicate the significance of the 3D 
cell culture model to in vitro testing of NPs toxicity and the need of implementing 
standardized 3D in vivo models for NP research. 
In the same way, the ICC scaffold-based spheroid culture system would undertake 
initial toxicity testing of drug candidate compounds as producing more physiologically 
relevant toxicological information. As a result, it can potentially improve the predictive 
power of in vitro screenings which in turn critically contribute to a reduction in animal 




BIOACTIVE ICC SCAFFOLDS FOR CELLULAR CO-CULTURES 
 
5.1. Introduction 
Adequate understanding and proper methods of control of cell signaling are 
important in emulating hematopoietic stem cell (HSC) niches since the rate and direction 
of the differentiation of HSCs are strongly affected by their 3D microenvironment and 
signaling molecules.[261, 262] Recent studies have shown that a 3D culture environment 
significantly promotes the efficiency of stem cell differentiation[263-265]. Intensive cell-
cell and cell-matrix interactions have been distinguished as key factors that determine the 
fate of individual cells by serving as important communication channels. 
As shown in Chapter 2, ICC systems possess high surface area with void fraction 
of 97% (i.e. combining 74% effective cellular porosity and 23% bulk hydrogel porosity) 
and a regularly spaced network of pores which provides a mechanically strong, well-
connected open porous geometry. These features enhance cell seeding efficiency, 
transport of nutrients and metabolites, and the rapid and uniform distribution of soluble 
signaling molecules. In addition the excellent control over porosity combined with a high 
degree of organization of ICC scaffolds enable much better control of cell-cell and cell-
scaffold interactions. Such unique characteristics of ICC scaffolds make them particularly 
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convenient for the use with HSC cultures, which can help uncover methods for 
successful tissue engineering of HSC niches such as bone marrow and thymus.  
Besides these advantages, the high level of organization and geometrical identity 
of different cavities make possible effective computer modeling of scaffold properties 
such as diffusion of nutrients and other signaling molecules, cell-cell and cell-matrix 
interactions, and other processes, which can substantially reduce experimental load. For 
instance, in fabricating effective scaffolds for in vitro tissue engineering applications, 
several design variables such as mechanical strength, diffusion and cell adhesion have to 
be considered. Currently, a significant bottleneck is the lack of adequate oxygen and 
nutrient transport as well as cell migration to the interior of the scaffold.[266] 
The hydrogel matrix rarely supports adherent cells adhesion without surface 
modification, because acrylamid polymer chains do not have cell adhesion receptors, and 
the hydrophilic nature of hydrogel inhibits adsorption of cell binding proteins on the gel 
surface. To render the surface bioactive, a layer-by-layer (LBL) surface modification 
technique was utilized instead of commonly used covalent coupling of specific peptide 
sequences such as RGD or an entire ECM protein to the polymer. It has been reported 
that 2D polyelectrolyte multilayer supported anchorage dependant cell attachment 
without using adhesive proteins. The driving forces of LBL coating are the electrostatic, 
Vander-Waals, and hydrogen bonding interactions between oppositely charged 
polyelectrolytes dispersed in aqueous solution. This unique feature of the LBL technique 
allows a complex porous 3D geometry, such as the intricate and convoluted ICC surface, 
to be coated as long as fluid transport in and out of the sample is not severely constrained. 
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In this chapter, a model system combining two types of cells co-existing in an 
ICC scaffold will be introduced having in mind the recreation of HSC niches in the bone 
marrow and thymus. The selection of particular model cell cultures was also aided by the 
fact that the characteristic geometry of the ICC scaffolds resembles that of bone marrow 
and thymus niches, i.e. stromal cells cover the surface and well intersticed sinus cavities. 
The surface of ICC hydrogel scaffolds was coated with LBL assembly of clay 
nanoplatelets and polydiallyldimethylammonium (PDDA) polymer to support stromal 
cell adhesion. Rotary cell culture vessels were utilized instead of micro-well plates to 
make dynamic culture environment. In addition, open porous ICC scaffolds were used 
rather than pocket ICC scaffolds to more effectively accommodate dynamic flows within 
the ICC geometry.  
Human thymus epithelial cells (Hs202.Th) and human monocytes (HL-60) were 
used as anchorage dependent feeder cells and suspension cells mimicking progenitors, 
respectively. Before using HSCs, I tried to use the HL-60 cells because it is easier to deal 
with and has been provided a unique in vitro model system for studying the cellular and 
molecular events involved in the proliferation and differentiation of normal and leukemic 
cells.[267] Microscopic characterization data clearly demonstrated the co-existence of 
two types of cells in same ICC chambers. Diffusion of nutrient and cell-cell interactions 
within ICC scaffolds were also evidenced by simplified Brownian Dynamics (BD) and 





5.2. Materials and Methods 
5.2.1. ICC scaffold preparation 
CCs were prepared with PS beads (D=100µm) following the protocol in Chapter 
2. Final scaffolds have 6.5mm diameter and 0.5-1mm thickness. All pores are open to the 
outer fluid which facilitates cell motility and media exchange in a dynamic culture 
condition.  
5.2.2. LBL 3D surface modification 
The surface of polyacrylamide hydrogel ICC scaffolds was coated with sequential 
layers of negatively charged 0.5% (w/w) clay platelets (average dimension of 1nm 
thickness and 70-150nm in diameter, Southern Clay Products) dispersion and positively 
charged 0.5% (w/w) PDDA (MW=200,000, Sigma) solution utilizing a LBL surface 
modification technique. ICC hydrogel scaffolds were immersed first in PDDA solution 
for 15 minutes and rinsed in deionized water for 30 minutes. Then the scaffolds were 
immersed in clay solution for 15 minutes and rinsed again with deionized water for 30 
minutes. This LBL coating cycle was repeated 5-10 times. The initial and outermost layer 
was PDDA and clay nanoparticles, respectively. To demonstrate 3D LBL coating on 
hydrogel ICC scaffolds, negatively charged fluorescein isothiocyanate (FITC) conjugated 
albumin (Sigma) was utilized instead of clay nanoparticles. An ICC hydrogel scaffold 
coated with ten bilayers of FITC-albumin and PDDA was imaged under confocal 
microscope (Leica SP2) with 10X objective lenses. Confocal series images taking 160µm 
depth were three dimensionally reconstructed using imaging software. In order to 
visualize polymeric component, fluorescent-PDDA was prepared taking advantage of 
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electrostatic interactions between FITC (negatively charged) and PDDA (positively 
charged). Unbound FITC molecules were separated via dialysis process.  
5.2.3. Cell cultures 
Human thymic epithelial cells Hs202.Th (CRL-7163) and human premyeloblasts 
HL-60 (CCL-240) were purchased from ATCC (Manassas, VA).  Hs202Th cells were 
grown in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% FBS 
(GIBCO, CA).  HL-60 cells were cultured in Iscove’s Modified Dulbecco’s Medium 
(IMDM) containing 20% FBS. The cells were maintained at 37ºC with 5% CO2 and 
media was changed twice a week until they reached a confluent or desired population on 
T-75 culture flasks.  
5.2.4. Dynamic 3D co-culture 
 Co-culture was carried out in a 10ml rotary cell culture vessel (RCCS-4D, 
Synthecon).  Scaffolds were sterilized by soaking in 70% EtOH for one hour followed by 
washing in PBS for 15 minutes twice. 2x105 Hs202.Th cells were placed in a culture 
vessel, which subsequently was filled with medium. The rotation speed was set at 12 rpm 
for the first 12 hours and later it was decreased to 8 rpm, the normal speed.  The medium 
was replaced once every three days. On day 6, the HL-60 cells were stained with 5µM 
chloromethyl derivatives fluorescent dye (CMRA) (Molecular Probes) and the Hs202.Th 
cells growing on the scaffold were stained with carboxyfluorescein diacetate 
succinimidyl ester (CFDA-SE) (Molecular Probes). After that, the culture vessel medium 
was changed to IMDM supplemented with 20% FBS, and 1x106 pre-stained HL-60 cells 
were seeded. Co-culture was maintained for 5 days.  
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5.2.5. Modeling approach 
The basic modeling problem is the escape of a particle trapped in an enclosed 
cavity through an aperture on the surface of the cavity.[268-271] This problem can be 
greatly simplified when the size of the aperture is small enough, because then it can be 
assumed that before being evacuated, the particle samples the cavity thoroughly. Under 
these conditions, the escape of the particle is a rare event that is characterized by a single 
exponential decay.[266, 271] Mathematically, it may be represented as  
S (t) = exp (- 4bDo/V)            (1) 
S(t): survival probability of the particle after a time t has elapsed 
Do: diffusivity of the particle in free solution 
b: radius of the circular aperture 
V: volume of the cavity 
 
For spherical cavities arranged on a simple cubic lattice connected to neighboring 
cavities by pores of radius b, the effective diffusivity is given by Deff /Do=6b/πR where R 
is the radius of the spherical cavity[272, 273]. Generalizing their expression for cubic 
lattices with co-ordination number Z (Z = 6 for a simple cubic lattice), we get  
Deff /Do = (Z/π) (b/R)          (2) 
Eq. (2) implies that escape of a particle from a cavity is proportional to the 
number of openings Z, i.e. the openings operate independently of each other. However, as 
the number of openings per cavity increases, there is significant cross-talk between 
adjacent openings, and the diffusion characteristics may deviate from Eq. (2).[271] This 
fact also underscores the importance of having the ordered scaffold for which the location 
of openings is geometrically defined. In case of random distance between openings as in 
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many chaotically organized scaffolds, the degree of cross-talk between them is uncertain. 
Here cavities formed from spheres close-packed on a face-centered cubic lattice of ICC 
were considered, for which Z=12. BD and MC simulations were used to describe the 
diffusion characteristics of particles in this lattice and compare it with Eq. (2).  
To model the cavities we first laid down spheres of radius Ror in a close packed 
hexagonal lattice so that each sphere had 12 other spheres touching it, which produces 
ICC geometry of the scaffolds. To form the intercavity pore of radius b we ‘‘enlarged’’ 
the original spheres slightly. This expansion caused the spheres to interpenetrate with a 
lens-shaped region of interpenetration. The edge of the lens defined the perimeter of the 
intercavity pore. From Figure 5.1A, it may be seen that R2 = Ror2 + b2, when b/Ror~0.1, 
R/Ror~1.005. The volume of the lens, thus formed, can be derived using straightforward 
geometrical arguments to be 
Vlens = 2πR3 (2/3 + 1/3 (Ror/R)3(Ror/R))     (3) 
The void fraction for a close-packed FCC lattice is π/3√2. After the expansion of 
the spheres the void fraction increases to 
φ = π / 3√2 (9 (R/Ror)2 – 5 (R/Ror)3 -3)      (4) 
Again, for b/Ror~0.1, φ increases slightly from 0.7405 characteristic of close-
packed spheres, to φ = 0.7515. We then uniformly distributed the nutrients in the matrix 
of interconnected cavities. In the simulations, we considered only Brownian and excluded 
volume effects. 
For point particles, we did BD simulations using reflecting boundary conditions 
for collisions with cavity walls. The time-step ∆t was chosen so that the characteristic 
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hopping distance √6D0∆t was 0.05b. We found that decreasing ∆t such that √6D0∆t = 
0.01b did not produce statistically important differences. During the course of the 
simulations we observed a set of trial moves which involved the migration of a nutrient 
from one cavity to another without passing through the interconnecting pore, but instead, 
by jumping over the cavity walls. Such moves obviously violated excluded volume 
conditions and we employed reflecting boundary conditions to rebound the particles back 
into the original cavity. 
For finite-sized particles, we did only dynamic MC simulations, choosing the 
same hopping distance, ∆r=0.05b. Any trial move that violated excluded volume 
constraints with the walls or with any of the other particles was rejected. Also, trial 
moves which involved migration of nutrients from one cavity of ICC to another by 
jumping over cavity walls were also rejected. We found that for point particles, both the 
BD and MC calculations gave essentially indistinguishable results.  
The parameters used in the calculations were normalized as follows: radius of the 
original spheres, Ror=1.0, radius of the pore, b=0.1, and free solvent diffusivity 
D0=0.0001. We used periodic boundary conditions and varied the size of the simulation 
box (for different concentration of nutrients) such that the number of nutrients was 
greater than 1000. We collected position data of all the particles at fixed intervals, and 





5.3. Results and Discussion 
5.3.1. Modeling molecular diffusion and cellular interactions 
Molecular diffusion in 3D ICC geometry 
The solubility of oxygen in water at 25°C is approximately 8mg/l, which 
corresponds to a concentration of approximately 1mM. Assuming the radius of a cavity in 
the ICC lattice to be 100µm, which is a median of cell culture scaffold size used 
previously in the experiments with hepatocytes and bone marrow cells[186, 188, 271], 
the number of oxygen molecules per cavity is of the order of 1012. Simulating such a 
large system is an almost impossible task. However, we find that the radius of an oxygen 
molecule along with its solvation shell is about 0.5nm[274], and that the size of a glucose 
molecule which is another important nutrient, is also about 1nm.[275] Therefore, the size 
of these nutrients is about 10-4 b, where b is the size of the pore connecting two cavities. 
It thus seems reasonable to treat these nutrients at point particles. For the ICC scaffold 
geometries relevant to cell organization and culturing, this mathematical approach will 
most likely hold in all possible cases. This assumption eases the computational problem 
dramatically. Point particles have no dimension and hence do not exert any repulsive 
excluded volume force on each other. Thus, they cannot ‘‘see’’ neighboring molecules 
and the diffusion characteristics are independent of the concentration of the nutrients in 
the medium in which they diffuse. This is brought out in Figure 5.1B which compares the 
ratio of D(t) to D0 of a point particle at different concentrations.  t* = R2/6D0 is the time-
scale at which a particle understands that it is confined in the cavity. As expected, the 
diffusivity falls to its effective long term value around t/t* ~ 1, and is independent of the 
concentration. 
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The average value of the effective diffusivity is Deff=0.3D0. If we use Eq. (2) to 
compute the effective diffusivity, we obtain Deff=0.382D0. As the co-ordination number Z 
increases, the probability that the particle has not completely sampled the cavity before it 
escapes also increases, as mentioned previously. If we define t`= 2R2/Deff [272]to be the 
characteristic time of escape and identify t* with the characteristic time to sample the 
cavity, then a small value of t*/t` signifies that the particle has sampled the cavity well. 
Using Eq. (2), we find that even for Z=12, t*/t`= 0.5Deff/D0= 0.191, which indicates that 
it might still be reasonable to assume that the cavity is well sampled.  
The observed discrepancy between Deff and D*eff could, therefore, be a 
consequence of ‘‘cross-talk’’ between the adjacent apertures. Each pore occupies only a 
small fraction (~0.25(b/R)2 ~0.0025) of the surface of the sphere. However, as elaborated 
in Berg et al. for a somewhat different case, when a number of small apertures are evenly 
distributed on the surface of a sphere their cooperative behavior can be significant. 
Crudely, this may be understood as follows: the presence of an aperture depletes the 
density (or alternatively likelihood of existence) of particles in its neighborhood. This, in 
turn, curtails the rate at which particles flow through adjacent apertures. Thus, eventually, 
the net transport of nutrients is less than what it would have been, if the apertures truly 
operated independently of each other. 
Additionally, Figure 5.1B also depicts the diffusion characteristics of point 
particles at low concentration (C = 1.0 particles/volume), when the size of the aperture is 
halved to b=0.05. It can be seen that Deff decreases, as expected, to an average value of 
0.165D0. If the conditions under which Eqs. (1) and (2) were strictly satisfied then Deff 
would have been proportional to the size of the aperture b. We suspect that the value 
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observed from simulation Deff (b=0.05) = 0.165D0 is greater than what we would expect 
naively, i.e. 0.5Deff (b=0.1) = 0.150D0 because of decreased cross talk between the pores. 
If there was no cross talk between the pores then D*eff (b=0:05) = 0.191D0. 
 
Figure 5.1 Molecular diffusion modeling in ICC geometry (A) The geometrical relation 
between the original radius of close packed spheres, Ror, the radius of the inter-cavity pore, b and 
the radius of the swollen spheres, R is given by R2= Ror2 + b2: The difference between Ror and R 
has been exaggerated for clarity. The volume of the shaded lens shaped region is given by Eq. (3).  
(B) Effect of concentration (thick, dotted and dashed lines) and size of aperture (thin line) on the 
effective diffusivity of point particles diffusing in an ordered matrix of spherical cavities. As the 
size of the aperture is reduced from b=0.1~0.05 (C=10.0), the effective diffusivity, Deff is 
approximately halved from 0.300 to 0.165.  
 
Cellular interactions within ICC geometry 
Floating cells can travel deep into the scaffold through interconnecting channels 
while they are temporarily entrapped in an ICC chamber due to limited channel numbers 
and size. To study the interaction of a floating cell with the scaffold quantitatively, we 
constructed a simplified BD model. The cell was treated as a hard sphere of radius, acell 
that is suspended in an ICC geometry, composed of hollow spherical chambers of 
nominal radius, R, connected by channels of radius, b. To simplify the treatment, we 
assumed that the fluid inside the scaffold was quiescent and that the motion of the cells 
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was purely diffusive. Under the assumptions stated above, the motion of the cell results 
from a balance between the drag force and the random Brownian force,  
ζ dr/dt =FB              (5) 
Where ζ=6πηacell is the hydrodynamic drag exerted by the solvent of viscosity (η) 
on a cell of radius (acell), and r is the position vector of the center of mass of the cell.  The 
Brownian force, FB, satisfies the fluctuation-dissipation theorem[276] which necessitates 
<FB> = 0, and <FBFB> = 2kBTζI.  Here, I is the unit tensor, kB=1.38x10-23 JK-1 is 
Boltzmann's constant, and T is the absolute temperature. 
The diffusivity (D) was obtained from the hydrodynamic drag via the Einstein 
relation[276], D=kBT/ζ.  In accordance with microscopy measurements, we took 
R=50μm, b=12.5μm, and acell=7.5μm. Thus, ζ=6π(1cP)(7.5μm)=1.414x10-4g/s, and D= 
kBT/ζ=2.91*10-2μm2/s.  We used the algorithm outlined in Larson[276] to implement the 
BD simulation, choosing the simulation time step, dt, so that √6Ddt ≈ 0.05acell.  We 
employed reflecting boundary conditions to model collisions between the cell and the 
scaffold. 
Grigoriev et al. considered a dimensionless Brownian particle trapped inside a 
spherical chamber of volume V.[268] They estimated that the time, t*, that it takes for the 
particle to escape from a small circular hole of radius b on the surface of the chamber, is 
given by t*=V/4bD, where D is the diffusivity of the particle. We adapted the expression 
for t* to obtain a crude estimate for the escape time of a Brownian particle of finite size 
from an ICC scaffold as, 
t*ICC = (π/3ZD) (R-acell)3/(b-acell)      (6) 
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where Z=12 is the co-ordination number of the ICC lattice.  From Eg. (6), we obtained 
t*ICC ~ 5.5*105/12 seconds ~ 12 hours. Thus, the ICC geometry provides very suitable 
geometry for cell interactions due to partial entrapment of the cells in the cavity. 
We simulated the dynamics of the cell in the ICC scaffold using BD, and recorded 
its trajectory from t=0 to t=1000 days. Over this period, the cell visited several chambers. 
From the simulation, we observed that by the time the cell vacated a chamber by escaping 
through the interconnecting channel to another chamber, it thoroughly, and uniformly, 
sampled the whole chamber. In other words, the amount of time the cell spent in any 
region of the chamber was proportional to the volume of that region. Figure 5.2A shows a 
cross section of a spherical chamber that has been divided into shells of equal thickness, 
ΔR=acell. These shells do not have the same volume. For illustration, if we approximate 
the volume of a shell by, ΔVshell = 4πRi2 ΔR, where Ri is the inner radius of the shell, we 
can see that the volume of the outer shells is greater than that of the inner shells. As 
mentioned previously, the center of mass of the cell resides in a shell, in proportion to the 
volume of that shell. Thus, it spends a significant fraction of time (about 41%, see Figure 
5.2B) in the outer-most shell, where the distance between the surface of the cell and the 
inner surface of the chamber is less than or equal to the radius of the cell. (Figure 5.2C)  
Thus the ICC geometry fosters contacts between the cell and the matrix surface or 




Figure 5.2 Modeling results of cell entrapment and interaction within ICC geometry. (A) 
Schematics of ICC topology and cell contacts within ICC geometry. Floating HSCs enter into a 
pore through interconnected channels that have diameters 2-3 times larger than that of a single 
cell. Temporarily entrapped HSCs undergo intense contacts with ICC pore surface where stroma 
cells grow. (B-C) Modeling data of radial probability distribution of a finite-sized Brownian 
particle of radius 7.5µm diffusing in a spherical ICC chamber obtained from BD simulations, 
when the chamber is divided into shells of the same (B) thickness, and (C) volume. In (B), the 
dotted arc and the disc represent the inner surface of the chamber, and the cell which is modeled 
as a hard sphere, respectively. The thickness of each shell is equal to the radius of the cell, acell. 
From (C), it can be seen that the cell spends the same amount of time in each of the equi-volume 
shells, whereas in (B), it spends more time in the exterior shells due to their greater volume. 
 
5.3.2. LBL 3D surface modification 
The LBL molecular assembly process is a novel film deposition technique 
utilizing electrostatic interaction between oppositely charged poly electrolytes[88]. The 
process consists of sequential dipping of a substrate into solutions of oppositely charged 
species alternating with water rinsing. In each dipping cycle, a monolayer of the species 
is adsorbed to the substrate while the rinse step removes their excess. The next dipping 
gives rise to enhanced adsorption of oppositely charged species, which is also 
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accompanied by the switch in the surface charge. The film thickness can be adjusted by 
repeating this cycle as many times as one needs, and the composition of films can be 
engineered through the sequential deposition of different materials without the need of 
complex chemistry. Notably, a uniform coating can be achieved in any substrate 
including a complex 3D porous ICC geometry, as long as fluid transport in and out of the 
sample is not severely constrained. This is probably the only technique that can create 
organized layered structures on cell scaffolds with intricate porosity and 3D 
organization[87]. (Figure 5.1B) 
To provide adequate adhesion of stromal cells, the pore surface of ICC hydrogel 
scaffolds was coated with clay/PDDA multilayer following the LBL technology[277]. 
PDDA is a positively charged polymer, while clay is negatively charged nano-platelets. 
(Figure 5.1A) The flat shape of clay NPs effectively covered the hydrogel surface 
combined with PDDA like brick-and-mortar. As a result, a thin layer of nano-composite 
was prepared on the surface of the scaffold. The hybrid organic-inorganic composite is 
mechanically compatible with the hydrogel and does not delaminate. Coated clay NPs 
also created nanoscale roughness, increased charging on the surface, and created much 
stiffer film than hydrogel[277]. Increase of Young modulus was shown to be the primary 
factor determining the adhesion of cells to materials[16, 278]. These synchronous effects 
promoted cell adhesion. Normally five bilayers of clay/PDDA effectively changed the 
surface property from cell repulsive to cell adhesive, and successfully support stromal 
cell adhesion on the hydrogel scaffold. In addition, nano-composites have minimal light 
scattering because the characteristic diameter of the inorganic component is smaller than 
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the wavelength of light, which is quite relevant for optical interrogation of biological 
processes.  
 
Figure 5.3 Schematic of clay/PDDA LBL surface coating of ICC hydrogel scaffold.  (A) 
Schematic of PDDA and Clay nanoparticles. (B) Schematic of LBL surface coating procedure.  
 
At first, the clay/PDDA LBL film formation was characterized on 2D hydrogel 
surface. Compared to glass slides substrate, hydrogel surface retains quite different 
physical and chemical properties such as high porosity, low mechanical strength and 
hydrophilicity, which caused somewhat dissimilar LBL film growth patterns. For 
instance, the LBL components did not cover the entire hydrogel surface during initial few 
dipping cycles rather than partially coat. Normally it took 3-5 cycles to completely cover 
the hydrogel surface as confirmed by gradually disappeared pores. The LBL coating on 
hydrogel surface was also thicker than a glass slide probably due to its porous hydrophilic 
structure. However, weak mechanical strength of the hydrogel made hard characterize the 
growth pattern and thickness of the LBL film. In addition, different cell adhesion and 
growth patterns were observed. For example, cells were fully spread on a glass substrate 
while they were less stretched on a Clay/PDDA coated hydrogel surface. (Figure 5.4E-F)  
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Figure 5.4 Clay/PDDA LBL film formation on 2D hydrogel and cell growth pattern  Gradual 
surface coverage of LBL coating (A) 1 bilayers, (B) 3 bilayers, (C) 5 bilayers, and (D) 25 bilayers 
on a thin 2D hydrogel substrate. Stromal cell adhesion and growth on (E) a glass slide and (F) 2D 
hydrogel surface 5 bilayers of clay/PDDA LBL film layered.  
 
Next, the LBL coating was applied to 3D hydrogel scaffolds. Since both clay and 
PDDA do not have fluorescent, the feasibility of 3D LBL coating was confirmed by 
employing fluorescent technique. For example, negatively charged FITC-conjugated 
albumin properly interacted with positively charged PDDA polymer. As a result, nicely 
formed 3D albumin/PDDA LBL film was observed under confocal microscope. (Figure 
5.5B) In order to directly visualize the clay/PDDA multilayer, FITC was electro-statically 
bound to PDDA before using. Although the clay/PDDA LBL film quality was less 
uniform compared to the film prepared on a glass slide, it was successfully extended to 
the surface coating on ICC hydrogel scaffolds that supported stroma cell adhesion and 




Figure 5.5 Confocal images of LBL film formation and stromal cell adhesion on ICC 
hydrogel scaffolds (A) Ten bilayers of fluorescent labeled PDDA (green) and clay NPs on ICC 
hydrogel scaffold soaked in rhodamin solution (red) (B) 3D reconstructed confocal image of ICC 
hydrogel scaffold after five bilayers of FITC-albumin(green)/PDDA LBL coating. (C) HS-5 bone 
marrow stromal cell adhesion on the scaffold after five bilayers of clay/PDDA LBL coating.  
 
5.3.3. Dynamic 3D co-culture 
Human thymic epithelial cells and human premeylote monocytes were co-
cultured in a rotary cell culture bioreactor. Rotary motion induced convective flow, and 
the scaffold geometry utilized this flow as a continuous driving force for the cell 
movement. After five days of co-culture, the hydrogel ICC scaffolds were imaged 
through a confocal microscope.  Different emission ranges of fluorescent dyes were used 
to stain the thymus cells and monocytes with green and red, respectively. Thymic 
epithelial cells attached to the cavity were observed as green circles, and floating 
monocytes were imaged as red spots. (Figure 5.6) Although many monocytes were 
diffused out of the scaffold during the sample preparation, some of them remained 
entrapped inside the pores. Confocal cross-sectional images reveal that suspended cells 




Figure 5.6 Confocal images of 2D and 3D co-culture models Representative image of co-
culture (A) on a 2D substrate and (B) in an ICC scaffold: thymic epithelial cells (green) and 
monocytes (red). (C) Top area image shows the surface of the scaffold was densely covered with 
thymic epithelial cells. Most of monocytes around the edge of the scaffold were released out. (D) 
A cross-sectional image after cutting the co-cultured ICC scaffold with a razor blade shows 
decreasing thymic epithelial cell density moving into the inside of the ICC scaffold. Monocytes 
were distributed the whole ICC scaffold and similar number of cells were entrapped at each pore. 
 
Co-cultured hydrogel ICC scaffolds were dehydrated and observed under SEM. 
The dehydration process deformed the structure, which is the reason for dimensional 
differences compared to the confocal images. It was found that the scaffold exterior was 
covered densely with thymic epithelial cells, and their population reduced the inward 
movement of other epithelial cells. (Figure 5.7A)  Secondly, epithelial cells migrated 
between pores through interconnected channels, and some colonies expanded over 
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several pores. (Figure 5.7C) Thirdly, a few suspension cells were entrapped inside when 
they were observed at the interior of the scaffold in SEM cross-sectional images. (Figure 
5.7B) It suggests that monocytes travel deep into the ICC scaffolds while temporarily 
entrapped in an ICC pore before moving into neighboring pores due to the finite size and 
number of interconnecting channels. 
 
Figure 5.7 SEM images of 3D co-cultured ICC scaffolds (A) Cross-sectional image of the 





A clay/PDDA LBL thin film successfully formed on an ICC scaffold pore surface 
which in turn significantly improved adhesion and growth of stromal cells. The unique 
geometry of ICC scaffolds accommodated two different types of cells within a same 
chamber. Floating cells mimicking HSCs were undergo extensive cell-cell and cell-
matrix interactions. Such cellular interactions within the ICC scaffold were demonstrated 
in both experimental and modeling works. Confocal images clearly showed that two 
types of cells co-exist in the same pore. Modeling results indicated that entrapped 
suspension cells spent a significant fraction of time in the vicinity of the ICC chamber 
wall or the stromal cell layer on the pore surface.    
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 Well controlled multi-scale structures which can build real-size organ systems and 
generate the essential subcellular morphology, are a key factor for the successful 
investigation of cell-molecular and cell-cell interactions. It is obvious that the full 
function of the tissues and organs cannot be recovered without rebuilding the ultra 
structure of the tissue itself. Proposed ICC scaffolds and surface modification utilizing a 
LBL technique will be excellent approach for this purpose. ICC scaffold structure 
generates super- and cellular- scale microenvironment for intense cell contacts with other 
types of cells or matrix. On this surface, various insoluble signaling molecules such as 
ECM components, membrane bound receptors and ligands can be incorporated through a 
LBL method which can produce subcellular, nanoscale resolution environment for 
cellular receptor-molecular interactions. In particular, this could greatly facilitate the 
study of B and T cell development from the stem cells which requires understanding and 




ENGINEERING PRIMARY LYMPHOID TISSUES 
 
6.1. Introduction 
Development of in vitro human HSC niches that can recapitulate the bone marrow 
and thymus function is imperative for understanding the fundamental biology of human 
hematopoiesis because most information on HSC self-renewal and lineage commitment 
has been based primarily on murine studies. Although rodent studies have provided 
important fundamental insights into hematopoietic development, there is much that can be 
learned regarding human hematopoiesis through the use of in vitro human hematopoietic 
systems that are unavailable in non-human models. For instance, such established 
functional tissue analogues can greatly serve as a valuable tool to identify specific 
signaling factors and their precise roles in hematopoiesis by systematically manipulating 
major experimental parameters. In vitro production of human HSCs and lymphocytes are 
also clinically important for the development of immune therapeutics such as monoclonal 
antibodies and cancer vaccines. Besides that, artificial analogs of primary lymphoid tissues 
can considerably accelerate the testing of a variety of types of drugs. 
However, construction of ex vivo analogs of lymphoid tissues is quite challenging 
since hematopoiesis is a complicated and tightly regulated process involving multiple 
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signaling factors.[279] (Figure 6.1A) Still the precise nature of HSC self-renewal 
and differential niches remains uncertain. Nevertheless, recent research efforts have 
discovered that supporting stromal cells and 3D ECM microenvironments are important in 
directing HSC self-renewal and differentiation. Here, stromal cells play a critical role in 
both presenting membrane bound ligands and secreting soluble signaling proteins[279-
288]. 3D ECM microenvironments coordinate cellular interactions between HSCs and 
stromal cells as well as spatio-temporal delivery of various signaling molecules to the 
cells[279, 287]. (Figure 6.1B) 
Although the native bone marrow environment can be recreated on 2D culture to 
some extent by the addition of proper growth factors and by the presence of co-cultured 
stromal cells, it is inefficient for the purpose of replicating hematopoiesis to produce 
functional leukocytes. Utilizing 3D cell scaffolds that induce more intensive cell-cell 
contacts between HSCs and stromal cells appears promising to provide the appropriate 
developmental niches[289-291].  
Similarly, three-dimensionally organized thymic stromal cells create a distinctive 
intrathymic 3D microarchitecture which coordinates the various signaling milieus.[292-
294] Thymocytes passing through the interstices of the 3D network of thymic stroma 
undergo extensive physical contacts with stromal cells that is the main mechanisms to 
promote T-cell differentiation and maturation. Due to such complexity, until recently the 
only reliable in vitro culture model for the successful T-cell differentiation was the fetal 
thymus organ culture (FTOC) which is composed of a three-dimensionally reaggregated 




Figure 6.1 Schematics of hematopoiesis and hematopoietic stem cell niches. (A) 
Hematopoiesis focused on B-/T-lymphocytes differentiation in primary lymphoid tissues and (B) 
Components consisting HSC niches.  
 
One of the difficulties in the development of a bone marrow and thymic analog is 
the availability of a suitable 3D matrix, which must possess sufficiently large surface area 
for cell attachment, high porosity for cell migration and transport of nutrients, substantial 
transparency for inspection of constructs with optical techniques, and variability in 
scaffold structure to control cell-to-cell contacts. Even though various types of 3D 
matrices have been introduced for this purpose, their approaches remain largely empirical 
rather than systematic due to limited controllability and reproducibility of microscale 
structures. For that reason, there has been little attention to the design of pore geometry 
that can effectively mimic the functional 3D microenvironments.  
In this chapter, ICC hydrogel scaffolds combined with a LBL surface engineering 
technique applied to create artificial human primary lymphoid tissues. ICC scaffold design 
clearly exhibited marked advantage of 3D organization for hematopoiesis and resulted in 
acquisition of structural requirements critical for a successful bone marrow and thymus 
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analog. (Figure 6.2) Regarding bone marrow niche, it was demonstrated that 3D dynamic 
co-culture model is capable of supporting substantial expansion of CD34+ HSCs and B-
lymphocyte differentiation, two main functions of bone marrow.  Production of functional 
B-cells was substantiated by enhanced secretion of immunoglobulin after exposing the 
culture to lipopolysaccharide (LPS). 
 
Figure 6.2 Morphological comparison ICC geometry and supporting bone marrow and 
thymic tissues. (A) ICC geometry, (B) Bone marrow, and (C) Thymic tissues. 
 
In terms of thymic niche, it focuses on notch signaling, an essential cell-cell 
signaling pathway promoting T-cell differentiation[298]. Specifically 3D micro-
architecture and notch ligand effects were combined utilizing LBL surface coating 
technique under the hypothesis that 3D ICC scaffolds coated with DL-1 notch ligand 
would considerably substitute for the structure and function of thymic stromal in addition 
to essential cytokines. The effectiveness of 3D ICC topology and the bioactivity of LBL-





6.2. Materials and Methods 
6.2.1. ICC scaffold preparation 
CCs were prepared with PS beads (D=100µm) following the previous method. 
Final scaffolds have 6.5mm diameter and 0.5-1mm thickness. All pores are open to the 
outer fluid which facilitates cell motility and media exchange in a dynamic culture 
condition.  
6.2.2. Bone marrow niche preparation 
Clay-PDDA multilayer preparation 
The surface of ICC hydrogel scaffolds was coated with Clay and PDDA following 
the LBL surface coating procedure in Chapter 5. The LBL coating was started with a 
PDDA layer and finished with a Clay layer.  
Bone marrow stromal cell culture 
Human bone marrow stromal cells HS-5 (CRL-11882, ATCC) were cultured with  
DMEM with 4mM L-glutamine, 4.5g/l glucose, 1.5g/l sodium bicarbonate, 10%(v/v) FBS, 
and 1%(v/v) penicillin-streptomycin. Human fetal osteoblasts hFOB 1.19 (CRL-11372, 
ATCC) were maintained with 45% Ham’s F12 medium, 45% DMEM, 10% FBS and 1% 
antibiotic. Once cell growth reached approximately 80% confluence, they were detached 
from the culture flask using 0.25%(v/v) Trypsin-EDTA solution and 105 cells were seeded 
on top of UV sterilized scaffolds. In order to characterize stromal cell growth in 3D 
scaffolds, HS-5 cells were stained with 5µM CFSE dye (Invitrogen). The cells growing 
within ICC scaffolds were imaged under a Leica SP2 confocal microscope with 20x 
objective.  
Human CD34+ HSCs isolation 
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Peripheral bloods were obtained from Gulf Coast Blood Bank or from donors (18-
50 years of age) after informed consent under protocols that were reviewed by the 
Institutional Review Board of The University of Texas Medical Branch. Cord blood and 
bone marrow were purchased from Lonza Inc. (Allendale, NJ).  The mononuclear 
leukocyte (MNL) fraction was isolated from these three CD34+ HSC sources using Ficoll 
density gradient separation medium (Amersham-Biosciences, NJ). CD34+ HSCs were 
enriched by counter current centrifugal elutriation of MNLs in a Beckmann J6M elutriator 
(Beckman Instruments, USA) using a Sanderson chamber. A Masterplex peristaltic pump 
(Cole Parmer Instruments) was used to provide the counter current flow. RPMI 1640 
supplemented with 2mM glutamine, 100units penicillin G and 100µg/ml streptomycin and 
10% heat inactivated defined fetal calf serum (Hyclone, Logan, UT) was used as 
elutriation medium.  3~6 x 106 cells were loaded at 3000rpm and HSCs were isolated using 
a step-wise reduction of rotor speed until the appropriate cell diameter population, 6-7 µm, 
of CD34+ enriched cells was collected. 
 Immunophenotypic analysis of elutriation with 5-7 µm diameter HSCs at the time 
of isolation and seeding of the scaffold showed that these cells were lin-1 mature leukocyte 
marker negative, CD34+ cells were further purified by negative selection of any remaining 
lin-1 positive or mature cell types using Dynall magnetic beads or by flow cytometric cell 
sorting using a FACSaria cell sorter.  
Human CD34+ HSCs expansion 
CD34+ cells were labeled with the CFSE dye as previously described[299]. 
Prestained 1-4x104 CD34+ HSCs in 50µl DMEM containing 5% pluronic F-127 were 
seeded in ICC scaffolds. A total of 3~5 scaffolds were placed in a standard 2 or 10ml 
135 
culture vessels mounted on a rotary bioreactor with a rotational speed at 5rpm. In a subset 
of experiment, the scaffolds were seeded with stromal cells from human bone marrow 
aspirates. After 3 days of stromal culture, non-autologous CD34+ HSCs were introduced 
to the culture vessel. HSC/stromal cell co-cultures were also incubated in plastic Petri 
dishes in order to compare 2D versus 3D cell cultures.  
Inducing B-Cell differentiation 
In order to induce B-cell differentiation, CD34+ cells were co-cultured with 
primary cell lines from bone marrow aspirates which included cells positive for 
CD105(100%), CD166(100%), CD44(95%), CD14(1%), CD34(1%) and CD45(<1%). 
Considering these surface markers, they were part of the stromal cell population and at 
least one cell type of them was actually of osteoblasts lineage as it was positive for 
osteonectin. These primary stromal cells formed densely populated layers similar to 
natural bone marrow and replicated the actual bone marrow stroma better than the feeder 
layer made from a single cell type. Growth factors used to promote hematopoiesis 
included interleukin (IL)-2 (5ng/ml), IL-7 (20ng/ml), Flt3 ligand (20ng/ml), stem cell 
factor-1 (SDF-1) (20ng/ml), BMP-4 (4ng/ml) and IL-3 (10ng/ml). Additives used to 
promote development of a B-lymphocyte lineage included soluble CD40L (5ng/ml), IL-4 
(10ng/ml), IL-5 (10ng/ml), IL-6 (10ng/ml), IL-10 (10ng/ml), IL-2 (5ng/ml), IL-7 
(20ng/ml), Flt3 ligand (20ng/ml), stem cell derived factor (20ng/ml), IL-3 (10ng/ml) and 
agonist anti-CD40 mAb (5µg/ml). 
To activate B-lymphocytes and induce plasma cell formation, cultures were 
exposed to 3.5µg/ml LPS. Secreted IgM in supernatant fluids from 2D and 3D cultures was 
quantitated using a human IgM ELISA assay (Diagnostic Automaton Inc.) as described by 
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the manufacturer. All samples were run in triplicate and averaged optical densities (OD) at 
450nm were compared to a standard curve using optical densities obtained for each of the 
standards. 
6.2.3. Thymic niche preparation 
Delta-like-1 notch ligand presenting complex LBL preparation 
First, the surface of hydrogel ICC scaffolds was coated with five bi-layers of clay 
and PDDA following the protocol in Chapter 5. Both starting and finishing layers were 
PDDA. Engineered DL-1 notch ligands consisted of the extracellular domain of Delta 1 
ligand fused to the Fc domain of human IgG was gifted from Prof. Irwin Bernstein‘s lab 
(University of Washington). Monolayer of DL-1 notch ligand coating was prepared on 
top of the Clay-PDDA film by immersing the scaffold in a 10µg/ml of DL-1 notch ligand 
solution for 30 minutes. For imaging purpose, the Fc portion of DL-1 notch ligands was 
bound with secondary antibodies conjugated to FITC before using.  
Cell culture 
Fresh unprocessed 25ml of human bone marrow was purchased from Cambrex. 
Mononuclear cells were isolated by utilizing a density gradient centrifugation in Ficol-
Paque solution (GE Healthcare) at 400xG for 30 minutes.  Mononuclear cells derived 
from human umbilical cord blood cells were gifted from Prof. Larry Lasky’s lab (Ohio 
State University). For CD34+/CD4- HSC culture, CD4+ cells were depleted first from 
the mononuclear cells and then isolated CD34+ cells utilizing magnetic activated cell 
sorting kits (MACS) (Milteney Biotech). Approximately 1~1.5x106 CD34+/CD4- HSCs 
were collected. Isolated mononuclear cells and HSCs were cultured in serum-free 
medium (StemSpan: Stemcell Technologies) supplemented with 20ng/ml of Flt-3 ligand, 
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Stem Cell Factor, and Thrombopoietic (Stemcell Technologies). Five scaffolds were put 
in a 10 ml rotary cell culture vessel and approximately 0.2x106 HSCs were seeded in each 
vessel. The rotary culture was maintained at 15rpm for 4 weeks and culture medium was 
changed in every 3 days. Experiment repeated three times and similar results were 
obtained.  
Characterization 
Cellular morphology and distribution within ICC scaffolds were characterized 
under SEM (FEI Nova NanoLab). HSCs-ICC scaffolds were fixed with 2.5% 
glutaraldehyde solution overnight and dehydrated through a series of ethanol solutions. 
Dehydrated samples were further freeze dried and then coated with gold using a sputter 
coater. Differential stage of HSCs was determined by surface markers analysis. HSCs 
growing ICC scaffolds were fixed with 4% formaldehyde and blocked with 10% normal 
goat serum to prevent non-specific binding of antibodies. Primary antibodies CD34, 
CD117, CD4, CD7, CD8 and TCRα (Santa Cruz biotechnology) diluted in blocking 
solution were applied for one hour. After washing, diluted secondary antibodies 
conjugated to Alexa fluro 488 and 568 dyes (Invitrogen) were introduced for one hour. 
The antibody stained scaffolds were visualized under confocal microscope (Leica SP2) 







6.3. Results and Discussion 
6.3.1. Bone marrow niche for ex vivo HSC expansion 
The two basic functions of the bone marrow are self-renewal of an 
undifferentiated population of HSCs and production of fully functional B-
lymphocytes.[300] Artificial bone marrow construction starts with isolating HSCs. 
However, surface antigens exclusively presented in HSC are not discovered yet, so the 
combination of multiple surface markers such as CD34, CD38, Lin, CD90, and CD117 
have been commonly used to identify and isolated them from mixture of blood cell 
populations.[301] Among them CD34 is the most commonly accepted surface marker in 
enriching HSCs, since the clinical importance of CD34 cells has been extensively 
reported in bone marrow transplantation.[302-304] Obviously a significant portion of 
CD34+ cells includes HSCs having a long term multi-lineage engraftment capability.  
CD34+ HSCs were isolated from human peripheral blood, umbilical cord blood 
or bone marrow. All cells were positive for CD34 and were lineage-1 (lin-1) negative 
when seeded onto the scaffolds. A small portion (1-2%) of CD34-expressing cells was 
positive for CD150, a cell marker also associated with long term multi-cell lineage 
reconstitution in irradiated mice[286]. Analogous cultures were also made on 2D plates 
to establish the importance of the 3D geometry in ICC scaffolds.   
Throughout this study ICC hydrogel scaffolds having 100µm of pore diameter and 
20-30µm of channel sizes were mainly used. These diameters were chosen because they 
provide efficient contacts between adhesion and dispersion cells, and allows for natural 
cell migration through the channels between the cavities, which is imperative for 
replication of hematopoietic tissues. To provide adequate adhesion of bone marrow 
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support cells, hydrogel matrixes were coated by clay/PDDA multilayer following the LBL 
technology in Chapter 5. Once stromal layer formed, CD34+ HSCs were introduced and 
the co-culture maintained in a dynamic culture condition utilizing a rotary cell culture 
system. (Figure 6.3) 
 
Figure 6.3 Schematic of 3D co-culture model for bone marrow niche. (A) Optimized pore 
(D=110µm) and channel (D=20-30µm) size for HSC (D=5~10µm) culture (B) 5 bilayers of 
Clay/PDDA LBL film to support stromal cell adhesion (C) Stromal cells were seeded and 
cultured for three days to allow stromal cell layer formation (D) Introduce CD34+ cells and co-
culture maintains under dynamic condition.  
 
Bone marrow stroma is comprised of a complex reticulum containing 
hematopoietic precursors, as well as non-hematopoietic cells such as fibroblasts, epithelial 
cells, nerve cells, reticular cells, adipocytes and osteoid cells[280-283, 288, 305].  It is 
unknown how many or all of these cell types may be necessary to support the development 
of fully functional leukocytes. To mimic the bone marrow stromal tissue function, human 
bone marrow stromal cells were seeded on scaffolds and cultured for three days which 
allows the formation of a support cell layer on the scaffold surface prior to the addition of 
CD34+ cells. Figure 6.4 shows typical confocal images of stromal and HSC co-cultured 
ICC scaffolds.  
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Figure 6.4 3D co-culture of stromal cell and HSCs. Red is bone marrow stromal cells were 
stained with a red dye and CD34+ HSCs were observed as yellow dots. (A) 2D section and (B) 
3D reconstructed images. 
 
Examination of ICC cultures on day 28 showed the continued presence of CD34+ 
HSCs. There was also formation of numerous actin-rich cell processes, which were absent 
in cell cultures on flat substrates. Similarly, maintenance of a population of CD150+ cells 
was seen in ICC matrices but not in donor matched 2D cultures after 28 days.  Data from 
flow cytometry show that there were significantly higher percentages of CD34+ cells in 
ICC cultures after 28 days, regardless of the original cell source, when compared to 2D 
plate cultures. (Figure 6.5B) This proves that an undifferentiated population of CD34+ 
cells was maintained over time and demonstrates the importance of the chosen 3D ICC 
organization of the cell cultures for replication of reproductive functionality of bone 
marrow. Active proliferation of HSC was also seen from observation of mitotic figures 
and analysis of loss of CFSE fluorescence intensity. (Figure 6.5A) Overall, ICC scaffolds 




Figure 6.5 Characterization ex vivo expansion of HSCs in 2D and 3D co-culture model on 
day 28 (A) Significantly more CD34+ cells were seen in ICC cultures for (BM) (P=0.01), cord 
blood (CB) (P=0.004), or peripheral blood (PB) (P=0.03) than for donor matched 2D plate culture. 
(n=6) (B) Comparison of 2D versus 3D cell cultures in ICC scaffolds by HSC proliferation 
analysis using CFSE loss for CD34+-derived from BM, CB or PB. (n=5)  
 
Although CD34+ cells hold great potential in various biomedical research and 
clinical practice, their practical usage has been significantly limited primarily due to the 
low number. Normally CD34+ cells comprise only 5% of total cell population in the bone 
marrow where is the best-known location for HSCs.[306] For sufficient engraftment and 
good clinical outcome 2-5 million of CD34+ cells should be transplanted.[306] However, 
in many cases, obtaining such a large quantity of CD34+ cells from the donor is difficult. 
For that reason, development of ex vivo system that can effective expand CD34+ cells has 
been desired in order to improve clinical transplantation.  
Besides effective bone marrow transplantation, the development of artificial bone 
marrow analogue that can continuously produce CD34+ cells is also imperative in drug 
discovery applications. For example, currently immune responses of drug molecules in 
the human body, particularly HSC activity in the bone marrow, cannot be estimated 
simply due to the absence of in vitro model system which recapitulates bone marrow 
functionality. Therefore, functional bone marrow analogue can be directly used for 
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screening immune toxicity of drug candidate compounds in a preclinical stage. In 
addition, it can potentially serve as a platform for developing leukemia drug that can 
regulate HSC activity which in turn simulates the production of immune cells.  
 
6.3.2. Bone marrow niche for ex vivo B-cell differentiation 
Bone marrow is also the site of long term antibody production after viral 
infection[305] and bone marrow stroma has been shown to play a role in plasma cell life 
cycle[264]. Similar to the maintenance of HSCs populations, the production of B-cells is 
an essential component for the development of ex vivo bone marrow, immune system 
studies, development of human monoclonal antibodies, drug evaluation, and disease 
treatment. B-cell development involves a series of stages where close 3D contact between 
bone marrow stroma and the developing B-cell is critical and hard to realize in 2D plate 
cultures.  
To assess the ability of the artificial bone marrow constructs to produce functional 
immune cells, B-lymphocyte production was focused since B-cells normally undergo the 
process of differentiation (as well as negative and positive selection) in the bone 
marrow.[282, 283, 307, 308] After three days of culture, ICC/stromal cell constructs 
containing growth factors to drive the B cell production were seeded with CD34+ HSCs. 
Cell cultures were examined for stage-specific markers of development and functionality 
on days 1, 7, 14, 28 and 40. ICC cultures showed nuclear specific expression of 
recombination activating gene 1 protein (RAG-1) by day 7, cell surface IgM by day 14, 
and co-expression of IgM with IgD by day 28 confirming differentiation of CD34+ into 
mature antigen naive B lymphocytes. (Figure 6.6A) In a separate comparative experiment, 
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more of the differentiating cell population were observed to express CD40 (P=0.0002) and 
IgM/IgD co-expression (P=0.021) in donor matched ICC cultures than in 2D cultures. 
(Figure 6.6B)   
These results show the expression of phenotypic cell surface markers of B-cells, 
which is an important step in development bone marrow replicas; however, this fact does 
not necessarily prove the functionality of the ex vivo generated B-lymphocytes. To 
evaluate the ability of these B-lymphocytes to respond to mitogenic or antigenic 
stimulation and fully mature into antibody producing cells, B-lymphocytes isolated from 
28 day ICC scaffold constructs and donor matched plate cultures were exposed to bacterial 
LPS, a major structural component of the outer wall of gram-negative bacteria and initiator 
of immune response to bacterial infection. Secreted IgM was quantified using a human 
IgM ELISA for all B-cell cultures differentiated from CB-derived, PB-derived and BM-
derived CD34+ cells. Significantly higher levels of IgM were produced from B-
lymphocytes generated in the ICC scaffold regardless of the initial source of the CD34+ 




Figure 6.6 Characterization of B-cell differentiation from the 3D co-culture model (A) 
Confocal microscopy images of 7μm sections of hydrogel scaffolds supporting CD34+ HSCs 
from cord blood.  DAPI nuclear stain is blue for all images.  (Top) Nuclear RAG-1 (red) 
expression and surface expression of IgM (green), day 7, 200X.  (Middle) Cell surface co-
expression of CD19 (red) and IgM (green), day 14, 630X.  (Bottom) Co-expression of cell surface 
IgM (green) and IgD (red) day 28, 630X. (B) The average expression of CD40, IgM, IgD and 
IgM + IgD co-expression for plate and ICC cultures using CD34+ from cord blood. (n=6) (C) 
Comparison of IgM production for LPS stimulated plate and ICC cultures from CB, PB or BM 









6.3.3. Stromal cell free 3D culture system 
Recent advances of biomaterial-process engineering enabled the recapitulation of 
the hematopoietic process to some extent on biomaterial-based in vitro culture 
environments.[309] Simple and directed preparation of artificial microenvironments was 
exceptionally beneficial to improve experimental controllability and reproducibility. It 
also allowed the systematic manipulation of experimental parameters which in turn 
deepen the fundamental understanding of thymic signaling effects. For instance, 3D co-
culture models of thymus established on 3D scaffolds significantly promoted T-cell 
differentiation of HSCs compared to the conventional monolayer cultures.[289, 310] In 
addition, these studies highlighted the importance of the proper design of a 3D scaffold to 
obtain the optimum range of pore size and density so as to maximize ex vivo HSC 
development. Nevertheless, 3D co-culture models retain several critical drawbacks: (i) 
difficulty in control the growth of stromal cells in 3D substrates; (ii) required an extra 
step to isolate a pure population of HSCs when the culture needs to be characterized; (iii) 
potential phenotypic change of feeder cells due to enhanced cell-cell and cell-matrix 
interactions in 3D culture condition.  
A different promising approach was stromal cell-free T-cell differentiation which 
presents multiple advantages such as better control over cell interactions and signaling, 
and efficient isolation and characterization of HCSs. Currently the most successful 
system is utilizing engineered delta-like 1 (DL-1) notch ligands in addition to essential 
cytokines.[311-313] Notch signaling is a major cell-cell signaling pathway determining 
HSC fate in the bone marrow and thymus.[298] The signaling is activated when a notch 
receptor on HSCs directly contacts the Delta and Jagged families of notch ligand present 
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on the stromal cell membrane. (Figure 6.7A) The expression of ligands and receptors is 
tightly regulated to balance between self-renewal and differentiation of HSCs in the bone 
marrow, and to promote T-cell lineage commitment and maturation in the thymus.[314, 
315] The importance of notch signaling in T-cell development was demonstrated with 2D 
ex vivo co-culture model of HSCs and OP9-DL1 stromal cells expressing the DL-1 notch 
ligand.[316] For example, the OP9-DL1 cells successfully supported T-cell 
differentiation of HSCs, whereas regular OP9 cells only induced B-cell differentiation. 
[317, 318] Although these in vitro culture models greatly contributed to the understanding 
of HSC biology, their purely biological nature presents inherent limitations including 
technically burdensome preparation, low yields, and highly variable outcomes.  
Recently DL-1 notch ligands were successfully synthesized from genetically 
engineered microbes which made possible thymic stromal cell free T-cell development. 
For instance, individual DL-1 notch ligands immobilized either by physical absorption on 
the bottom of a well-plate[311, 312, 319] or by chemical conjugation to micro-
carriers[313] successfully supported T-cell development. Moreover, the readily 
adjustable ligand density of this technique distinguished the different effect of notch 
signaling intensity to determine the fate of HSC differentiation.[312, 320, 321] Notch 
ligand presenting acellular microenvironments are attractive approach to create in vitro 
HSC niches in a convenient and consistent manner; however, it has remained in only 2D 
substrates, probably due to the absence of suitable 3D substrates and coating techniques.  
In this section, DL-1 notch ligand effects were extended to the ICC scaffold 
utilizing a LBL surface engineering technique under the hypothesis that 3D scaffolds 
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coated with DL-1 notch ligand would considerably substitute for the structure and 
function of thymic stroma in addition to essential cytokines. (Figure 6.7B)  
 
Figure 6.7 Schematic of stromal cell free approach (A) In the thymus, three-dimensionally 
organized thymic stromal cells present membrane bound notch ligands and secrete soluble 
cytokines for the T-cell differentiation of HSCs. (B) ICC topology provides 3D intrathymic 
microstructure and the multi-component LBL film (i.e. monolayer of DL-1 notch ligands on top 
of five bilayers of clay/PDDA film) substitutes thymic stromal cell functions in addition to 
soluble cytokines. 
 
The same pore and channel dimensions of ICC scaffolds were utilized in this 
study. The surface of hydrogel scaffolds was coated with five bilayers of Clay/PDDA 
following the previous method. Then, a monolayer of DL-1 notch ligand was prepared on 
top of clay/PDDA film instead of seeding stromal cells. The pre-deposited clay/PDDA 
multilayer provided better environment for the following DL-1 notch ligand 
immobilization as increasing surface charges of the hydrogel surface. Finally CD34+ 
cells were introduced and then the culture was maintained in a rotary cell culture vessel 




Figure 6.8 Schematic of stromal cell free 3D culture model for thymic niche (A) Optimized 
pore (D=110µm) and channel (D=20-30µm) size for HSC (D=5~10µm) culture (B) Five bilayers 
of Clay/PDDA LBL film to support stromal cell adhesion (C) Monolayer of DL-1 notch ligand 
coating on top of clay/PDDA layer (D) Introduce CD34+ cells and the culture maintains under 
dynamic condition.  
 
The LBL process created a homogenous 3D artificial thymic layer in a short time 
compared to the previous 3D co-culture model which normally took several days to reach 
a confluence on 3D ICC scaffolds. To characterize the quality of 3D LBL coating, the Fc 
portion of the ligand was tagged with a secondary antibody conjugated to a fluorescent 
dye before coating and visualized under confocal microscope. As shown in Figure 6.9B, 
DL-1 notch ligands were well coated on the surface of ICC scaffold but slightly weaker 
fluorescent intensity was observed inner side pores which would be caused by the 
relatively less diffusive environment of interior pores.  
 
Figure 6.9 Structure of DL-1 notch ligand and LBL immobilization (A) Schematic of 
engineered DL-1 notch ligand structure. (B) Confocal images of DL-1 notch ligand coated ICC 
hydrogel scaffold. For imaging purpose, DL-1 notch ligands were bound to antibodies conjugated 
to FITC.  
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The LBL adsorption technique affords the scaffolds to retain high stability and 
activity of the notch ligands since the LBL coating is conducted in a mild condition while 
maintaining pristine protein structures.[322-324] Moreover, the clay/PDDA multilayer 
promotes immobilized DL-1 notch ligands function in two ways. First, the alternative 
layer of the inorganic (Clay) and organic (PDDA) composite is mechanically compatible 
with polyacrylamide hydrogel which supports steadfast immobilization of DL-1 notch 
ligands. This is an important feature for receptor-ligand based cell signaling because 
ligands existing in a soluble state, although they can bind to receptors and activate signal 
transduction, normally undergo rapid internalization into a cell, which in turn 
considerably reduces the intensity and duration of cell signaling.[325] Other investigators 
demonstrated that the surface-tethered epidermal growth factor (EGF) more effectively 
promoted cell spreading and survival than a saturating concentration of soluble EGF due 
to the longer duration of intense ligand-receptor interactions.[326] Similarly it has been 
shown that DL-1 notch ligands are required to be immobilized to activate the proper level 
of notch signaling.[312, 327]  
Second, LBL-immobilized ligands can have a moderate level of flexibility 
because, although individual clay platelets provide local mechanical strength, the overall 
LBL film provides softness and elasticity found in ECM due to the hydrated polymeric 
component. It was shown that mechanical properties of a clay/PDDA LBL film are 
strongly decreased in humid environment.[277] The flexibility of immobilized ligands is 
essential for the proper development of the ligand docking with the receptor for 
intracellular signal activation.[328] Hence, the behavior of LBL-coated DL-1 ligands 
would be quite different when compared to ligands directly adsorbed on a solid surface. 
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Considering that cellular ligands are actually embedded in a flexible plasma membrane, it 
is a more realistic and effective approach.  
 
6.3.4. Thymic niche for ex vivo T-cell differentiation 
First, the ICC topological effect was tested by culturing mononuclear cells 
derived from bone marrow or umbilical cord blood. As shown in Figure 6.10A, a 
significant number of cells were observed deep inside of ICC scaffold after 15 days of 
culture. This demonstrates that the mononuclear cells were deeply transported into the 
ICC scaffold and the LBL surface modification promoted cell adhesion. Since HSCs are 
only a small fraction of mononuclear cells (1-2%), most of cells were non-HSCs. 
However, interestingly I could observe the development of pre-erythrocytes attaching on 
the pore surface which might be the result of activated notch signaling.[319] In addition, 
dendritic-like cells scavenging across ICC pores were observed that vividly captured an 
in vivo 3D bone marrow microenvironment. (Figure 6.B)  
As a next step CD34+/CD4- HSCs were isolated from mononuclear cells and 
cultured in the same condition. It is important utilizing CD34+ HSCs to mimic the thymic 
niches because an initial stage of cellular population entering into the thymus is mostly 
bone marrow derived HSCs. Moreover, it is necessary to deprive CD4+ cells from the 
initial cell population to confirm the bioactivity of LBL coated DL-1 notch ligands since 
notch-1 signaling induces CD4+ T-cell lineage commitment at the late stage of 
differentiation.[298, 329] In addition, MACS method usually cannot isolate target cells 
with 100% efficiency. Therefore, CD4+ cells were depleted from mononuclear cells and 
then CD34+ cells were enriched from there. (Figure 6.11A)  
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Figure 6.10 Initial cell populations and 15 days culture scaffolds (A) Confocal images after 
CD4 depletion and CD34 enrichment utilizing a magnetic activated cell sorting method. The 
initial cell population consists of majority CD34+ and negligible CD4+ cells. (Scale bar is 40µm) 
(B) Typical transmission image of a CD34+/CD4- HSC growing ICC scaffolds after 15 days of 
culture.  
 
A small diameter of HSCs (< 10µm) readily moved deep into ICC scaffolds and 
intimately associated with the surface of DL-1 notch ligand coated ICC pores. After 14 
days of culture, the pore surface was densely covered with cells. (Figure 6.10C) This 
result inferred that HSCs proliferated multiple times subsequent to entering into the ICC 
scaffolds. Notch signaling would be activated on the surface associated HSCs which in 
turn stimulated T-cell lineage commitment and differentiation. However, it was hard to 
distinguish differentiated T-lymphocytes from HSCs under SEM due to their similarity in 
morphology, size and shape. (Figure 6.10D) In the absence of DL-1 notch ligand coating, 
mononuclear cells readily adhered to the surface of ICC scaffolds which was comparable 
to the notch ligand coated scaffolds. (Figure 6.10E) However, without clay/PDDA LBL 
surface coating, hydrogel ICC scaffolds could not support cell adhesion and most of 
pores appeared empty. (Figure 6.10F) Although a few numbers of cells were entrapped in 
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the pores during dynamic cell culture, most of them were released out during the sample 
preparation procedure due to the well-interconnected open porous ICC geometry. 
 
Figure 6.11 SEM images after 15 days of stromal cell free culture. (A-B) Mononuclear cells. 
(A) Various cell types co-existed deep inside of ICC pores. (B) Development of pre-erythrocyte 
associating with the LBL coated surface and migrating dendritic-like cells across pores. It well 
recapitulated the bone marrow microenvironment. (C-D) Isolated CD34+ cells from bone marrow 
derived mononuclear cells. (C) DL-1 notch ligand immobilized pore surface was densely covered 
with cells. Restricted cellular population mimicked the thymic microenvironment. (D) Due to 
similar morphology and size, it is hard to distinguish developing T-lymphocytes from CD34+ 
HSCs under SEM. (E-F) Control experiments of 15 days cultured CD34+ cells. (E) ICC scaffolds 
could support cell adhesion without DL-1 notch ligand coating. (F) However, without clay/PDDA 
LBL coating (bare hydrogel), ICC scaffolds could not allow any cell adhesion.  
 
In order to confirm T-cell differentiation of HSCs, the progression of differential 
stage specific surface marker expression was characterized for 4 weeks under confocal 
microscope. Besides the CD34 molecule, CD117 so called a C-kit receptor is another 
representative surface marker of primitive HSCs that also maintains the earliest 
thymocyte progenitors.[26] Examination of ICC cultures on day 15 and 22 showed the 
continued presence of CD117 which proved that the ex vivo 3D culture system 
successfully supported self-renewal or maintaining undifferentiated population of HSCs. 
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(Figure 6.12A) In addition, the presence of T-cell receptor (TCR) α and CD3 molecules 
were observed on day 22 culture. (Figure 6.12B) TCR is a complex of integral membrane 
proteins consisting of α/β heterodimers associated with CD3 molecules. Pre-TCR 
expression is one of initial signs in T-cell lineage commitment and development in the 
Thymus.[296] Therefore, these data substantiate the preserved bioactivity of LBL-coated 
notch ligands so as to promote pre-T-cell differentiation of HSCs.  
 
Figure 6.12 Biological effects of LBL immobilized DL-1 notch ligands Representative 
confocal images of (A) CD117 and CD3 after 15 days of culture, and (B) CD117 and TCR α after 
22 days of culture.  (Scale bar is 40µm) 
 
The expression of CD4 and CD8 molecules over the longer period of ICC cultures 
were further characterized to identify followed double positive and single positive 
differentiation stages. On 28 days of culture we could observe some CD4 positive but 
CD8 negative cells. (Figure 6.13A) However, they would not be functional CD4 helper 
T-cells because in our system the major histocompatibility complex (MHC) molecules; 
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important factors involved in cell screening processes, i.e. positive and negative selection, 
were missing. Generally more than 95% of thymocytes undergo apoptosis during the 
screening processes[26], but we did not observe severe cell apoptosis during the culture. 
Without DL-1 notch ligand coating, we could not observe either CD4 or CD8 molecules 
on 28 days of culture. (Figure 6.13B) However, the culture continuously expressed a 
CD34 surface marker for 14 days which infers that 3D dynamic cell culture stimulates ex 
vivo HSC expansion without notch signaling. Another important thing was that ECM-like 
molecules progressively developed on the surface of cell/scaffold over the culture period 
which reduced the quality of surface marker analysis. For that reason, 28 days cultured 
samples showed relatively weaker fluorescent signals than the samples cultured shorter 
period of time.  
Although the 3D culture model demonstrated promising features to create in vitro 
HSC niches, it was difficult to rapidly isolate large enough number of cells from ICC 
culture due to strong cellular association with the LBL coated surface and the complex 
ICC geometry limiting the release of cells. Flow cytometric analysis of individual cells is 
critical to quantitatively corroborate the study of cell differentiation pathways 
accompanied with qualitative confocal surface marker characterization. To overcome 
these drawbacks, the development of effective cell harvesting methods needs to be 




Figure 6.13 CD4 T-cell differentiation after 28 days of culture. (A) DL-1 notch ligands coated 
ICC scaffolds induced CD8-/CD4+ T-cell development. (B) Neither CD4 nor CD8 molecule was 
detected on the ICC scaffold in the absence of DL-1 notch ligand coating. (Scale bar is 80µm) 
 
Potentially the LBL coating system can also be applied to recapitulate the other 
function of stromal cells, releasing soluble growth factors. Since multiple functional 
components can be sequentially incorporated into a growing film, a compartmentalized 
LBL film consisted of soluble signaling molecule embedded bottom layers and ligands 
presenting top layers can be prepared on the surface of 3D scaffolds. Diffusion of soluble 
factors can be regulated by hydrolytically degradable polymer components.[89] In 
addition, recently discovered an exponential LBL system can be used for loading and 
unloading soluble signaling molecules.[330, 331]  As a result, such multicompoent and 
functional LBL film on 3D scaffolds can deliver both insoluble and soluble signaling 
molecules to the cells, which in turn significantly improve the creation of artificial 3D 
HSC niches in a simple and effective way. 
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6.4. Summary 
ICC hydrogel scaffolds combined with a LBL surface modification technique 
enabled to create functional HSC niches for bone marrow and thymic tissues. The 
described bone marrow construct replicates two of the key reproductive functions of 
normal bone marrow. Notch ligand immobilized ICC scaffolds also successfully 
promotes T-cell development of HSCs in the absence of stromal cells. These data 
demonstrate that proper organization of cells provided by the ICC scaffold has 
tremendous importance in ex vivo replication of HSC niches. As a valuable tool, the 
LBL-ICC scaffold system can significantly contribute to the realization of artificial bone 
marrow and thymus construction one step closer. It can potentially allow not only ex vivo 
production of clinically important stem/immune cells but also preclinical immunotoxicity 




SUGGESTED FUTURE DIRECTIONS & CONCLUSION 
 
7.1. Suggested future directions 
7.1.1. Direction for ICC scaffold fabrication 
In this dissertation work, all PS and glass microparticles were purchased from 
commercial vendors. Although highly ordered uniform size spherical pore arrays is the 
distinguished feature of ICC scaffolds, the high cost of uniform size beads has been the 
major bottleneck to realize the mass production of the scaffolds. This issue should be 
overcome. The solution can be found in emulsion polymerization that has been 
extensively utilized for the preparation of mono-dispersed polymeric particles utilizing 
simple micro-fluidic devices.  
Recently glass capillary based micro-fluidic device design was introduced which 
made possible simple preparation of uniform size polymeric microparticles[332]. The 
most representative system is PCL and PLGA microparticle synthesis utilizing two 
syringe pumps[333]. As shown in Figure 7.1, the device set-up is very simple and 
preliminary result was quite promising. However, significant amount of work should be 




Figure 7.1 PCL microparticle syntheses via emulsion polymerization (A) Schematic of PCL 
microparticle synthesis via micro-emulsion technique, (B) Solidified PCL microparticles.  
 
7.1.2. Direction for spheroid engineering 
The engineering liver tissue spheroid culture system can be applied to other types 
of cells including primary cells, stem cells and tumor cells. For example, aggregates of 
embryonic and neural stem cells can form embryonic bodies and neurospheres, 
respectively[334]. It has been known that the stem cell spheroid size is closely related to 
the degree of differentiation. ICC scaffolds would be a valuable tool for the systematic 
investigation of such relationship.  
Another interesting direction will be employing biodegradable microparticles 
including signaling molecules during the stem cell spheroid formation. Microparticles 
having a similar dimension to cells could be incorporated as a part of cell aggregate and 
then slowly release signaling proteins corresponding to their degradation within the 
spheroid. As a result, it can generate more homogenous signaling molecules profile 
across the spheroid which in turn improves unidirectional stem cell differentiation than 
normal culture condition, typically having a diffusion gradient of signaling molecules. In 
addition, these microparticles can be used for sensing local chemical and physical 
environments in spheroids.   
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Besides stem cells, tumor spheroids culture model will be another important 
research topic. Although HepG2 spheroids exhibited liver tissue-like functions to some 
extent, overall their morphology and functions are closer to tumors because they were 
originally derived from tumors. Indeed the reduced metabolic activity of HepG2 
spheroids in Chapter 3 can be regarded as dormant stage tumor nodules. They can be 
used as a tumor dormant model for better understanding tumor cells metastasis and 
repopulation. In addition, the spheroid size controllable feature can be applied to develop 
a tumor hypoxia model as increasing their size larger than the diffusion limit of oxygen 
(300 µm>). It can also serve as an early stage tumor nodule model for diagnostic and 
treatment purposes. Currently small size tumors are difficult to detect while hypoxic 
environment reduce the effectiveness radiation therapy. Well controlled in vitro tumor 
spheroid model can significantly contribute to overcome these issues.  
Lastly tumor spheroids and immune cells co-culture model also will be an 
interesting research area. A tumor spheroid entrapped in an ICC pore takes up only 50 % 
of pore volume, whereas the remaining 50 % of pore volume can be used as a pathway 
for circulating immune cells (i.e. T-/B-lymphocytes, dendritic cells and macrophages) 
within the scaffold. As a result, immune cells can effectively scavenge and contact with 
tumor spheroids. Such a unique immunological microenvironment can be used for 
answering various questions such as suppressed immune response by cancer cells, 
anticancer mechanism by activated immune cells, etc. Particularly these data will 
significantly contribute to the cancer vaccine research. (Figure 7.2) 
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Figure 7.2 In vitro tumor spheroid culture models (A) (Left) Tumor spheroids µ-CT imaging 
after OsO4 (osmium) staining. Densely packed tumor cell aggregates appear brighter than 
background hydrogel matrix. (Right) An enhanced contrast image clearly shows spheroids. (B) 
Schematic of tumor spheroids and immune cells co-culture model. 
 
7.1.3. Direction for immune system engineering 
Although primary lymphoid tissue models were successfully accomplished, 
significant research efforts should be followed to realize their practical application in the 
drug testing application. The two most critical issues are (i) how to realize similar 
dynamic fluids in a micro-well plate to a rotary cell culture system and (ii) how to 
effectively extract target cells from ICC scaffolds. Potential solutions can be found in 
engineering functional ICC scaffolds and culture devices. For example, ICC scaffolds 
including magnetic components such as magnetic NPs, magnetic micro-beads or 
magnetically susceptible stainless steels can deliver motility of the scaffolds under the 
magnetic fields. It can generate a continuous dynamic media flow within the ICC 
scaffolds. For this purpose, specific design of magnetic device should be made 
simultaneously to apply periodic and homogeneous magnetic fields in each well.  
The development of effective cell harvesting system is equally important because 
here the final products are individual HSCs or immune cells rather than a bulk functional 
tissue. ICC geometry is exceptionally beneficial for HSC culture: however, their intricate 
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pore structure limits efficient harvesting target cells from the scaffold. For this purpose, 
the development of smart hydrogels that can rapidly dissolve or swell under 
physiologically tolerable chemical or physical environmental changes would be 
promising approach.  
The dissertation primarily focuses on primary lymphoid tissues, i.e. bone marrow 
and thymus, but the same system can be also applied to create secondary and tertiary 
lymphoid tissues. Secondary lymphoid tissues including spleen, lymph nodes and 
mucosal lymphoid tissues are essential for initiating adaptive immune responses[335-
337]. Tertiary lymphoid tissues located at sites of chronic inflammation have 
considerable morphological and functional similarity to secondary lymphoid tissues. Both 
tissues provide proper 3D microenvironments for the appropriate interactions between 
antigens, antigen presenting cells and lymphocytes which is the key process immune cell 
activation. The unique feature of ICC geometry for inducing intimate cell-cell contacts 
between floating and adherent cells can significantly contribute to the secondary and 
tertiary lymphoid tissue engineering. (Figure 7.3) 
Lastly all research efforts have been focused on creating in vitro function 
lymphoid tissues. However, faithfully established tissue models can be used for 
investigating the mechanisms of how tissues lose their function. Such ex vivo human 
lymphoid tissue models would greatly accelerate understanding and curing diseases 
related to the human immune system.  
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Figure 7.3 Schematic of secondary and tertiary lymphoid tissue engineering (A) LBL 
immobilized antigens on ICC pore surface to activate immune cells (B) Co-culture of antigen 
presenting cells and naïve T-/B-lymphocytes 
 
7.2. Concluding remarks 
My doctoral work mainly focuses on two directions: (i) developing robust 
techniques for the ICC scaffold fabrication and (ii) demonstrating exclusively 
distinguished biological significance of the ICC scaffold. The most important 
achievement in the first part was the improvement of the method for obtaining highly 
ordered CCs in microscale that enabled ICC scaffolds research more conveniently and 
effectively. In the second part, I evaluate that my most significant devotion was 
developing a new opportunity of ICC scaffolds as a distinctive platform for spheroid 
culture. This work was successfully expanded to the standardized liver tissue spheroid 
culture model and further utilized as an in vitro toxicity testing platform.  
I would like to make four important aspects of this dissertation. First, the thesis is 
looking for a new opportunity of tissue engineering escaping from the classical tissue 
engineering theme. Tissue engineering for in vitro applications is a quite new idea and it 
is becoming more concrete and feasible accompanied with recent advances in stem cell 
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research, biotechnologies and scaffold fabrication techniques. My work demonstrated 
promising potential of this research direction and discussed many critical considerations 
particularly for the scaffold design.  
Second, the primary lymphoid tissue engineering is relatively new. Typical tissue 
engineering models include skin, bone, cartilage, liver, heart, muscle, blood vessels, and 
so on. Here we aimed to recreate more complex and functional 3D HSC niches for bone 
marrow and thymus. Although significant research efforts should be followed, our results 
clearly demonstrated the pivotal role of scaffold-engineering techniques in functional 
reconstitution of stem cell niches. I expect these work would bring broad and significant 
attention from the stem cell research society. 
Third, it adequately balances the modeling and experimental works. Highly 
regulated ICC structures made possible computer modeling approach, which delivered 
guidelines for the scaffold design and proved biological significance of the scaffold 
combined with experimental data.  
Lastly, I would like to stress that this dissertation research not only remains in 
publications but also significantly contributes to commercialization of the ICC scaffold 
that I believe one of major missions of biomedical engineers. My doctoral work provided 
backbone techniques for launching a company specialized in ICC scaffold manufacturing 
i.e. 3D Biomatrix (www.3d-biomatrix.com). I hope the ICC scaffold can significantly 
contribute to the improvement of human health. 
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